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Abstract
It is now clear that RNA is more than a messenger and performs vast and diverse functions.
These functional RNAs include the ribosomal, transfer, and splicing-associated RNAs along with
a cast of tiny RNAs, including microRNAs and other families. In addition to these classic
examples, there were a handful of known functional large ncRNAs that play important biological
roles.
To identify additional functional large ncRNAs we exploited a chromatin signature of actively
transcribed genes to define discrete transcriptional units that do not overlap any known protein-
coding genes. Using this approach we identified -3,500 transcriptional units in the human and
mouse genomes that produce multi-exonic RNAs that lack any coding potential. We termed
these large intergenic non-coding RNAs (lincRNAs). Importantly, these lincRNAs exhibit strong
purifying selection across various mammalian genomes.
To determine whether the lincRNA transcripts themselves have biological functions, we
undertook systematic loss-of-function experiments on most lincRNAs defined in mouse
embryonic stem cells (ESCs). We showed that knockdown of the vast majority of ESC-expressed
lincRNAs has a strong effect on gene expression patterns in ESCs, of comparable magnitude to
that seen for the well-known ESC regulatory proteins. We identify dozens of lincRNAs that upon
loss-of-function cause an exit from the pluripotent state and dozens of additional lincRNAs that,
while not essential for the maintenance of pluripotency, act to repress lineage-specific gene
expression programs in ESCs.
Despite their important functional roles, how lincRNAs exert their influence was unknown. We
showed that many lincRNAs physically interact with the Polycomb Repressive Complex. We
systematically analyzed chromatin-modifying proteins that have been shown to play critical roles
in ESCs and identified 11 additional chromatin complexes that physically interact with the ESC
lincRNAs. Altogether, we found that -30% of the ESC lincRNAs are associated with multiple
chromatin complexes. These interactions are important for proper regulation of gene expression
programs in ES cells.
Our data suggests a model whereby a distinct set of lincRNAs is transcribed in a cell type and
interacts with ubiquitous regulatory protein complexes to give rise to cell-type-specific RNA-
protein complexes that coordinate cell-type specific gene expression programs.
Thesis Supervisor: Eric S. Lander
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More than half a century after being placed as the intermediate in the central dogma it is
now clear that RNA is more than a mere messenger and can perform diverse functional roles.
Shortly after the discovery of messenger RNA (mRNA), a large class of heteronuclear RNAs
(hnRNA)1 was described much of which did not consist of mRNA nor were they associated with
2polyribosomes . After years of sifting through these hnRNAs, the first RNA subfamilies emerged
including the small nuclear RNAs involved in splicing3 , small nucleolar RNAs involved in
ribosome biogenesis4 , and the 7SL RNA of the signal recognition particle involved in protein
5~6-8transports adding to the ribosomal RNAs and transfer RNAs involved in translation -. More
than a decade later, genetic studies identified a few tiny RNAs that act to silence mRNAs 9 -11
12-14 15-18leading to the discovery of a class of microRNAs2- and other small RNA regulators
The world of RNA genes became even more complex with the discovery of RNAs that
resembled mRNA in length and splicing structure yet did not code for proteins. The first
example, termed H19, was identified as an RNA induced during liver development in the
19
mouse . The mouse H19 transcript contained no large open reading frames (ORFs), but only
small sporadic ORFs that were not evolutionarily conserved, could not template translation in
vivo, and did not produce an identifiable protein product20. Shortly after, another ncRNA,
termed XIST, was found to be expressed exclusively from the inactive X chromosome21 and later
shown to be required for X inactivation in mammals . Over the next two decades a few
additional large ncRNA genes were discovered including Air 23, Tug 24, NRON 25, and
26HOTAIR
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Following the sequencing of the human genome, the next major hurdle was to define the
genes it encoded. Studies probing global transcriptional activity yielded a surprising result: the
mammalian genome is pervasively transcribed with nearly the entire genome being transcribed
into RNA under some circumstance 27-30 . As the numbers of non-coding transcripts increased, so
too did concerns that many of the transcripts were simply 'transcriptional noise' without a
31,32biological function . The reasons for concern included the observation that many of the
transcripts are expressed at extremely low levels and exhibit no evolutionary conservation. It was
unclear whether the few functional examples represented quirky exceptions, or exemplified a
major class of functional large ncRNAs. Distinguishing between these possibilities required
additional biological information.
In this thesis, I present our contributions to the identification and functional
characterization of a class of functional large intergenic non-coding RNA (lincRNA) genes in the
mammalian genome. First, I describe the identification of thousands of well conserved lincRNAs
in the human and mouse genomes by exploiting a chromatin signature of actively transcribed
genes. Second, I describe the development of a statistical method for de novo reconstruction of a
mammalian transcriptome from RNA-Seq data and its application to define the transcript
structures of lincRNAs. Third, I describe systematic loss-of-function studies, which
demonstrated that lincRNAs play a clear functional role in the cell and that many lincRNAs play
an essential role in maintaining the pluripotent cell and repressing differentiation programs.
Finally, I describe our work demonstrating that many lincRNAs act through their physical
interaction with multiple chromatin protein complexes to regulate gene expression programs.
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To provide context, I begin by briefly reviewing the key classes of regulatory RNAs that
have emerged in the past 50 years. Next, I describe the identification of the first large ncRNAs
and describe the few well characterized examples. I highlight the key regulatory principles and
themes learned from these examples and explore parallel studies linking chromatin regulation
and RNA. Finally, I review genome-wide efforts to annotate the mammalian transcriptome and
describe the plethora of transcripts both small and large that have been identified from these
efforts. I summarize the specific contributions of this thesis toward identifying and functionally





Figure 1: A timeline of major discoveries in RNA biology.
Credit: Sigrid Knemeyer, Mitchell Guttman, and John Rinn
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RNA from messenger to regulator
Little more than a half a century ago, the importance of RNA was easily missed33 . It was
clear for several decades that proteins were functional actors3 4 and it had recently been
discovered that DNA was the genetic material35,36. Understanding how DNA encoded the genetic
material and how this information was translated into protein products was a critical challenge.
Pioneering genetic studies by Jacob and Monod suggested the importance of a "messenger" in
bridging the genetic (DNA) to the functional (protein)37 . Shortly after this suggestion, the elusive
messenger was identified as an unstable RNA species that was quickly turned over in cells38. The
identification of this messenger RNA (mRNA) led to the notion of a central dogma in the flow of
39genetic information; DNA gives rise to RNA which gives rise to protein
With the discovery of mRNA, it was important to define precisely how the cell translated
this information into proteins. Central to this entire process was Crick's "adaptor hypothesis",
40the notion that another molecule was responsible for bridging mRNA and amino acids . A key
component of this adaptor proposal was the thought that RNA would be uniquely able to
function as this adaptor because of its ability to base pair with the mRNA4 4. With the discovery
of the tRNAs8 that match the sequence on an mRNA with the corresponding amino acids 41' 42 it
became clear that RNA itself was in fact this adaptor molecule. Beyond the adaptor tRNAs, it
was already clear that the site of translation itself, the ribosome, was composed of RNA 43. The
centrality of RNA in the process of transcription and translation was now clear.
It did not take long before the notion that DNA-RNA-Protein was challenged. The
first challenge was the discovery of viruses that encoded their genetic material as RNA, rather
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than DNA44 . Soon after, an enzyme was identified that could convert the RNA genome into
45,46DNA using an encoded reverse transcriptase enzyme . Not only did this establish that RNA
could act as the genetic material but that the path from DNA to RNA was a reversible course.
The second challenge was the identification of RNA enzymes, termed ribozymes that
demonstrated that RNA alone, in the complete absence of protein, contains catalytic activity.
This discovery initially identified RNaseP in bacteria4 7 and RNA self-splicing in
Tetrahymena 4849demonstrated the role of RNA as a functional molecule. More recently it has
become clear that the ribosome itself is made up of catalytic RNA where the RNA itself is
critical for the peptidyl transferase reaction rather than the proteins within the ribosome 0 52
Over the ensuing decades, the numbers of known catalytic RNAs have expanded and their roles
broadened to include roles in diverse processes including splicing49, translation51, metabolite
53 54
sensing , and gene regulation . Taken together, these observations supported the notion of an
ancient "RNA world", where RNA -- rather than DNA or protein -- was the original molecule
55-57given its ability to both encode genetic information and catalyze reactions
Discovery of abundant small RNA species
The importance of RNA was becoming clearer with the continued discovery of an ever
expanding collection of functional RNA molecules. Shortly after the discovery of mRNA, a large
class of heteronuclear RNAs (hnRNA)l was described. While much of the hnRNAs would soon
be explained by the discovery of splicing 58, there were still many hnRNAs that did not associate
with mRNA 59. These non-mRNA associated hnRNAs contained many of the same features as
mRNA, including the 5' cap structure and in some cases a 3' poly-A tail2,59. Yet, most of these
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transcripts did not enter polyribosomes 2. After years of sifting through these hnRNAs, the first
RNA subfamilies emerged including the small nuclear RNAs involved in splicing3 , small
nucleolar RNAs involved in ribosome biogenesis4 , and the 7SL RNA of the signal recognition
particle (SRP) involved in protein transport5 , adding to the ribosomal RNAs and transfer RNAs
involved in translation6 7
The small nucleolar RNAs (snoRNAs) and small nuclear RNAs (snRNAs) were
originally discovered based on their abundance in the nuclei of mammalian cells 3 . These RNAs
ranging in size from 90-300nts were distributed both in the nucleus, the site of transcription and
splicing, as well as the nucleolus, the site of ribosomal RNA transcription, processing, and
assembly4 ; some were even primarily cytoplasmic 5. Importantly, these different small RNA
3,60
species were shown to be conserved across different eukaryotes from yeast to mammals
The first class of small RNAs in this population was the snoRNAs, identified in the
nucleolus. Because the snoRNAs were identified in the nucleolus, it was immediately suspected
3,60that they would play a role in processing of the ribosomal RNAs' . This was confirmed with the
identification that several of the snoRNAs base pair with the ribosomal RNA, providing the first
clue as to how they may act4,6 1. Several of the snoRNAs were subsequently shown to play a
direct role in rRNA processing, as depletion of snoRNAs in mouse extracts resulted in impaired
cleavage of the ribosomal RNA 60 . Beyond their role in rRNA processing, other snoRNAs are
60important for guiding various modifications of the rRNA
The second class was the snRNAs. Unlike the snoRNAs, at the time of their discovery,
the function of these RNAs were unclear '. The first clues to their possible function required the
discovery of mRNA splicings8 62. Initial clues to the function of snRNAs came from the
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discovery of sequence complementary between the dominant U1 snRNA and the canonical 5'
63-65
splice site . Beyond the U 1 snRNA, other snRNAs interact with different splice sites
including the branchpoint site, 3' splice site, and non-canonical splice sites6 s,66 . These snRNAs
interact with protein cofactors to give rise to the spliceosome, which interacts with mRNA
65,67,68precursors and is responsible for the splicing reaction . Interestingly, the snRNAs are
transcribed in the nucleus and immediately exported to the cytoplasm where they are processed
and assembled into snRNPs, which are then reimported into the nucleus to function in the
66splicesome . While the snRNAs themselves are not sufficient to catalyze the splicing reaction, it
appears likely that the RNA may play some role, in conjunction with other protein cofactors, in
68the catalysis of the splicing reaction
Initial discovery of the snRNA and snoRNAs also revealed another extremely abundant
RNA, the 7SL RNA3', which was later shown to be a component of the SRP5 . The SRP is a
large RNA-protein complex consisting of the 7SL RNA and as many as 6 different proteins 69.
The SRP is required for transport of nascent proteins from the ribosome to the endoplasmic
reticulum, based on recognition of signal sequence in the nascent peptide5 . The 7SL RNA itself
is essential for the function of the SRP complex 5 and is important for stabilizing the structure of
the SRP proteins69 and kinetically enhances the interaction between the SRP and SRP-
6970
receptor ' . The 7SL RNA promotes catalysis by acting as a transient tether between the SRP
and associated receptor, thereby stabilizing the transition state and enhancing the interaction
between the two complexes70'71.
At the time, characterizing each RNA within a complex population was quite
challenging. Accordingly, much of the RNA species within the hnRNA mix remained
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uncharacterized. A commonality across these few identified RNA species was their abundant
expression and ubiquity across all cell types3 4 60
A class of tiny RNAs that regulate mRNA
Beyond the role of ncRNAs in constitutive cellular processes, we now know that there
are many ncRNAs that are expressed in more cell-type specific ways and play a role in cell-type
specific regulation. One of the first such classes identified were the microRNA genes -14 . The
first miRNA was identified in a genetic screen in C. elegans for mutations that affect timing of
development10 . This screen turned up a mutation in the lin-4 gene; subsequent characterization
showed that this gene lacked an open reading frame (ORF) and instead encoded a 21-nucleotide
RNA product processed from a larger 61-nucleotide precursor10 . This tiny RNA product had
strong sequence complementarity to the 3' untranslated regions (UTRs) in the lin-14 protein-
coding gene, which genetic experiments had previously shown it to repress' 10 . A few years later,
another example of a tiny RNA, termed let-7, was identified in C. elegans that seemed to work in
a comparable way 1 . Homology mapping on the let- 7 RNA showed that it was conserved in all
bilaterally symmetric animals from worms to humans 72. Genomic strategies used to sequence
tiny RNAs of similar size and sharing the chemical modifications of the previous RNAs revealed
that these were not the exception and in fact there were hundreds of tiny RNAs, termed
1214,73
microRNAs2-1'
The last decade has seen an explosion in our understanding of miRNAs, which have now
been demonstrated to play critical roles in diverse biological processes and diseases all through a
shared mechanism 3 '"4. The mature miRNA associates with the Argonaute proteins to form the
19
RNA-induced silencing complex (RISC). The miRNA within RISC acts to provide target
specificity through the six nucleotide miRNA seed region, which base pairs with an mRNA,
usually in the 3' untranslated regions 4 . The complex primarily leads to mRNA destabalization 5 ,
likely through mRNA de-adenylation76 78
Beyond miRNAs, there are several other classes of small RNA species that similarly
associate with argonaute proteins and act as 'guides' to target genes. Another class of small
RNAs, highly expressed in the testis, are the piwi-interacting RNA (piRNAs), so named because
they interact with the Piwi-family of Argonaute proteins5' 79 . The piRNAs localize these
complexes to active transposons in the germ line and silence them8 0 through changes in
chromatin and DNA8 1.
A handful of functional large ncRNAs in mammals
The world of RNA genes became even more complex with the discovery of RNAs that
resembled mRNA in length and splicing structure yet did not code for proteins. The first
example, termed H19, was identified as an RNA induced during liver development in the
19
mouse . The mouse H19 transcript contained no large open reading frames (ORFs), but only
small sporadic ORFs that were not evolutionarily conserved, could not template translation in
vivo, and did not produce an identifiable protein product20. H19 opened up the possibility that
many more messenger-like RNAs may in fact be non-coding RNAs. Shortly after, another
ncRNA, termed XIST, was found to be expressed exclusively from the inactive X chromosome2 1
22and later shown to be required for X inactivation in mammals . Over the next two decades a
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few additional large ncRNA genes were discovered including Air2 3 , Tug124, NRON25 , and
HOTAIR26
Individual ncRNAs involved in specific processes have been functionally characterized
(reviewed in reference 81). For example, XIST is critical for random inactivation of the X-
chromosome , Air is critical for imprinting control at the Igf2r locus 2 3 , HOTAIR affects
expression of the HoxD gene cluster 26 as well as multiple genes throughout the genome
8 2-84
HOTTIP affects expression of the HoxA gene cluster85, lincRNA-RoR affects reprogramming
efficiency 6, NRON affects NFAT transcription factor activity 2, and Tug 1 affects retina
development through regulation of the cell cycle24 . While there are now many examples of large
ncRNAs that are required for proper regulation of gene expression, this is just one function for
large ncRNAs, which play critical roles in telomere replication87 and translation 8.
In parallel to the discovery of the first large ncRNAs, the relationship between RNA and
chromatin was beginning to emerge89'90. A growing body of literature from yeast to mammals
suggested that RNA plays an important role in chromatin-state formation90. I
Schizosaccharomyces pombe, a process known as RNA Induced Transcriptional Silencing
(RITS) has been shown to play an important role in heterochromatin formation over centromeric
repeats91. Similarly, short RNAs have been shown to play an important role in the establishment
of heterochromatic silencing in plants90 . In C. elegans, genetic screens have identified Polycomb
homologs to be required for proper gene silencing in an RNA-dependent manner90. In mammals,
there is evidence that RNA plays a key role in shaping mammalian epigenetic landscapes. For
example, depletion of single-stranded RNA (ssRNA) in mouse fibroblasts inhibits global
heterochromatin formation by delocalizing the HPI complex from genomic sites92 . Similarly,
ssRNA but not ssDNA is required for the maintenance of the histone modifications H3K27me3
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and H3K9me3 through proper localization of proteins in the polycomb family93 . Taken together,
these studies suggested a role for RNA in maintenance and localization of chromatin regulatory
complexes to genomic DNA targets. Yet, what these RNAs were remained uncharacterized.
The discovery of the XIST ncRNA made clear that an RNA can play a direct role in
silencing large genomic regions. To determine how the XIST ncRNA works, several groups
looked at the sequence of events follows induction of the XIST ncRNA as it nucleates the X-
chromosome 94 . This led to the observation that alongside XIST accumulation on the
chromosome, several histone modifications such as the H3K27me3 modification and the
polycomb complex localize to the chromosome, suggesting that the XIST ncRNA may
physically interact with the polycomb complex 95. Recently, direct RNA-protein interaction
mapping has demonstrated that the XIST ncRNA can in fact physically interact with the
polycomb complex 96, leading to the condensation of chromatin and transcriptional repression of
an entire X chromosome and deletion of the domain of interaction allows proper localization to
97DNA but prevents X-chromosome silencing
Similar to XIST, several other large ncRNAs have been identified that physically
associate with chromatin regulatory complexes and 'guide' the associated complexes to specific
genomic DNA region. These include the antisense transcript AIR 23 ,98 ,9 9 which is associated with
the chromatin-modifying complex G9a, an H3K9me2 methyltransferase100 ; and the Kcnqlotl
transcript99 that binds both G9a and PRC2101. More recently, HOTAIR has been shown to
contain distinct protein-interaction domains that can associate with PRC2 26 and the
CoREST/LSD1 complex83 , which together enable its proper function 3
22
In addition to their role in chromatin regulation, large ncRNAs can also modulate the
regulatory activity of other protein complexes. As an example, a ncRNA upstream of cyclin D1
102
can bind to the TLS RNA binding protein, changing it from an inactive to active state'o2
Similarly, the NRON ncRNA can bind to the NFAT transcription factor rendering it inactive by
preventing nuclear accumulation2. ncRNAs can also act as molecular 'decoys' by preventing
proper regulation through competitive binding. For example, the GAS5 ncRNA binds to the
glucocorticoid receptor and prevents the receptor from binding to its proper regulatory
103 104
elementso and the PANDA ncRNA can prevent NF-Y localization leading to apoptosis.
Similarly, several recent studies report that large ncRNAs can act as 'decoys' to other RNA
species, such as miRNAs, to control their levelsis'10 6
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ba cis tether (e.g., XIST) trans regulation (e.g., HOTAIR)
C Allosteric modification (e.g., CCNDI ncRNAs)
d Decoy (e.g., GASS, PANDA)
Figure 2: Examples of large ncRNA regulatory mechanisms. (a) A model of ncRNAs that act
in cis while remaining tethered to their site of transcription. In this model, RNA polymerase
(green) transcribes an RNA which can associate with regulatory proteins (blue) to affect it
21,10
neighboring regions as proposed for XIST 07. (b) One model for ncRNA regulation in trans. In
this model a ncRNA can associate with DNA binding proteins (gray) and regulatory proteins to
83localize and affect expression of targets, as proposed for HOTAIR . (c) A model for ncRNAs
that bind regulatory proteins and change their activity in this case leading to change in
modification state and expression of the target gene, as proposed for the CCND1 ncRNAs that
interact with the TLS protein1 0 2.(d) A model for ncRNAs that act as 'decoys'. In this model,
ncRNAs bind protein complexes and prevent them from binding to their proper regulatory
103targets as proposed for GAS5
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Extensive transcription in the mammalian genome
While the human genome has now been sequenced108 the functional elements encoded
within it remain largely uncharted. More than 5% of the genome has clearly been under purifying
selection over the past 100 million years and thus must be functional' 09, but only ~1.2% encodes
protein 108,109110. Within the remainder, an important and growing category consists of genes
encoding functional RNA molecules. These include: classical examples such as ribosomal,
transfer and splicing-associated RNAs; a recently discovered cast of tiny RNAs, including
microRNAs and other families' 111 .
When we began this work, there were about a dozen well-characterized examples in
mammals, with transcript size ranging from 2.3 to 17.2 kb 20, 21. They each play distinctive
biological roles through diverse molecular mechanisms, including functioning in X-chromosome
inactivation (XIST, TSIX) 21,112, imprinting (H19, AIR) 20,98 , trans-acting gene regulation
(HOTAIR)26 and regulation of nuclear import (NRON)25. It was unclear whether these few cases
represented quirky exceptions, or whether they heralded an entire world of functional large
intergenic non-coding RNAs.
Over the past decade, there have been extensive efforts to characterize the mammalian
transcriptome. Following the sequencing of the human genome, several groups created tiling
microarray spanning human chromosome 22, which probed the transcriptional activity across
many tissues'3'3 14. This led to the observation of widespread transcriptional activity across the
chromosome with an estimate of -10:1 non-coding to protein-coding transcription. This result
was soon generalized to all human chromosomes with the creation of genome-wide tiling
arrays 2 9 ,1 15 . In parallel, high-throughput sequencing of mouse cDNAs reported the identification
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of tens of thousands of transcripts of which only a small fraction were accounted for by protein-
coding genes27,116. These studies, while limited to specific tissues and cell types, made clear that
the mammalian genome is pervasively transcribed, giving rise to many thousands of non-coding
transcripts. This culminated in the publication of the pilot Encyclopedia of DNA Elements
(ENCODE) project which suggested that -100% of the human genome is transcribed into RNA
in some cell type28
As the numbers of discovered non-coding transcripts increased, so did the uncertainty
about their functional role. It was unclear whether the majority of these transcripts have
biological function or merely reflect "transcriptional noise" 31,3231,3231,3231,3231,3231,3231,32
spurious transcription due to random initiation by RNA polymerase 31,32, or incidental by-
products of transcription from enhancer regions1 '118 . In support of these concerns, many of the
reported transcripts occur at extremely low levels - orders of magnitude below the levels for
protein-coding genes1 19 . While some of the transcripts show tissue-specific expression, such
expression patterns may simply reflect transcription from randomly-occurring RNA polymerase
binding sites in open chromatin in a given cell type1 2 0 , or possibly transcription whose purpose
121is to modify local chromatin structure
Importantly, not all non-coding transcripts act as functional RNA molecules. Several
examples of intergenic transcription have been identified where the act of transcription alone
changes the chromatin and transcription factor binding landscape allowing activation and
repression of neighboring genes224 An analogous mechanism has been suggested for the H 19
ncRNA which through its transcription may affect allelic imprinting by competing for enhancer
125,126
26
The only way to prove that an RNA is functional is to show that its disruption has a
deleterious consequence. In principle, this can be done in two ways: (i) by demonstrating clear
evolutionary conservation (that is, purifying selection) or (ii) by perturbing the gene in a
laboratory experiment. The first approach is vastly more efficient, because it involves
computational analysis that can be applied to an entire collection of RNAs, and more general
because it does not require prior knowledge of the biological context in which the gene
functions.
Attempts to prove the functionality of the observed non-coding RNAs through
evolutionary conservation were discouraging. Initial studies found that non-coding transcripts
show no better conservation than random intergenic sequence12 7. A more recent study reported
that the conservation levels are slightly better than random - but still extremely low"2. Some
authors proposed that most non-coding RNAs are functional, but show little conservation
because they are evolving rapidly12 0 . Few, non-coding transcripts were identified to have a
phenotypic effect in a large-scale screen performed with these sets25 . A reasonable hypothesis is
that amongst this pervasive transcription there are some bonafide functional non-coding RNAs
hidden in a much larger background of transcriptional noise.
While some of these transcripts may indeed represent 'transcriptional noise'31, within the
remainder, we now know there are many distinct subclasses including processed small
RNAs 30,129,130, promoter associated RNAs 0'131, transcripts from enhancer regions 117118, and
functional large ncRNAs 26,132 each of which vary in their expression and conservation
properties 128,133. Distinguishing between these classes of RNA transcripts required additional
27
biological information including coding potential of the RNA and chromatin modifications of the











Figure 3: Genomic layers define subclasses of non-coding transcription. (a) Genomic regions
are color coded by the presence of different genomic annotations. RNA transcription of a locus
(black), K4-K36 chromatin signature (red), K4mel and P300 modifications (green), and protein
coding potential (blue). Overlaying this information reveals distinct transcripts including













Contributions of this thesis
At the beginning of my graduate work, we reasoned that among a background of
'transcriptional noise', there were likely to be at least some bona fide functional large ncRNAs
hidden. The challenge was how to systematically identify them. Taking a cue from protein-
coding genes, we looked at a chromatin signature of active transcription.
Genomic DNA is wrapped around histone proteins and packaged into higher order
structures termed chromatin 134. These histones can be modified in different ways indicating the
functional state of the underlying DNA region. Recent advances in sequencing technologies have
enabled a comprehensive characterization of the chromatin modification landscape of
135-138mammalian genomes-1 . These studies revealed combinations of histone modifications,
termed chromatin signatures, that correspond to various gene properties, including a signature of
active transcription' 35,138. This signature consists of a short stretch of trimethylation of histone
protein H3 at the lysine in position 4 (H3K4me3) corresponding to promoter regions followed by
a longer stretch of trimethylation of histone protein H3 at the lysine in position 36 (H3K36me3)
covering the entire transcribed region 35' 138
Chromatin maps revealed that, like protein-coding genes, many ncRNA genes also
contain a 'K4-K36' signature138. We reasoned that by identifying K4-K36 domains that lay
outside known protein-coding gene loci, we would be able to systematically discover functional
large ncRNAs. To do this, we developed a computational algorithm that identifies K4-K36
domains from genome-wide chromatin datasets and excluded those that overlapped any
annotated gene. This analysis yielded a set of -1600 and -2,500 unannotated intergenic K4-K36
domains in the mouse and human genomes. Using tiling microarrays, we demonstrated that the
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vast majority of the intergenic K4-K36 domains produced multi-exonic RNAs with many
canonical features of RNA Polymerase I transcription. These transcripts had little capacity to
encode a functional protein of any significant size. We termed the RNAs expressed from these
'K4-K36'domains large intergenic ncRNAs (lincRNAs) because identification by this chromatin
signature required that they be contained within intergenic regions. Importantly, these lincRNAs
demonstrated clear evolutionary conservation across mammalian genomes, providing strong
evidence that the lincRNAs are biologically functional. This work demonstrated that the
mammalian genome encodes thousands of functional lincRNAs.
Transcriptome reconstruction
Having identified a class of conserved lincRNAs, we next sought to determine the
function of these lincRNAs. A critical pre-requisite for comprehensive experimental studies of
lincRNA function is defining their precise sequences. While hybridization to tiling microarrays
provided initial insights, it did not allow the precise identification of lincRNA sequences.
Advances in massively-parallel cDNA sequencing, termed RNA-Seq, were allowing for the
sequencing of cDNA at an unprecedented scale providing an unbiased way to collect data from a
transcriptome, including both coding and non-coding genes. Yet, at the time there were only a
few RNA-Seq studies which were limited to studying the expression and refining the splicing
patterns of known genes. There were no studies to determine novel genes from RNA-Seq data.
Discovering lincRNA gene structures required reconstructing a mammalian transcriptome
from scratch, a significant computational challenge as read lengths are significantly shorter than
the size of the original RNA. To address this challenge, we developed a statistical method, called
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Scripture, which was the first method to accurately reconstruct a mammalian transcriptome
without prior gene models. We performed RNA-Seq on mouse ES cells, mouse lung fibroblasts,
and mouse neural progenitor cells. Applying Scripture, we successfully recovered the gene
structure of virtually all expressed protein-coding genes demonstrating the accuracy of the
method. Importantly, Scripture identified the full-length gene structure of the vast majority of
expressed lincRNA genes. This allowed us to pinpoint specific regions within each lincRNA that
are under purifying selection demonstrating clear 'patches' of strong evolutionary constraint
within the lincRNAs.
'Guilt-by-association' associates lincRNAs with diverse biological processes
Despite the identification of thousands of large ncRNAs it remained to be determined
how these RNAs function. Determining the functional role of ncRNAs requires direct
perturbation experiments such as loss of function and gain of function yet without a clear
hypothesis of what phenotype to look for proved difficult in characterizing the functions of most
25ncRNAs . To more globally classify putative functional roles of lincRNAs we developed a
'guilt-by-association' method to systematically associate functions based on correlation of gene
139expression . This method associates ncRNAs with biological processes based on common
expression patterns across cell types and tissues, and identifies groups of ncRNAs associated
with specific cellular processes. Utilizing this approach allowed us to classify hundreds of
ncRNAs across diverse biological processes such as stem cell pluripotency, immune response,
neural processes, and cell cycle regulation139 .
While such correlations do not prove that ncRNAs function in these processes, they
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provide hypotheses for targeted loss-of-function experiments. To test these predictions, we
performed targeted perturbations to determine the role of specific ncRNAs in the associated
classes. As an example, we predicted 39 ncRNAs involved in the p53-mediated DNA damage
response and showed that one of these candidates, termed lincRNA-p21, is a direct target of
140p513 . Perturbation of this ncRNA affected the apoptosis response upon exposure to DNA
damage. Another lincRNA, lincEncll 39, was predicted to have a roll in cell-cycle regulation in
ESCs and shown in a distinct study to affect proliferation in ESCs141. Overall, our 'guilt-by-
association' approach implicated lincRNAs in diverse biological processes86 04 139 140 142
lincRNAs regulate cell states in an embryonic stem cell
Using the lincRNA sequences, we set out to determine the functional role of lincRNAs
using loss-of-function experiments. Unlike correlation analysis, these perturbation-based
experiments provide evidence for the functional role of a ncRNA. We focused on mouse ES cells
because the signalling, transcriptional, and chromatin regulatory networks controlling
pluripotency have been well characterized providing an ideal system to determine how lincRNAs
integrate into the molecular circuitry of the cell. We designed, cloned, and validated shRNAs
targeting all lincRNAs expressed in mouse ES cells. To determine whether lincRNAs play an
important function in the cell, we studied the effects of knocking down each lincRNA on global
transcription. Upon knockdown, virtually all of the lincRNAs showed a significant impact on
gene expression demonstrating that the lincRNAs are functionally important in the cell.
Next, we sought to determine if lincRNAs play a role in regulating the ESC state. We
studied the effects of lincRNA knockdown on the expression of Nanog, a key transcription factor
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that is required to establish and uniquely marks the pluripotent state. We identified 26 lincRNAs
that had major effects on endogenous Nanog levels along with other markers of the pluripotent
state. To determine if lincRNAs play a role in repressing differentiation programs, we compared
the overall gene expression patterns resulting from knockdown of the lincRNAs to gene
expression patterns resulting from induced differentiation of ESCs. We identified 30 lincRNAs
whose knockdown produced expression patterns similar to differentiation into specific lineages.
This work demonstrated that many lincRNAs play important roles in regulating the ESC state.
Many lincRNAs interact with multiple chromatin regulatory proteins
Having demonstrated the functional importance of lincRNAs in the cell, we wanted to
determine how lincRNAs affect gene expression. Motivated by the XIST and HOTAIR ncRNAs,
which interact with the polycomb complex, we tested whether lincRNAs more generally
associate with the polycomb complex. We found that -20% of expressed human lincRNAs and
~10% of the ESC lincRNAs physically associate with the polycomb complex. Next, we
systematically analyzed chromatin-modifying proteins that have been shown to play critical roles
in ESCs. We screened antibodies against 28 chromatin complexes and identified 11 additional
chromatin complexes that are strongly and reproducibly associated with the ESC lincRNAs.
These chromatin complexes are involved in 'reading',. 'writing', and 'erasing' histone
modifications. Altogether, we found that -30% of the ESC lincRNAs are associated with at least
one of these chromatin complexes. Interestingly, many of the lincRNAs physically interacted
with multiple chromatin complexes.
34
Next, we sought to determine if the identified interactions are important for lincRNA
mediated regulation. To do this, we examined the effects on gene expression resulting from
knockdown of individual lincRNAs that are physically associated with particular chromatin
complexes and from knockdown of the associated complex itself. For most of these lincRNA-
protein interactions, we identified a significant overlap in affected gene expression programs.
Together, these data demonstrate that many of the ESC lincRNAs physically associate with
multiple different chromatin regulatory proteins to affect gene expression programs.
Outlook
Our data suggests a model whereby a distinct set of lincRNAs is transcribed in a cell type
and interacts with ubiquitous regulatory protein complexes to give rise to cell-type-specific
RNA-protein complexes that coordinate cell-type specific gene expression programs. Because
many of the lincRNAs studied here interact with multiple different protein complexes, one
hypothesis is that they act as cell-type specific 'flexible scaffolds' 87 to bring together protein
complexes into larger functional units. This model has been previously demonstrated for the
yeast telomerase RNA87 and suggested for the XIST97 and HOTAIR83 lincRNAs. The hypothesis
that lincRNAs serve as flexible scaffolds could explain the uneven patterns of evolutionary
conservation seen across the length of lincRNA genes1 33 : the more highly conserved patches
could correspond to regions of interaction with protein complexes.
While a model of lincRNAs acting as 'flexible scaffolds' is attractive, it is far from
proven. Testing the hypothesis for lincRNAs will require systematic studies, including defining
all protein-complexes with which lincRNAs interact, determining where these protein
35
interactions assemble on RNA, and ascertaining whether they bind simultaneously or
alternatively. Moreover, understanding how lincRNA-protein interactions give rise to specific
patterns of gene expression will require determination of the functional contribution of each
interaction and possible localization of the complex to its genomic targets.
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Chapter 1: Chromatin signature reveals more than a thousand well
conserved, large non-coding RNAs in mammals
In this chapter, we describe the identification of a class of thousands of well conserved lincRNAs in the
human and mouse genomes by exploiting a chromatin signature of actively transcribed genes.
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The role of large intergenic non-coding RNAs (lincRNAs) in mammals remains highly
controversial. There is evidence of extensive transcription across the mammalian genome,
based on large-scale cDNA sequencing and hybridization to DNA microarrays. However,
the functional significance of most of these transcripts has been unclear because their
expression levels are often very low and their sequence shows little evolutionary
conservation. At present, only about a dozen functional lincRNAs have been well-
characterized, with roles in diverse processes such as X-inactivation, HOX gene regulation
and repression of nuclear import. Here, we report a new approach to identifying lincRNAs
by using chromatin-state maps to define discrete transcriptional units that do not overlap
any known protein-coding genes. By examining four mouse cell types and six human cell
types, we identify -3500 such transcriptional units. The majority produce large multi-
exonic RNAs that show strong purifying selection in their genomic loci, exonic sequences,
and promoter regions, but lack protein-coding potential. These lincRNAs are regulated by
the canonical general transcriptional machinery and by specific transcription factors
including Oct4, Sox2, and Nanog in ES cells. Together, these results demonstrate that
functional lincRNAs are abundant in the mammalian genome.
Introduction
Although the human genome has now been sequenced' the functional elements encoded
within it remain largely uncharted. More than 5% of the genome has clearly been under purifying
selection over the past 100 million years and thus must be functional 2,but only ~1.2% encodes
1-3protein -3. Within the remainder, an important and growing category consists of genes encoding
functional RNA molecules. These include: classical examples such as ribosomal, transfer and
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splicing-associated RNAs; and a recently discovered cast of tiny RNAs, including microRNAs
and other families4- .
There are tantalizing signs of another class of functional RNAs, which we will refer to as
large intergenic non-coding RNAs (lincRNAs). There are currently about a dozen well-
characterized examples in mammals, with transcript size ranging from 2.3 to 17.2 kb1 3' 14 . They
each play distinctive biological roles through diverse molecular mechanisms, including
14,15 13,16,17functioning in X-chromosome inactivation (XIST, TSIX) '', imprinting (H19, AIR) 31
trans-acting gene regulation (HOTAIR)l8 and regulation of nuclear import (NRON)' 9.
Importantly, these well-characterized lincRNAs show clear evolutionary conservation
confirming that they are functional. It has been unclear whether these few cases represent quirky
exceptions, or whether they herald an entire world of functional large intergenic non-coding
RNAs.
Over the past decade, there have been extensive efforts to characterize mammalian RNAs,
both by massive shotgun sequencing of cDNAs2 0 and by hybridization of RNA to 'tiling arrays'
representing genomic sequence2 '-25. These studies have identified evidence of widespread
transcription, leading to the recent suggestion that nearly the entire genome is transcribed into
RNA under some circumstances3.
It has been unclear, however, whether the majority of these transcripts are biologically
functional or merely reflect "transcriptional noise"3 ,2629. Many of the reported transcripts occur
at extremely low levels - orders of magnitude below the levels for protein-coding genes. While
some of the transcripts show tissue-specific expression, it has been argued that such expression
patterns may simply reflect transcription from randomly-occurring RNA polymerase binding
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sites in open chromatin in a given cell type, or possibly transcription whose purpose is to modify
local chromatin structure 30-32. Given the ubiquity of RNA transcription, it has been hard to
discern which of these transcripts, if any, are functional.
The only way to prove that an RNA is functional is to show that its disruption has a
deleterious consequence. In principle, this can be done in two ways: (i) by demonstrating clear
evolutionary conservation (that is, purifying selection) or (ii) by knocking out the gene in a
laboratory experiment. The first approach is vastly more efficient, because it involves
computational analysis that can be applied to an entire collection of RNAs, and more general
because it does not require prior knowledge of the biological context in which the gene
functions.
Attempts to prove the functionality of non-coding RNAs through evolutionary
conservation have been discouraging. Initial studies found that non-coding transcripts show no
better conservation than random intergenic sequence 33 . A recent study reported that the
conservation levels are slightly better than random - but still extremely low29 . Some authors
have proposed that most non-coding RNAs are functional, but show little conservation because
they are evolving rapidly 28. A reasonable hypothesis is that the current transcript collections
contain some bonafide functional non-coding RNAs hidden in a much larger background of
transcriptional noise. But, there has been no systematic way to extract wheat from chaff.
We therefore decided to take an entirely different approach to discovering functional non-
coding RNAs, which relies on exploiting chromatin structure. We recently developed an efficient
technique to create genome-wide chromatin-state maps, using chromatin immunoprecipitation
(ChIP) followed by massively parallel sequencing. We observed that genes actively transcribed
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by RNA polymerase II are marked by Histone 3-Lysine 4 trimethylation (H3K4me3) at their
promoter and Histone 3-Lysine 36 trimethylation (H3K36me3) along the length of the
transcribed region34,35 . This distinctive structure, which we will refer to as a 'K4-K36 domain', is
found both at known protein-coding genes as well as well-known ncRNAs, including miRNAs34
We hypothesized that, by identifying K4-K36 structures that lay outside known protein-coding
gene loci, we could systematically discover large intergenic non-coding RNAs.
Here, we report the identification of -3500 large non-coding RNAs in the mouse and
human genomes using our chromatin-based approach in four cell types. These RNAs share many
of the same features as protein coding transcripts but lack the evolutionary signature of protein
coding potential. The ncRNAs are typically poly-adenylated, 5'-capped, and spliced. We
characterize the conservation properties of the ncRNAs and find that the genomic locus, exons,
and promoters of these regions are highly conserved. These ncRNAs are regulated in cell-type
specific manners by key transcription factors. It is likely that many additional lincRNAs exist
and can be identified by studying additional cell types.
Results
Discovery of novel large RNAs based on chromatin structure
We searched for K4-K36 domains in genome-wide chromatin-state maps of four cell types
-- mouse embryonic stem cells (mES), mouse embryonic fibroblasts (mEF), mouse lung
fibroblasts (mLF), and neural precursor cells (NPC) - created by chromatin
immunoprecipitation-sequencing (ChIP-Seq)3 4. For this purpose, we developed a computational
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algorithm that identifies K4-K36 domains of at least 5Kb in size (Methods). Using this approach
we identified 10,623 K4-K36 domains. We then excluded all regions that overlap a protein-
coding gene annotated in the mouse genome, as well as those that are syntenic to protein-coding
genes annotated in the human, rat or dog genomes. We also excluded all microRNA genes
36annotated in the MIRBASE database
The analysis yielded a set of 1684 unannotated intergenic K4-K36 domains (Figure la).
To exclude the possibility that any of the domains might represent extensions of known protein-
coding genes, we then applied a stringent criterion to define a 'conservative' subset. Specifically,
we excluded any K4-K36 domains that lie within any reported cDNA that extends into a region
containing a protein-coding gene (even if the cDNA does not encode a protein-coding gene).
This conservative subset contains 1109 K4-K36 domains. In our analysis below, we refer to the
conservative set, but similar conclusions hold for the full set of 1,684 domains.
We tested whether the intergenic loci with K4-K36 domains produce RNA transcripts. We
designed DNA microarrays containing oligonucleotides that tile across a random sample of 350
of the regions (50 base probes spaced every 10 bases) and various control regions, and we
hybridized poly(A)*-selected RNA from each of the four cell types to the arrays. We developed
an algorithm (methods) to identify regions of significant hybridization and used it to define
putative exons of transcripts detected at the loci. For -70% of the intergenic loci with K4-K36
domains present in a cell type, we found clear evidence of RNA transcription in that cell type
(Figure lb,c). The proportion is similar to what we see for protein-coding genes: -72% of K4-
K36 domains corresponding to known protein-coding genes in these cell-types show similarly
strong evidence of RNA transcription. For intergenic loci with K4-K36 domains present in
multiple cell types, we typically observed corresponding patterns of hybridization in the various
cell types, consistent with the presence of a reproducible transcript.
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To independently validate the putative exons detected on tiling arrays, we employed RT-
PCR. We confirmed the presence of 93 of 107 (87%) randomly selected exons, representing at
least one exon from 19 of 20 K4-K36 domains tested. We also confirmed the connectivity of
consecutive exons in 52 of 67 (78%) of cases, including one from each of 16 K4-K36 domains
tested (Figure ic). We further validated the presence of discrete transcripts by hybridization to
RNA northern blots. We found that 15 of 17 tested loci show detectable distinct bands (Figure
1b). The cases that were not confirmed may reflect imperfect definition of the exons based on
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Figure 1: Intergenic K4-K36 domains produce multi-exonic RNAs. (A) Representative
example of an intergenic K4-K36 domain and the K4-K36 domains of two flanking protein
coding genes. This illustrates that novel K4-K36 domains have similar chromatin structures, at
similar enrichment levels, as annotated K4-K36 protein coding domains. Each histone
modification is plotted as the number of DNA fragments obtained by ChIP-Seq at each position
divided by the average number for each position across the genome. Black boxes indicate known
protein coding regions and gray boxes are intergenic K4-K36 domains. Arrowheads indicate the
orientation of transcription, inferred from the position of the promoter (K4 domain) (B)
Intergenic K4-K36 domains were interrogated for presence of transcription by hybridizing RNA
to high-resolution DNA tiling arrays (10bp resolution). Each RNA track is plotted as a
normalized hybridization intensity. RNA peaks were determined (Methods) and are represented
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5~Kb
by gray boxes. The presence of a 4.5Kb spliced transcript, approximately the same size as
predicted from the tiling array, was validated by hybridization to a Northern blot (right). (C)
Connectivity between the inferred exons was validated by RT-PCR, indicating that intergenic
K4-K36 domains produce spliced multi-exonic RNA molecules. Right top shows RT-PCR
validation of each exon. Right bottom validates by RT-PCR the connectivity of each consecutive
exon at the predicted sizes.
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RNAs encoded by intergenic K4-K36 structures are not protein-coding
Determining whether a transcript is non-coding is challenging because a long non-coding
transcript is likely to contain an ORF purely by chance37 . Accordingly, the case for the absence
of coding potential for the XIST and H19 genes rested on the lack of evolutionary conservation
of the identified ORFs, the lack of homology to known protein domains, and the inability to
template significant protein production 3'38 . We generalized these conservation properties to
classify coding potential across thousands of transcripts by scoring conserved ORFs across
dozens of species using the 'codon substitution frequency' (CSF) algorithm39 40
Computational methods such as CSF 39'40 leverage evolutionary information to determine
whether an ORF is conserved across species and provides a general strategy for determining
coding potential (Figure 2a). Due to the large number of available genome sequences, these
methods have the ability to accurately determine conserved coding potential in regions as small
as 5 amino acids*1 making them extremely sensitive to potential small peptides, such as the 11
amino acid peptide encoded by the tarsal-less (tal) gene 42 ,4 3 (Figure 2b).
In principle, the transcripts encoded by the intergenic loci with K4-K36 domains could
either be novel protein-coding genes or non-coding RNAs. To explore this issue, we tested
whether the genomic loci and the exons show the characteristic evolutionary signatures of
protein coding genes. The CSF metric can accurately distinguish between a protein-coding exon
(CSF > 0) and neighboring UTR or intronic sequence (CSF <0) (Figure 2b). It has been shown
to accurately distinguish between protein-coding and non-coding genes in mammalian
genomes44 . While the method was developed for assessing a specific candidate sequence, it can
be adapted to scan regions by computing the CSF score in sliding windows and taking the
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maximum value (max-CSF score). To study evolutionary conservation, we analyzed aligned
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genomic sequence from 29 mammalian species
Applying the approach to the genomic regions defined by the K4-K36 domains, 95% of
protein-coding genes have a high score (max-CSF > 20) whereas 97.5% of untranslated regions
(UTRs) and 100% of the known lincRNAs fall below this threshold. We found that 90% of the
intergenic loci fall below this threshold as well, with a distribution that is similar to the set of
known lincRNAs. We conclude that at least 90% of the intergenic loci with K4-K36 domains
lack any significant protein-coding potential across the entire genomic region (Figure 2c).
We similarly applied the approach to the putative exons detected by hybridization to the
tiling micorarrays (Methods). Whereas all protein-coding exons on our tiling array show a
normalized CSF scores greater than 0, approximately 95% of the exons of the intergenic K4-K36
domains have negative scores, inconsistent with the evolutionary signatures of protein-coding
genes. Consistent with this, fewer than 2.5% of the exons show any similarity to known protein-
coding genes, using the BLASTX program (methods). The other 5% may encode protein-coding
genes and are excluded in the analysis below.
Despite their sensitivity, conservation-based methods will fail to detect newly evolved
proteins since they will not contain a conserved ORF 39,40 . However, three lines of evidence
suggest that this is unlikely for the novel intergenic K4-K36 domains. First, a recent study44
provides strong evidence that very few new protein-coding genes have appeared in mammals.
Second, we show below that, while the intergenic K4-K36 loci lack evolutionary signatures of
protein-coding genes, they do show strong evolutionary conservation at the nucleotide level
across mammals - indicating that they do not represent recently arising functions. Finally, these
domains do not contain conserved ORFs even within the rodent lineage and single nucleotide
polymorphisms (SNPs) within mice do not retain the coding region (Figure 2d).
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Because the majority of the intergenic loci with K4-K36 domains appear to encode large
RNAs that lack significant coding potential and do not overlap known annotations, we will
hereafter refer to the loci that lack protein-coding conservation as encoding large intergenic
ncRNAs (lincRNAs).
It is important to note that a recent paper claims that the majority of lincRNAs are in fact
translated 46. This conclusion is drawn from experimental methods, such as ribosome profiling,
which provides a strategy for identifying ribosome occupancy on RNA and has been proposed as
a method to distinguish between coding and non-coding transcripts46. While this method can
clearly distinguish between coding regions and untranslated regions occurring after the ribosome
encounters a stop codon and ribosomes are released47 , it has yet to be demonstrated to accurately
distinguish between coding and non-coding transcripts46,48. Demonstrating this will require
identification of the predicted protein products at significant abundances in vivo. Importantly,
the mere association of an RNA with the ribosome cannot be taken as evidence of protein-coding
potential as both the RNase P ribozyme and telomerase RNA can be detected in the ribosome46'49
50,51despite clear mechanistic roles as ncRNAs
An alternative explanation for these observed associations is "translational noise", spurious
association that may lead to non-functional translation products. Consistent with this, virtually
all of the transcripts suggested to encode small peptides by ribosome profiling46 lack
evolutionary conservation of their proposed coding regions4 1'52 even across different mice which
is in striking contrast to almost all known protein-coding genes44 including the few well-
characterized functional small peptides42,43,53 54 (Figure 2b). Accordingly, identification of any
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Figure 2: RNA molecules transcribed in intergenic K4-K36 domains do not have coding
potential. (a) A cross-species alignment of a coding (left) and non-coding (right) gene. Boxes
represent codons and each row represents a different aligned species. Blue boxes represent
mutations that cause a synonymous substitution and red boxes represent mutations that cause a














species, aligns sequences in all frames and scores mutations that maintain coding potential (blue
boxes) relative to mutations that break coding potential (ie non-synonymous mutations, stop
codons, and frame shifting insertion/deletions) (red boxes). (b) CSF score in sliding windows
across the entire K4-K36 domains of known protein coding gene, Sirtl (top panel). CSF values
in each window that are greater than 0 are represented by black bars, CSF scores below 0 and
likely non-coding RNA are shown in grey. The CSF score across the K4-K36 domain of a
known ncRNA, XIST (middle panel). The CSF score of a novel lincRNA, linc-ZFAT 1, across
the K4-K36 domain (bottom panel). The CSF score of a known gene encoding four discrete
small peptides of 11 and 32 amino acids (tarsal-less), contains positive scores over all known
small peptides. Gene annotations are indicated below, showing that high CSF scores occur at the
location of protein-coding regions, but not in the two lincRNAs. (c) Density plot of the
maximum CSF score (Methods) across intergenic K4-K36 domains (grey) and a random sample
of 1000 known protein-coding genes (black). The max-CSF scores for the handful of well
characterized lincRNAs are indicated as points at the bottom of the figure. (d) A cumulative
distribution of the CSF scores within the rodent lineage for introns (red), protein-coding exons
(green), and lincRNAs (blue). (e) A cumulative distribution of the coding potential measured by
the dN/dS ratio across 17 mouse strains for introns (red), protein-coding exons (green), and
lincRNAs (blue).
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Conservation properties of lincRNAs
To assess whether the lincRNA genes are likely functional, we studied their conservation
properties. While the genes do not show the evolutionary signatures of protein-coding genes,
they show striking and consistent evolutionary conservation in all other ways, and also have
additional properties of bonafide genes.
(i) lincRNA transcripts show high levels of sequence conservation across mammals.
The lincRNA genes show clear conservation by several methods both across the genomic loci
and specifically in their exons. Using a method to assess evolutionary constraint on sequences
that explicitly models the underlying substitution rate5 5 (7r, see methods), we found that the
lincRNA loci show clear conservation across their transcribed region (defined as the region of
K36me3 enrichment) when compared to other intergenic regions (Figure 3A). Using another
approach based on conserved elements defined by the PhastCons program 5, we also found that
the transcribed regions are highly enriched for conserved elements compared to other intergenic
regions (p<.0001, permutation test).
The exons of lincRNAs show even stronger conservation (Figure 3B). The extent of
exonic conservation is much higher than seen for random intergenic regions and is similar to that
seen for known lincRNAs - although it is lower than that seen for protein-coding exons, likely
reflecting a lower degree of constraint on RNA structures than on amino acid codons. We also
note that lincRNA exons are significantly more conserved than the UTRs of protein coding genes
(Supplemental Figure 4). The presence of strong purifying selection provides strong evidence
that the vast majority of the lincRNAs are biologically functional in mammals.
(ii) lincRNA promoters show high levels of sequence conservation across mammals.
We defined the promoter-proximal regions of the lincRNAs to be the peaks of K4me3
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enrichment nearest to the transcribed unit (median size = 1.1 kb). Applying the conservation
scoring methods used above to analyze the transcribed regions, the promoter regions show strong
conservation relative to random intergenic regions (p<.001, permutation test). Moreover, the
distribution of conservation scores is essentially indistinguishable from that seen for the
promoters of known protein-coding genes (Figure 3C).
(iii) lincRNA loci show conserved chromatin structure in human. We constructed
chromatin-state maps in human lung fibroblasts (hLF) and compared them to the chromatin
structure seen in mouse lung fibroblasts (mLFs), to study the occurrence of K4-K36 domains in
the two species. Interestingly, -70% of the human K4-K36 domains also exhibited a K4-K36
domain in the syntenic region of the mouse genome. The proportion is similar to that seen for
protein-coding genes (-80%). The lack of complete correspondence may simply reflect
thresholds of detection.
lincRNAs promoters exhibit canonical features of general transcriptional initiation.
The lincRNA promoters show a striking enrichment of 'CAGE tags' that mark transcriptional
start sites (TSS) 57 (Figure 3D). CAGE tags are obtained by shotgun sequencing of cDNAs
prepared from RNA molecules captured on the basis of containing the 7-methylguanosine cap
structure that marks the 5'-end of mRNAs 8; they have been systematically catalogued in mouse.
Most of the promoters regions of lincRNAs (85%) contain a significant cluster of CAGE tags,
with the density tightly localized around the promoter. The proportion and localization are
similar to that seen for protein-coding genes".
Additionally, we found that the lincRNA promoters show strong enrichment for binding of RNA
Poll and Transcriptional initiation factor 2D (TF2D) in mouse ES cells, compared to random
genomic regions (p<2x 10-16, Wilcoxon test). Together, these results suggest that the transcription
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and processing of lincRNAs is similar to that for protein-coding genes - including Poll
transcription, 5'-capping and polyadenylation (inasmuch as the transcripts are detected in
poly(A+)-selected RNA).
In embryonic stem cells, many lincRNA promoters are bound by Oct4 and Nanog.
The promoters of lincRNAs with K4-K36 domains in embryonic stem (ES) cells show strong
enrichment for binding of the pluripotency-associated transcription factors Oct4 and Nanog
compared to intergenic regions marked by K4me3 but not K36me3 in ES cells, based on analysis
of ChIP-PET (Paired End Ditags) data in mouse ES cells59 . Specifically, by analyzing ChIP-PET
data from mouse ES cells we found 249 regions across the genome that are bound by either Oct4
or Nanog and do not correspond to known protein-coding genes. Of these regions, 118 coincide
with the promoters of lincRNAs. Of the lincRNA promoters bound by Oct4 or Nanog, 86%
occur at lincRNAs whose K4-K36 domain is present only in ES cells - consistent with the fact
that Oct4 and Nanog are specific to the pluripotent state (Figure 3e).
Among 101 lincRNAs with K4-K36 domains present only in ES cells and containing an
Oct4 or Nanog binding site, we noticed that one lincRNA was ~100 kb from the Sox2 locus,
which encodes another key transcription factor associated with pluripotency. We cloned the
promoter of this locus (which we will refer to as lincRNA-Sox2) upstream of a luciferase
reporter gene and transfected the construct into mouse cells transiently expressing either Oct4,
Sox2, or both, as well as several controls. We found that Sox2 and Oct4 were each sufficient to
drive expression of this lincRNA promoter. We further found that Oct4 and Sox2 together
synergistically increased expression of lincRNA-Sox2 (Figure 3f). Together, these results
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Figure 3: lincRNA K4-K36 domains, exons, and their promoters are highly conserved. (A)
Cumulative distribution of sequence conservation across 21 mammalian species for the genomic
region of the K4-K36 domain of each lincRNA (blue), protein coding gene (green), and random
intergenic regions (red). (B) Cumulative distribution of sequence conservation across 21
mammals for lincRNA exons (blue), protein coding exons (green), and protein coding introns
(red). (C) Cumulative distribution of sequence conservation across 21 mammals for the
































conservation measure (Methods) normalized by random genomic regions; thus larger scores
reflect higher conservation. (D) Enrichment of various promoter features plotted as the distance
from the start of the K36me3 region averaged across all lincRNAs. (Top) Enrichment in each
cell type of K4me3 domains across ES (red), MEF (black), MLF (blue), NPC (green) is shown.
(Middle) Enrichment of 5' CAGE tag density representing 5' end of RNA molecules, indicating
the K4me3 regions correspond to apparent transcriptional start site. (Bottom) Conservation
scores within the K4me3 region. (E) K36me3 enrichment across 4 cell types for lincRNAs bound
by Oct4 or Nanog. Red indicates high enrichment and blue low enrichment. The Venn diagram
indicates the total number of ES specific lincRNAs bound by Oct4 or Nanog (Gray) compared
with the total number of Oct4 or Nanog bound regions (Black). (F) Direct transcriptional
regulation of lincRNA-Sox2 promoter by Sox2 and Oct4. The lincRNA-Sox2 promoter was
cloned into a luciferase reporter construct and assayed for transcriptional activity with co-
transfection with either Sox2 or Oct4 alone, in combination and the same reporter construct
without the lincRNA-Sox2 promoter. The y-axis represents the transcriptional activity of this
promoter relative to a renilla construct control to control for transfection efficiency.
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Identification of human lincRNAs
While this studies clearly demonstrate that there are many functional lincRNAs, a key
questions remains: How many lincRNAs are encoded in mammalian genomes? To further extend
the catalog of lincRNAs, we sought to analyze chromatin-state maps of six human cell types:
human embryonic stem cells (hESC) 60 , two hematopoetic stem cells (CD133+ and CD36+) 61, T-
cells 3, lung fibroblasts (hLF)41 , and normal embryonic kidney (hEK). Using our previous
computational approach, we identified K4-K36 domains that are well-separated from (i) the
regions containing known protein-coding genes and all known classes of small non-coding
RNAs in human and (ii) the orthologous regions of known protein-coding genes in mouse, rat
and dog. We also eliminated the orthologous regions of our previously identified mouse
lincRNAs. (We previously showed that, for similar cell types in mouse and human, lincRNA loci
show cross-species conservation not only at the level of nucleotide sequence, but also with
41
respect to the presence of K4-K36 domains
We found a total of 1833 novel intergenic K4-K36 domains in these six human cell types.
We analyzed the coding potential of each such K4-K36 domain using the codon substitution
frequency score (see Methods) and found that <8% showed any evidence of protein-coding
capacity39. After eliminating these cases, we were left with 1703 loci encoding putative
lincRNA genes.
To test whether these loci actually encode lincRNAs, we designed genomic tiling
microarrays (at 10 base resolution) across 1147 of the 1703 loci (see Methods) to determine their
exonic structure. We hybridized poly(A*)-amplified RNA from hES, brain, breast, hEK, hFF,
hLF, K562, ovary, skin, spleen, testis, thymus tissues. We analyzed the hybridization data using
our previously reported peak-calling algorithm. This analysis revealed multi-exonic RNA
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transcripts in 74% of the K4-K36 domains examined. There was an average of 9 exons per K4-
K36 domain (total of 7523 exons). We further focused on the 535 K4-K36 domains that were
discovered in cell types in which RNA from the same cell type was hybridized. In these three
cell types, RNA hybridization revealed multi-exonic RNA transcripts in 85% of the tested loci;
this detection rate is similar to that previously seen for K4-K36 domains corresponding to known
protein-coding genes and lincRNA loci in mouse4 1 . Given that such a high proportion of the
human K4-K36 domains tested were validated as encoding lincRNAs, we conclude that the vast
majority of the full set of 1703 loci encode bonafide lincRNAs.
We then studied the evolutionary conservation of the novel lincRNA loci. For each exon,
we calculated the extent of sequence conservation across 29 mammalian species as previously
described (see Methods). The novel lincRNAs showed evolutionary conservation at levels
similar to those seen for the lincRNAs in mouse.
Combining the 1586 human orthologs of the lincRNA genes reported in our previous
study with the 1703 newly discovered human lincRNA genes identified in this study, our catalog
of human lincRNA genes now includes 3289 distinct loci. This catalog is certain to be
incomplete, because it is based on chromatin-state maps of only ten cell types (four mouse and
six human). Nonetheless, it is possible to make a rudimentary estimate of the total number of
human lincRNAs based on the observation that 73% of all protein-coding genes are expressed in
at least one of the ten cell types analyzed here. If a similar proportion applies to lincRNAs, the
total number of human lincRNAs would be estimated to be -4500. If lincRNAs have expression
patterns that are more tissue- or condition-specific, the total number could be considerably




Although it has become clear that abundant transcription in mammalian genomes generates
many large RNAs without protein-coding capacity62, the biological significance of these
molecules remained in doubt because most of the cases identified by shotgun cDNA sequencing
or microarray hybridization show little evidence of sequence conservation indicative of function.
It is likely that many-perhaps most-of these RNAs represents transcriptional noise, but that
hidden among them are important classes of ncRNAs.
We therefore developed an alternative approach to finding lincRNAs, based on
identifying novel genomic regions carrying a distinctive chromatin structure associated with
actively transcribed genes (K4-K36 domains). Studying chromatin-state maps across four mouse
cell types and 6 human cell types revealed -3500 lincRNA loci. Analysis of these loci show that
most indeed encode large RNA transcripts that exhibit strong cross-species conservation at the
level of sequence (in both exons and promoters), transcription and chromatin structure and show
promoter binding by both general (PolII) and relevant specific transcription factors (Sox2 and
Oct4 in ES cells). Yet, the vast majority shows no evidence of protein-coding capacity. Overall,
these properties closely resemble those of the roughly dozen known lincRNAs (e.g. HOTAIR,
and XIST)62
Our results show that chromatin structure can identify sets of lincRNAs that show a high
degree of evolutionary conservation, implying that they are biologically functional. (We do not
exclude the possibility that lincRNAs identified by shotgun sequencing that fail to show
conservation are nonetheless functional, but other evidence will be required to establish this
point.) Together, the results suggest that the mammalian genome may encode a large collection
of functional lincRNAs. The precise number of lincRNAs is difficult to estimate from the current
data. As a first approximation, we note that -75% of all protein-coding genes are expressed in at
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least one of the four cell types. If a similar ratio pertains to lincRNAs, the total might exceed
4500. If lincRNAs are more tissue specific, however, the total could be much higher. We
emphasize that our analysis focuses only on large intergenic RNAs. It thus excludes many other
classes of non-coding RNAs, including those overlapping protein coding genes such as promoter
associated RNAs2 5 , intronic and antisense transcription 3 and small RNAs, such as miRNAs,
piRNAs and snoRNAs4 . In addition, our analysis would likely not be sensitive to extremely low-
level transcription; such low level transcription could be biologically important.
The next steps will require detailed characterization of structure and function of
lincRNAs - including obtaining full-length cDNAs; expanding the gene-expression compendium
to more tissues and more lincRNAs; performing RNAi-mediated knockout in appropriate
settings; studying interactions with cellular proteins and DNA; and finally genetic deletion of
lincRNAs in mouse model systems. Whatever their functions, the well-conserved lincRNAs




Chromatin data for H3K4me3 and H3K36me3, for mouse Embryonic Stem Cells (mES), mouse
Embryonic Fibroblasts (MEF), and mouse neural precursor cells (NPC) were taken from
Mikkelsen et al. 2007 and were downloaded from (ftp://ftp.broad.mit.edu/pub/papers/chipseq/).
Chromatin data in mouse lung fibroblasts and human lung fibroblasts were generated as
34previously described
Identifying K4-K36 Enriched Domains
To identify regions of enriched chromatin marks we employ a sliding window approach: we slide
windows, score each window based on the number of ChIP fragments, compute a threshold for
significance, and use the significant windows to define intervals. Specifically: (i) We fix a
window size w and slide it across each position of the genome. For each position, we compute a
score, Sw, as the number of reads aligned within the window. (ii) To identify windows that have
significantly more reads than would be expected by chance, we define a null model based on the
randomization of read locations across the genome. This null model is estimated as a Poisson
distribution where k is defined as the number of reads in the library divided by the number of
possible non-overlapping windows of size w. (iii) Given the null model, we choose a threshold T
on the score such that the genome-wide probability that the Score Sw exceeds the threshold T by
chance is less than 0.01 (Prob(Sw>T)<0.01). We therefore cannot compute this probability
exactly, since the scores Sw occur in overlapping windows they are not independent values or
multiple testing corrected values. We therefore estimate it genome-wide across overlapping
windows using the scan statistic procedure 63. Therefore, windows that pass this threshold T are
significantly enriched after multiple testing correction. (iv) We retain only windows that pass this
threshold T, and merge overlapping significant windows into a single contiguous interval. We
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refine the boundaries of this interval by taking the maximum contiguous subsequence. (vi) To
generalize for multiple window sizes, we compute a threshold for each window size separately
and repeat the above procedure, merging windows of different sizes. (v) Finally, we score each
interval and test if it is significantly enriched using the same scan statistic approach introduced
above. The result is a set of intervals and their p-values.
To identify the intervals that encode intergenic K4-K36 domains we applied this approach to
independently find K4 and K36 regions. We filtered all K4 and K36 regions that overlapped with
known annotations (as described below). We identified all K4 and K36 intervals that were
adjacent. To define a K4-K36 domain we required that the interval from the K4 region through
the end of the K36 region was significantly enriched for K36 using the same scan statistic
approach. We then filter the list by regions that are at least 5Kb in length.
All results were produced in the March 2006 (MM8) freeze of the Mouse genome.
Filtering Gene Lists
We filtered the list of K4-K36 domains to eliminate all regions annotated as containing a protein
coding gene in mouse or orthologous protein coding genes in human, rat, or dog.
We obtained the list of all human protein coding genes as determined by Clamp et al. 2007 in the
Human genome (Hg 17) from (http://www.broad.mit.edu/mammals/alpheus/data/) and used the
liftOver (http://genome.ucsc.edu/cgi-bin/hgLiftOver) tool to identify their orthologous location
in the mouse genome (MM8). We also used the list of allRefSeq protein coding genes (MM8)
along with all RefSeq genes annotated in the Human (Hg 18), Rat (Rn4), and Dog (canFam2)
genomes. All refSeq gene lists were obtained from the UCSC Genome Browser
(http://hgdownload.cse.ucsc.edu/downloads.html). The liftOver tool was similarly used to place
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genes from other species in the mouse genome (MM8). In our analysis, we eliminated all regions
that overlapped any portion of a protein coding locus, including introns, exons, and UTRs. We
also excluded all regions that overlap a known miRNA gene obtained from the MIRBASE
64database
RNA Preparation and Sources
We purchased total RNA for mouse lung, brain, testes, and ovary (Ambion). We isolated RNA
from Mouse whole embryo, forelimb, and hindlimb from developmental time points E9.5, 10.5
and 13.5. These mice were generated using timed mating embryo isolation and dissection. We
obtained mES, mEF, and NPC RNA extracted from cell lines using the Qiagen RNAEasy Kit.
Bone Marrow dendritic cells were extracted as previously described 65, and stimulated with
various ligands (see below). We extracted RNA after 6 hours using the Qiagen RNAEasy Kit.
Tilling array design, hybridization and analysis.
High resolution DNA tiling arrays containing 2.1 million features were designed on the
Nimblegen platform (HD2) to represent a random sampling of -400 intergenic K4-K36 domains
identified in the mouse genome. Total RNA from mES, mLF, NPC and mEF was amplified
using poly-dT and labeled as described 8 . Arrays were hybridized and washed according to the
Nimblegen protocols and kits (Roche/Nimblegen). Array image files were processed using
Nimblescan (Roche/Nimblegen) and arrays were normalized by mean centering the data.
A second array was designed on the Nimblegen platform (HD 1) arrays containing 300,000 and
representing -150 K4-K36 domains. We hybridized mES, mEF, mLF, NPC, BMDC, TLR2,
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TLR4, TLR9, lung (Ambion), brain (Ambion), testis (Ambion), ovary (Ambion), whole embryo,
forelimb, and hindlimb to this array from developmental time points E9.5, 10.5 and 13.5. Total
RNA was amplified and labeled for array as described1 8 . For both arrays we tiled across all Hox
genes as well as handful of other genes as controls.
Determining Transcribed Segments From Tiling Arrays
To identify transcribed regions of K4-K36 domains, we hybridized poly-A RNA to a tiling
microarray. We developed a statistical algorithm to identify peaks in hybridization, representing
likely exons in a mature transcript.
We normalized the data by dividing each probe value by the average probe intensity across the
array. We scanned the K4-K36 domains using sliding windows of width w. We computed a score
defined as the sum of the normalized probe intensities. To determine the significance of this
score we permuted the intensity values assigned to each probe and recalculated the statistic. We
took the value for each permutation as the maximum score obtained for any random region. We
performed 1000 permutations and assigned a multiple testing corrected p-value to each region
based on its rank within this distribution. All regions with a p-value less than 0.05 were retained.
After determining the transcribed segments from each sample on the array, we defined exons as
the union of all bases covered by a transcribed segment.
RNA blot analysis.
RNA blot analysis was performed on Ambion first choice RNA blots (Ambion). The blots
contained RNA from various mouse tissues including heart, brain, liver, spleen, kidney, whole
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embryo, lung, thymus, testes, and ovary. Probes were designed to selected lincRNA exons, as
determined by tiling arrays, and hybridized to the RNA blot. Probes were prepared by PCR of
genomic regions followed by biotin incorporation using the North2South @ Biotin Labeling Kit
(Pierce). Probes were hybridized to the RNA blot for 14-15 hrs using the North2South @
Hybridization Kit (Pierce). The resulting chemiluminescence was detected using a CCD camera.
RT-PCR
RT-PCR analysis was performed on cDNA libraries made from total RNA from mouse embryo
(13.5), lung, brain, MEF, NPC, and ES cells reverse transcribed using Superscript II (Invitrogen)
and a poly-dT /random hexamer primer mix.
To validate the presence of individual lincRNA exons and their connectivity within a locus we
designed primers within and across exon boundaries using the Primer3 computer program. PCR
was performed as previously described" on reverse transcribed cDNAs. We performed a
negative control using a no RT reaction and a positive control using the mouse GAPDH gene.
The PCR products were analyzed by gel electrophoresis. To confirm splicing across exons, the
PCR products were purified with QlAquick PCR Clean-up kits (Qiagen) and then sequenced,
using the forward primer. To characterize apparent alternative splicing, the products were run on
2% NuSieve agarose (Lonza) gels and the multiple bands purified with a QlAquick Gel
Extraction kit (Qiagen) and sequenced. The primers used are detailed in supplemental table 6.
Multiple Species Alignments
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All multiple species alignments were the MULTIZ alignments obtained from the UCSC genome
browser (build MM9, http://hgdownload.cse.ucsc.edu/goldenPath/mm9/multiz30way/).
Coding Potential
We tested for protein coding potential of K4-K36 domains by determining the maximum
CSF39,66 score observed across the entire genomic locus. We downloaded the alignments from
UCSC and computed the CSF scores across sliding windows of 30 base pairs. We then scanned
all 6 possible reading frames in each window. After computing a score for each window, we
defined the 'max CSF score' for a K4-K36 domain to be the maximum observed score across the
region.
We also computed a 'normalized CSF score' for each individual exon. The 'normalized CSF
score' for each exon was defined to be the CSF score for each exon divided by the nucleotide
length of the exon.
PhastCons Enrichment Within K4-K36 Domains and Promoter Regions
We downloaded the phastConsElements30way from the UCSC Genome Browser (MM9). We
counted the number of phastCons elements within each K4-K36 domain as well as the number of
these elements within random, size matched, genomic regions. We constructed a distribution
based on the random genomic regions. A p-value was computed based on the rank of the K4-
K36 domain's rank within the random genomic distribution. This statistic was similarly applied
to the promoter regions of lincRNAs.
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Computing Pi Constraint
To detect sequence constraint within large ncRNAs, we chose to use a method that explicitly
models the rate of mutation as well as the level of constraint. This is especially relevant for
detecting constrained sequences in noncoding regions of the genome since many of these sites
are known to be degenerate and can tolerate mutations between certain nucleotides.
Briefly the method we used to identify purifying selection uses a probabilistic neutral model of
evolution. Given a phylogenetic tree T and a substitution rate matrix Q, constrained regions will
be evident because they are poor fits to the neutral model. In this framework, selection can be
apparent in 2 ways either through contraction of the tree length that depends on the intensity of
selection (o>) or through a mutation pattern (n) that is not concordant with the rate matrix.
We compute a log-odds score, Pi LOD score, which is the estimate of the sequence evolution
compared to neutrally evolving sequences. Sitewise LOD score estimation provides low
sensitivity to determine conservation, we therefore integrated across multiple bases. We chose
12mers based on empirically testing the tradeoff between sensitivity and specificity for various
kmers. Since the estimation of functional constraint is site specific, we can determine the log-
odds score for a region by adding the log-odds scores for each base contained in the region 5 .
Exon Conservation and K4-K36 Pi LOD Enrichment
To identify functional constraint within exons of large ncRNAs, we analyzed each exon
separately. We computed the Pi LOD score for each 12-mer contained within the exon. We took
the maximum 12-mer value for each exon. In order to normalize for the size differences between
different exons we computed a size matched random score. To do this we randomly generated
size matched regions of the genome and divided the observed LOD score by the average LOD
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score from the random regions. This normalization procedure produces a score for each exon in
the genome that reflects a size-independent level of constraint on each exon. The
Observed/Expected score can be interpreted as an enrichment level of the LOD score compared
with the genomic average. The distributions of this normalized score were then compared among
multiple different classes of genomic units, specifically protein coding introns, exons, and
untranslated regions (UTRs), as well as known large non-coding RNAs and non-coding cDNA
sequences. This statistic is robust to detecting regions of the genome that, while highly
constrained in sequence, are not neccessarily highly conserved over the entirety of the region.
We performed the same analysis for the K4-K36 domain, using 75bp windows.
CAGE and RNA Poll Enrichment
For each promoter region, we computed the number of CAGE tags or ChIP-Seq reads for PolIl.
We compared the number of aligned reads in the promoters to the number of aligned reads in
random regions of similar size (excluding repetitive regions of the genome). We computed
enrichment with a wilcoxon rank sum statistic between the promoters and random genomic
DNA.
CAGE data were downloaded from http://fantom31p.gsc.riken.jp/cage/download/mm5/ and the
regions were mapped to the MM8 build using the liftOver tool (http://genome.ucsc.edu/) CAGE
scores were computed by summing the number of reads in each tag cluster (Carninci et al. 2006).
RNA Polymerase II ChIP-Seq data was generated as previously described 34 in mES cells.
Oct4/Nanog Enrichments in ES-specific lincRNAs
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We used data generated by Loh et al 200659. Briefly, Chromatin Immunoprecipitation (ChIP)
was performed using antibodies against Oct4 and Nanog in mES cells. The resulting library was
sequenced using 454 sequencing and the 'paired end reads' were mapped to the genome. We
downloaded the read clusters mapped on the mouse genome (build MM5) from
http://www.nature.com/ng/journal/v38/n4/suppinfo/ng1760_S1.html. We used the liftOver tool
(http://genome.ucsc.edu/) to place the reads on the MM8 build of the mouse genome. We defined
binding events as clusters with at least 3 independent ChIP sequencing reads, as described in Loh
et al. 2006.
In order to determine the enrichment of intergenic Oct4/Nanog binding sites we counted the
number of intergenic Oct4/Nanog binding sites that overlapped with a K4me3 peak in the four
cell types. Next we counted how many of these regions coincided with the promoter of a
lincRNA in the four cell types. We then counted the number of these lincRNA promoter binding
events in ES cells and the number that had strong enrichment levels specifically in ES cells. A
hypergeometric statistic was applied to determine if the intergenic binding of Sox2 and Oct4 was
enriched at lincRNA promoter regions (K4) compared to other intergenic non-lincRNA K4
regions.
Luciferase Reporter Assay
We amplified individual regions of the lincRNA-Sox2 promoter using AccuPrime Pfx
polymerase (Invitrogen) and cloned the products into the pCR 2. lTOPO vector (Invitrogen).
Each region was subsequently cloned into pGL3 firefly Luciferase Reporter Vector (Promega).
293T cells were transiently transfected in triplicate using FuGENE 6 transfection reagent
(Roche) and analyzed 24 hours post-transfection by Promega Dual-Luciferase Reporter Assay
kit. Analysis was performed using the Veritas Microplate Luminometer system. Expression of
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the promoter regions was detected by firefly luciferase activity and was determined by obtaining
the relative value compared to the transfection control plasmid (CMV Renilla luciferase).
Comparison with Previous Transcript Maps
We downloaded the cDNAs sequenced by the FANTOM consortium from
(ftp://fantom.gsc.riken.jp/FANTOM3/). We defined two sets of FANTOM transcripts: the first
was the ncRNA conservative set, as provided on their site, and the second was all FANTOM
cDNA transcripts. We computed significant overlap between the genomic locus of a lincRNA
and a FANTOM unit by asking how much of a K4-K36 domain was covered by a FANTOM unit
and how much of a FANTOM unit was covered by a K4-K36 unit. We identified all cases in
which a transcript overlapped at least 25% of a K4-K36 domain or vice versa. We performed a
similar analysis between exons determined by our tiling arrays and FANTOM exons.
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Chapter 2: Ab initio reconstruction of transcriptomes of pluripotent
and lineage committed cells reveals gene structures of thousands of
lincRNAs
In this chapter, we describe the development of a method for ab initio reconstruction of a
mammalian transcriptome from RNA-Seq data and used it to define the precise sequence of
lincRNAs.
This work was first published as:
Guttman M, Garber M, Levin JZ, Donaghey J, Robinson J, Adiconis X, Fan L, Koziol MJ,
Gnirke A, Nusbaum C, Rinn JL, Lander ES, Regev A. (2010) Ab initio reconstruction of
transcriptomes of pluripotent and lineage committed cells reveals gene structures of thousands of
lincRNAs. Nature Biotechnology 28(5):503-10
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Recent studies have suggested that mammalian genomes encode thousands of large non-
coding RNA (ncRNA) genes, including large intergenic ncRNAs (lincRNAs). Defining the
gene structure of lincRNAs is essential for experimental and computational studies of their
function. Recent advances in massively parallel cDNA sequencing (RNA-Seq) provide an
unbiased way to study a transcriptome, including both coding and non-coding genes. To
date, most RNA-Seq studies have critically depended on existing annotated genes, and thus
focused on studying expression levels and structural variation in known transcripts. Here,
we present Scripture, a method to reconstruct the transcriptome of a mammalian cell using
only RNA-Seq reads and the unannotated genome sequence. We apply this approach to
mouse embryonic stem cells, mouse neuronal precursor cells, and mouse lung fibroblasts to
accurately reconstruct, for the vast majority of expressed genes, the full-length gene
structures at single-base resolution, including different splice isoforms. We identify novel
high-confidence biological variation in known protein-coding genes, including thousands of
novel 5'-start sites and 3'-ends, and almost a thousand novel internal coding exons. We
then determine the gene structures of over a thousand lincRNA loci, 27% of which show
alternative isoforms. The gene structures demonstrate that lincRNAs show strong
signatures of evolutionary conservation and pinpoint the specific regions under purifying
selection. Finally, we also identify hundreds of large multi-exonic anti-sense transcripts,
which show substantially lower conservation than the lincRNAs. Our results open the way
to direct experimental manipulation of thousands of non-coding RNAs, and demonstrate




A critical task in understanding mammalian biology is defining a precise map of all the
transcripts encoded in a genome. While much is known about protein-coding genes in mammals,
relatively little is known about non-coding RNA (ncRNA) genes. Recent studies have suggested
that the mammalian genome encodes many thousands of large ncRNA genes -3, including a class
of large intergenic ncRNAs (lincRNAs) 4 . Recently, we used a chromatin signature, combining
Histone 3 Lysine 4 tri-methylation modifications (H3K4me3) that mark the promoter region and
Histone 3 Lysine 36 tri-methylation modifications (H3K36me3) that mark the entire transcribed
region, to discover the genomic regions encoding ~1600 lincRNAs in four mouse cell types
(mouse embryonic stem cells, embryonic fibroblast, lung fibroblasts, and neural progenitor
cells)4 , and -3300 lincRNAs across 6 human cell types5.
Defining the complete gene structure of these lincRNAs is a pre-requisite for both
experimental and computational studies of their function, including over-expression and
knockdown experiments, site-directed mutagenesis, and analysis of functional sequence features
and conservation. In our previous studies, we gained initial insights into the gene structure of
lincRNAs by hybridizing total RNA to tiling microarrays defined across the K4-K36 region. This
provided a coarse list of putative exonic locations and suggested that lincRNAs are likely to be
multi-exonic, spliced transcripts. However, due to the limited resolution of tiling arrays, the
precise gene structures of these lincRNAs - including 5' and 3' ends, intron-exon boundaries,
and connectivity between different exons - have remained unclear.
Advances in massively-parallel cDNA sequencing (RNA-Seq) have opened the way to
unbiased and efficient assays of the transcriptome of any mammalian cell6 ,7,8,9. In principle,
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RNA-Seq allows the identification of all expressed transcripts, both protein-coding and non-
coding. Recent studies in mouse and human cells have mostly focused on using RNA-Seq to
study known genes -for example, to quantify their expression level,' 8 , assess the level of
alternative splicing between known splice junctions7',0 and identify fusions between known
genes in cancers . However, these studies have critically depended on existing annotated genes,
and have focused on understanding variability within known transcripts. They were thus of
limited utility for discovering the complete gene structure of large numbers of non-coding
transcripts, such as lincRNAs.
An alternative strategy is to use an ab initio reconstruction approach 9,"2 -14 to learn the
complete transcriptome of an individual sample from only the unannotated genome sequence
and millions of relatively short sequence reads. A complete ab initio transcriptome
reconstruction of a sample will (1) identify all exons within the transcriptome; (2) enumerate all
the splicing events that connect these exons; (3) combine these connected sequences into
complete transcriptional units; (4) determine all isoforms of these transcripts, including
alternative 5' and 3' ends, and (5) discover novel transcriptional units. A successful ab initio
method should be applicable to large and complex genomes such as in mammals, and should be
able to reconstruct transcripts of variable sizes (short and long), expression levels (high and low)
and protein-coding capacity (coding and non-coding). When applied to diverse cell types, ab
initio reconstruction can thus render a comprehensive and unbiased picture of transcriptome
variation including novel alternative splicing events, variation in existing annotations, and
previously unknown genes.
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Despite early successes in yeast9, ab initio reconstruction of a mammalian transcriptome
has remained an elusive and substantial computational challenge. There has been important
recent progress in mammals, including (1) efficient gapped aligners (e.g., TopHat) that can map
short reads that span splice junctions ('spliced reads')13; (2) use of such gapped alignments to
identify novel splicing events9,13; (3) exon identification methods that can be used in principle to
piece together transcripts14; and (4) direct genome-independent assembly of the unmapped reads
to create sequence contigs (e.g., Abyss ). Each of these methods provides an important
component towards reconstruction, but none can reconstruct the complete transcriptome of a
mammalian cell. The ab initio approach applied in yeast9 does not scale to mammalian genomes
which are significantly larger, contain mostly multi-exonic transcripts, and have substantial and
complex alternative splicing. Exon identification methods14 treat each exon in isolation (as a
'transcribed region') but do not handle splicing directly. Thus, they are underpowered to identify
short or low-expressed exons, can miss whole genes despite strong cumulative evidence,
generate disconnected exons rather than (alternatively spliced) transcripts, and cannot resolve
anti-sense from overlapping sense transcription. Finally, approaches for genome-independent,
assembly-based reconstruction such as Abyss' 2 (that assemble the reads directly without
mapping to the genome) can currently only be applied to transcripts with immense coverage, and
are hence partial and biased in practice.
Here, we present Scripture, a comprehensive method for ab initio reconstruction of the
transcriptome of a mammalian cell, and apply it to transcriptomes of mouse embryonic stem
(mES) cells, neural progenitor cells (NPCs), and mouse lung fibroblasts (MLFs) to discover the
complete gene structures of 9738 protein coding genes, 1868 lincRNA genes (1073 from
previously undescribed loci), and 446 large, multi-exonic anti-sense genes. Our approach uses
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gapped alignments of spliced reads followed by reconstruction of the reads into statistically
significant transcript structures. For example, when applied to mES cells, we correctly identify at
high confidence the complete annotated full-length gene structures from 5' to 3' end at single
nucleotide resolution for 78% of mES expressed genes. Of the remainder that are expressed in
ESC, we successfully build the annotated 5' start for 20% of genes and the annotated 3' end for
71% of genes. For many of the expressed genes, we reconstructed structures that differ from the
reported annotation but we demonstrate that many of these alternative structures are supported
by independent experimental data. The three reconstructed transcriptomes reveal substantial
variation between cell types, including thousands of novel 5'-start sites for protein coding genes,
hundreds of alternative 3'-ends, and thousands of additional coding exons spliced onto annotated
protein-coding genes.
We also discover the gene structure and expression level of over 2000 non-coding
transcripts. These include hundreds of transcripts from previously identified loci encoding mouse
lincRNAs, more than a thousand additional previously unknown lincRNAs with similar
properties, and hundreds of multi-exonic antisense ncRNAs transcribed from the opposite strand
of an overlapping protein-coding gene locus. These detailed gene structures allow us to identify
distinct alternatively spliced isoforms of lincRNAs in different cell types, definitively show that
they have no significant coding potential, and show that they are evolutionary conserved,
including identifying for the first time the specific regions of conserved sequence within these
lincRNAs. These results open the way to direct experimental manipulation of this new class of
genes. Finally, our sensitive approach can correctly determine the transcribed strand, allowing us
to detect gene structures for hundreds of novel multi-exonic antisense ncRNAs transcribed from
the opposite strand of an overlapping protein-coding gene locus. Our results highlight the power
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of RNA-seq along with an ab initio reconstruction to render a comprehensive picture of cell




We used massively parallel (Illumina) sequencing to sequence a cDNA library from
polyA(+) mRNA from mES, NPCs and MLFs cells. We used a cDNA preparation procedure that
combines a random priming step with a fragmentsation step'' 9 ' 5 and results in fragments of -700
nucleotides in size (Methods). We previously found'15 that this protocol provides relatively
uniform coverage of the whole transcript, thus assisting in ab initio reconstruction. We
sequenced each library on three lanes of the Illumina Genome Analyzer. For example, for the
mES library, we generated a total of 152 million paired-end reads of 76 bases in length. Using a
gapped aligner' 3, 93 million of these reads were uniquely alignable to the genome, providing
497Mb of aligned bases, at an average 262X fold coverage of the 38Mb within known protein
coding genes expressed in mES cells. We obtained similar results for the NPCs and MLFs
libraries (Methods).
Most uniquely aligned reads are consistent with the position of annotated protein coding
genes and measured expression levels, supporting the quality of our dataset. For example, in
mES cells, 76% of these reads map within the exonic regions of known protein-coding genes,
9% are in introns of known protein coding genes, and 15% map in intergenic regions.
Furthermore, less than 0.001% of paired reads extend across multiple known protein-coding loci,
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indicating lack of chimeras. Finally, we found a strong correlation between expression levels of
protein-coding genes as measured by the number of sequence reads obtained here compared to
Affymetrix expression arrays (r=0.88 for all genes).
Scripture: a statistical method for ab initio reconstruction of a mammalian transcriptome
We next developed Scripture, a genome-guided method to reconstruct the transcriptome
using only an RNA-Seq dataset and an (unannotated) reference genome sequence. Scripture
consists of six steps (Fig. 1): (1) We use reads uniquely aligned to the genome, including those
with gapped alignments spanning exon-exon junctions ('aligned spliced reads')' 3 (Fig. 1c); (2)
From the aligned spliced reads, we construct a connectivity graph representing spliced
connections between base pairs in the genome (Fig. 1d); (3) Using all spliced and non-spliced
(contiguous) read data, we use a statistical segmentation approach4 to traverse the connectivity
graph and identify significant paths (Fig. le); (4) From the paths, we construct a transcript graph
connecting each exon in the transcript (Fig. If); (5) We augment the transcript graph with
connections based on paired-end reads and their distance constraints, allowing us to join
transcripts or remove unlikely isoforms (Fig. 1g); and (6) We generate a catalogue of transcripts
defined by the transcript graph. We discuss each of these steps in detail below.
We first map our reads to the genome, using a gapped aligner13 that efficiently handles
reads that span splicing junctions (Fig. la). This step is critical since -30% of 76 base reads are
expected on average to span an exon-exon junction (Methods). Furthermore, 'spliced' reads
provide direct information on the location of splice junctions within the transcript.
We next use only the spliced reads to infer a connectivity graph across the genome,
where each base in the genome is connected to those bases in the genome that are its immediate
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neighbors either in the genomic sequence itself or within a spliced read (Fig. 1d). Furthermore,
we use agreement with splicing motifs at each putative junction in the graph to orient the
connection (edge) in the connectivity graph9" 3 (Fig. Id, Methods).
To infer transcripts, we apply a statistical segmentation approach that identifies
significantly enriched paths in the connectivity graph using both spliced and non-spliced reads
(Fig le). Briefly, our segmentation approach identifies regions of mapped read enrichment
compared to the genomic background. This is done by scoring a sliding window using a test
statistic for each region, computing a threshold for genome-wide significance, and using the
significant windows to define intervals (Methods). To define intervals, we scan short windows
to identify consecutive coverage blocks that have a read coverage scoring above the genome-
wide significance threshold we computed. This approach is based on our successful method for
identification of chromatin modified regions in genomes4 , but is applied here to the connectivity
graph rather than to the linear genome.
The result is a set of statistically significant directed transcript graphs (Fig if), each
representing one or more splice isoforms of a transcript. Each node in a transcript graph is an
exon and each edge is a splice junction. A path through the graph from an exon with no
incoming edges (first exon) to an exon with no outgoing edges (last exon) represents one isoform
of the gene. Since each graph is directed, all multi-exonic paths are oriented (i.e. strand-specific,
Fig. le). Alternative spliced isoforms are identified by considering all possible paths in the
transcript graph; since this number may be large and represent spurious paths, we refine it in the
next step.
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Paired-end reads in transcriptome reconstruction and resolution of alternative spliced
isoforms
Paired-end information, consisting of reads that came from the two ends of the sequenced
RNA fragment, can provide two kinds of valuable additional information in the reconstruction.
First, the presence of paired-ends linking two regions shows that they appear in the same
transcript; such a connection might not otherwise be apparent because low expression levels or
non-alignable sequence might prevent a continuous chain of overlapping sequence reads (spliced
or unspliced) across the transcript. We thus augment the transcript graphs with paired-end
information, where available, to (indirectly) link nodes in the graph. We use these indirect links
(Fig. 1g) to add edges between disconnected graphs, add internal nodes (exons) that might have
been missed within a path (transcript), and add extra support for existing edges. This refines the
structure of our transcripts and increases our confidence in them, especially in lowly-expressed
transcripts that are more likely to have coverage gaps.
Second, the distribution of library insert sizes constrains the distance between the paired
end reads; these distance constraints can be used to infer the relative likelihood of some potential
transcripts (for example, those in which the paired ends would be much closer or much further
than typical). We infer the distribution of insert sizes for a given library from the position of read
pairs on transcripts from those genes for which there is only a single transcript model (i.e., no
detectable alternative splicing) (Methods). Indeed, for our ES library, for example, this
estimated distribution matches extremely well with the experimentally determined size range
(data not shown). We use this distribution to assign likelihoods to each read pair occurring within
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Figure 1: Scripture: a method for ab initio transcriptome reconstruction from RNA-Seq
data. (a) Spliced and unspliced reads. Shown is a typical expressed 4-exon gene
(1500032D16Rik, top, exons: grey boxes) with coverage from different type of reads. Unspliced
reads (black bars) fall within a single exon, whereas splice reads (dumbbells) span exon-exon
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junctions (thin horizontal lines connect the alignment of a read to the exons it spans). The
coverage track (bottom) shows the aggregate coverage of both spliced and unspliced reads. (b-g)
A schematic description of Scripture. (b) A cartoon example. Reads (black bars) originate
from sequencing a contiguous RNA molecule. Shown are transcripts from two different genes
(blue and red boxes), one with seven exons (blue boxes) and one with three exons (red boxes),
which are adjacent in the genome (black line). The grayscale vertical shading in subsequent
panels is shown for visual tracking. (c) Spliced reads. Scripture is initiated with a genome
sequence and spliced aligned reads (dumbbells) with gaps in their alignment (thin horizontal
lines). Scripture uses splice site information to orient splice reads (arrow heads). (d)
Connectivity graph construction. Scripture builds a connectivity graph by drawing an edge
(curved arrow) between any two bases that are connected by a spliced read gap. (Edges are color
coded to relate to the original RNA and eventual transcript). (e) Path scoring. Scripture scans
the graph with fixed-sized windows and uses coverage from all reads (spliced and non-spliced,
bottom track) to score each path for significance (p-values shown as edge labels). (f) Transcript
graph construction. Scripture merges all significant windows and uses the connectivity graph to
give significant segments a graph structure (three graphs in this example). (g) Refinement with
paired-end data. Scripture uses paired-end (dashed curved lines) to join previously
disconnected graphs (Gene 1, bold dashed line), find break point regions within contiguous
segments (e.g. no dashed lines between Gene 1 and 2), and eliminate isoforms that result in
paired-end reads mapping at a distance with low likelihood.
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Correct reconstruction of full-length gene structures at single-base resolution for the
majority of protein-coding genes
We first applied Scripture to our mouse ES RNA-Seq dataset, and estimated the method's
sensitivity and accuracy by comparing our reconstructions to known annotations of protein-
coding genes. Scripture identified 15,246 nonoverlapping, multi-exonic transcript graphs which
correspond to 16,122 known genes from the NCBI RefSeq project 16. The average number of
transcript graphs per gene is 1.3, with 76.6% of reconstructed genes covered by a single graph
(single transcript in the reconstruction, though possibly with multiple paths for different splice
isoforms) and 18.5% covered by two transcript graphs (the transcript is split to two separate
pieces in the reconstruction).
For -78% (10,355) of the expressed transcripts, Scripture reconstructed the full-length
structure of the longest known splice isoform (from 5' to 3' end of the gene, including all exons
and splice junctions) at single base resolution (e.g. Fig. 2a). All of our reconstructed transcripts
for known multi-exonic transcripts also had the correct orientation (strand). In particular,
Scripture was able to correctly reconstruct known genes that overlap one another on opposite
strands (e.g. Fig. 2a).
Complete transcript structures are recovered across a very broad range of expression
levels (Fig. 2b,c). For example, Scripture accurately reconstructs the full-length transcript of
-73% of the known protein-coding genes at the second quintile of expression (68.4X mean
coverage), -88% of genes from the third quintile (144X fold coverage), and 94% of the genes
from the top quintile. Similarly, the average proportion of bases constructed for each transcript
(considering both full and partial reconstructions) was high (Fig. 2c). For example, even for the
bottom 5% of expressed genes (15X mean coverage), where we reconstruct the full length gene
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structure for only 19% of the transcripts (Fig. 2b), we do recover on average 62% of each of
these transcripts' bases (Fig. 2c). This demonstrates the power of Scripture to reconstruct a
substantial portion of lowly expressed transcripts.
In the remaining -22% (3007 genes) of cases that do not correspond to annotated full-
length transcripts, 71% (15% of the total) match at the annotated 3'-end, 20% (4% of the total)
match at the annotated 5' start; and the remainder (3% of total reconstructed transcripts) match at
neither end. Importantly, we show below that many of these variant transcripts likely represent
true alternative isoforms.
We obtained similar results in the other two cell types, with 20,854 transcript graphs that
correspond to 12,854 known genes in NPCs and 22,216 transcripts graphs corresponding to
13,257 known genes in MLFs. Taken together, our analysis shows that Scripture can accurately
reconstruct full-length gene structures at nucleotide resolution for the majority of expressed
genes. Since the minority of genes that are not reconstructed are those with low expression
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Figure 2: Scripture correctly reconstructs full length transcripts for the majority of
annotated protein coding genes. (a) A typical Scripture reconstruction on mouse chr9. Top
(red) - RNA-Seq read coverage (from both non-spliced and spliced reads); middle (black) -
three transcripts reconstructed by Scripture, including exons (black boxes) and orientation (arrow
heads); bottom (blue) -RefSeq annotations for this region. All three transcripts are fully
reconstructed from 5' to 3' ends capturing all internal exons; notice that Scripture correctly
reconstructed the overlapping transcripts Pus and Hyls1. (b) Fraction of genes fully
reconstructed in different expression quantiles (5% increments) in ESC. Each bar represents
a 5% quantile of read coverage for genes expressed (mean read coverage is noted in blue). The
height of each bar is the fraction of genes in that quantile that were fully reconstructed. For
example, ~20% of the transcripts at the bottom 5% of expression levels are fully reconstructed;
~94% of the genes at the top 95% of expression are fully reconstructed. (c) Portion of gene
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length reconstructed in different expression quantiles in ESC. Shown is a box plot of the
portion of each transcript's length that was covered by a Scripture reconstruction in each 5%
coverage quantile. The black line in each box is at the median, the rectangle spans the 25% and
75% coverage quantiles; the whiskers depict the annotations in the quantile most and least
covered by our reconstruction. For example, at the bottom 5% of expression, Scripture
reconstruct a median length of 60% of the full length transcript.
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Novel transcriptome variations in annotated protein-coding genes
Given that the vast majority of the significant ab initio reconstructions of protein-coding
genes are extremely accurate, we next investigated the differences between the reconstructed
mESC transcriptome and the known gene annotations. We focused on transcripts in mESC with
(i) novel 5' start sites; (ii) novel 3' ends; and (iii) previously unidentified exons within the
transcriptional units of known protein-coding genes. In each category, we first discuss below the
reconstructed transcripts in mESC and then consider the results for the NPCs and MLFs.
(i) Alternative 5' start sites in mouse ES cells are supported by H3K4me3 marks
We found 1804 transcripts in mESCs that match the annotated 3'-end but have an
alternative 5' start site. We distinguish between internal alternative 5' start sites (1397 cases,
Fig. 3a) that occur downstream of the annotated start, and external alternative 5' start sites (407
cases, Fig. 3b) that occur upstream of the annotated start. These novel 5 start sites are derived
from an additional exon (coding or UTR) not overlapping the annotated first exon.
We sought independent experimental support for the accuracy of 1397 internal 5'-start
sites by examining the location of H3K4me3, a mark of the promoter region of genes 7 . We
found that 1260 (90%) of the internal 5'-starts contain H3K4m3 marks, consistent with being
actively transcribed promoters. Notably, in 63% of cases with an internal 5'-start site, our
reconstructed transcriptome contained no isoform starting at the annotated 5'-start site.
For the 407 transcripts with external 5' start sites, we found that 75% are marked with
H3K4me3. These alternative start sites are on average 21Kb upstream of the annotated site
(48Kb SD), substantially revising the annotated promoters. For 66% (214 transcripts) of these
cases, our reconstructions contain only the novel 5' start site and not the annotated start site.
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We observed similar results from NPCs and MLFs cells (Fig, 3ab) Altogether, we
identified 2502 internal 5' start sites (2193 are supported by K4me3 in their respective tissues) in
at least one cell type (1870 are specific to one cell type, 497 are present in two cell types, and
135 in all three), and 635 external 5' start sites in at least one cell type (396 are specific to one
cell type, 149 are present in two cell types, and 90 in all three). In particular, 44% of these novel
5' ends are unique to the ESC state and are not present in either MLFs or NPCs.
(ii) Alternative 3' UTRs used in mES cells supported by polyadenylation motifs
Among our reconstructed transcripts in mES cells, there are 551 (-4%) cases with an
alternative 3'-end downstream of the annotated 3'-end (mean distance 30 Kb ± 67Kb SD
downstream, e.g. Fig. 3c). Of these, 275 (-50%) have evidence of a polyadenylation motif
within the novel 3' exon, which is only slightly lower than for annotated 3' ends (60%), and
much higher than for randomly chosen size-matched exons (6%). The frequency of the
polyadenylation motif supports the accuracy of the reconstruction.
Accurately detecting upstream (early) termination is more challenging, because it is
difficult to distinguish between early termination and incomplete reconstruction, especially in the
case of genes with relatively low expression levels and sequence coverage. We therefore
designated novel 3' ends only in those cases that did not overlap any of the known exons in the
annotated transcript and required that all considered transcripts contain complete 5' start sites
(further reducing the likelihood of incomplete reconstruction). We identified 759 transcripts with
upstream 3'-ends in mESCs (Fig. 3d); the vast majority of them (90%) also had isoforms that
contained the annotated 3' end. Of these upstream 3'-ends, 44% contain a poly-adenylation
motif. This is lower than the -60% for annotated 3'-ends, but much higher than the 6% for other
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size-matched exonic regions; it thus supports the biological relevance of many of the novel
upstream 3'-ends. We note that the isoform with alternative 3' internal end tends to be expressed
at a somewhat lower level than the isoform with the annotated 3' end (at a median 1.5 fold, p<
0.002, paired t-test).
We observed similar results for NPCs and MLFs cells (Fig. 3c,d). Altogether, we
identified 868 downstream 3' ends in at least one cell type (635 are specific to one cell type, 144
are present in two cell types, and 93 in all three) and 1609 upstream 3' ends in at least one cell
type (1221 are specific to one cell type, 318 are present in two cell types, and 70 in all three).
(iii) 903 additional coding exons within known gene structures are highly conserved and
preserve ORFs
We found 534 high confidence transcripts in mESC with at least one additional
previously unannotated internal coding exon (neither first nor last) spliced into annotated
protein-coding transcripts (Fig. 3e). These transcripts contained 591 novel internal exons,
ranging in length from 6bp to 3.5Kb (mean length of 217bp ± 388bp SD, comparable to
annotated exons). Of these additional exons, 322 (60%) are present in all versions of the
reconstructed transcript in mESC, whereas the remaining additional exons are part of some
transcript isoforms but not others within the same cell type.
The vast majority (83%) of these novel exons retain the reading frame of the transcript,
consistent with their being novel protein-coding exons. Moreover, the vast majority of these
novel coding exons are as highly conserved as known coding exons, further supporting their
functionality. We tested for the presence of the novel exons within 5 transcripts, using RT-PCR
followed by Sanger sequencing (Methods), and validated all of these tested cases.
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We observed similar results in MLFs (194 transcripts, with 212 exons) and NPCs (300
transcripts, 309 exons) (Fig. 3e). In -70% of cases, the novel exons are present in all versions of
the reconstructed transcript within a cell type. Altogether, we identified 903 novel internal exons
in at least one cell type (739 are specific to one cell type, 128 are present in two cell types, and
36 in all three, Fig. 3e). The vast majorities of these retain the ORF and show clear evolutionary
conservation.
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Figure 3: Alternative 5' ends, 3' ends and novel coding exons in transcripts reconstructed
by Scripture. Shown are representative examples (tracks, left) and summary counts (Venn
diagrams, right) of five categories of variations discovered in Scripture transcripts compared to
the known annotations. In each representative example, shown is the coverage by RNA-Seq
reads (top track, red), the reconstructed annotation (middle track, black), and the known
annotation (bottom track, blue). The novel regions in the reconstruction are marked by gray
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shading. In each proportional Venn diagram we show the number of transcripts in this class in
each cell type (ESC - green, NPC - blue, MLF - red) and their overlap. (a) Internal alternative
5' start; (b) External alternative 5' start; (c) Alternative downstream 3' end (extended
termination); (d) Alternative upstream 3' end (early termination); (e) Novel coding exons.
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Discovery of the complete gene structures of hundreds of lincRNA loci
We next turned to identifying the gene structures of transcripts expressed from known
lincRNAs loci. In our previous work, we had identified 317 lincRNAs based on K4-K36
domains in mES cells and using conservative filtering criteria . In the mES RNA-Seq data, we
were able to reconstruct multi-exonic gene structures for 250 (78.8%) of these 317 loci (e.g. Fig.
4a). (This is comparable to the proportion (78.5%) reconstructed for protein-coding genes with
K4-K36 domains in mES cells.) We accurately reconstructed 88% (160/183) of mES lincRNAs
for which we previously identified an RNA hybridization signal from tiling microarrays. In 11
cases we identified a single reconstructed lincRNA structure that spans across multiple K4-K36
regions and in 55 cases we identified a single K4-K36 locus that corresponded to two distinct
lincRNA gene structures in opposite orientations. These discrepancies are likely due to the lower
resolution of our chromatin maps compared with the base-pair resolution of our transcript maps.
We failed to reconstruct transcripts for the remaining 67 lincRNAs that had been
previously identified based on K4-K36 domains in mESC. These lincRNA genes may not have
been reconstructed because they are either expressed at lower levels, are single exons, are false
positives of our chromatin signature, or are false negatives of the reconstruction approach. For
example, 30 of our previously identified K4-K36 domains are reconstructed as likely connected
to a new isoform of a neighbouring protein coding transcript and thus are no longer counted as
lincRNAs in our refined catalogue. The principal reason we miss the remaining 37 K4-K36
domains is low expression levels. Nonetheless, 67% of these remaining lincRNA loci (25
lincRNAs) are significantly enriched for reads (average of 0.76 reads/bp compared to expected
0.01 reads/bp, nominal p<0 .0 0 1, random permutation of reads against size matched random
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regions). This is consistent with these loci being transcribed. With higher coverage, it should be
possible to reconstruct them.
The reconstructed lincRNA transcripts in mESCs have 3.7 exons ± 2.1 SD on average, an
average exon size of 350 ± 465 bp, and an average mature spliced size of 3.2 ± 1.7 Kb
(compared to 9.7 ± 9.5 exons, exon length of 291 ± 648 bp, total length of 2.9Kb ± 2.3 Kb for
protein coding genes). Since lincRNAs contain canonical splice acceptor and splice donor sites at
their exon-intron boundaries, we can use these to identify the strand information for >99% of
reconstructed lincRNAs. The predicted strand is consistent with that inferred from the location of
K4me3 modification, which marks the 5' end, and with the orientation determined from a strand-
specific RNA-Seq library which we generated independently (below, Methods). At least 82% of
lincRNAs in mESCs (205 lincRNAs) likely represent 5'-complete transcripts, as indicated by
overlap between the reconstructed 5'-ends of lincRNAs and a site of H3K4me3 modification.
Furthermore, the majority of the lincRNAs appear to be 3'-complete as well (since -50% contain
a polyadenylation motif, comparable to 60% for protein-coding genes and far above background
of 6%).
We had similar success in reconstructing lincRNA gene structures for K4-K36 lincRNA
loci in MLFs and NPCs. We identified 211 out of 264 multi-exonic lincRNAs in MLFs and 202
out of 245 in NPCs. 69% of lincRNAs in MLFs (145 lincRNAs) and 81% of lincRNAs in NPCs
(163 lincRNAs) likely represent 5'-complete transcripts based on sites of H3K4me3
modification; 18% of lincRNAs in MLFs (37 lincRNAs) and 37% in NPCs (75 lincRNAs) have
detectable 3' polyadenylation sites. In addition to these lincRNAs, we successfully reconstructed
another 103 lincRNAs previously identified only in mouse embryonic fibroblasts but which were
now reconstructed in at least one of the other three cell types (Methods). Altogether, we
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identified gene structures for 567 previously defined lincRNA loci in at least one of the three cell
types (78% of those previously defined in these 3 cell type; 56% of those present in the previous
catalogue in any cell type). 312 of the 567 lincRNAs are specific to one cell type, 174 are present
in two cell types, and 80 are in all three.
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Figure 4: Non-coding transcripts reconstructed by Scripture. (a) A representative example of
a lincRNA expressed in ESC. Top panel - mouse genomic locus containing the lincRNA and its
neighbouring protein coding genes. Bottom panel - zoom in on the lincRNA locus showing the
coverage of H3K4me3 (green track), H3K36me3 (blue track), and RNA-Seq reads (red track)
overlapping the transcribed lincRNA locus, as well as its Scripture reconstructed transcript
isoforms (black). (b) A representative example of a multi-exonic antisense ncRNA expressed in
ESC. Top panel - mouse genomic locus containing the antisense transcript. Bottom panel -
zoom in on the antisense locus showing the coverage of H3K4me3 (green track), H3K36me3
(blue track), and RNA-Seq reads (red track) overlapping the transcribed antisense locus, as well
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Additional novel lincRNAs identified across mES cells, MLFs and NPCs
In addition to previously annotated protein-coding genes, pseudogenes, and lincRNA loci, our
catalog contains another 1073 reconstructed multi-exonic transcripts that map to intergenic
regions in at least one cell type (591 in mESCs, 369 in MLFs, and 445 in NPCs; 846 are cell type
specific, 185 in two of the three, and 63 appear in all three cell types). These represent novel
intergenic transcripts. In principle, they could be either protein coding or non-coding RNAs.
The majority (88%) of the 1073 novel intergenic transcripts do not appear to encode
proteins, and can be designated as novel lincRNAs, based on the Codon Substitution Frequency
(CSF) scores 1'19 (Methods) across the mature (spliced) RNA transcript (Fig. 5a). Furthermore,
the vast majority (-80%) of the transcripts do not contain any open reading frame (ORF) larger
than 100 amino acids (Fig. 5b). The remaining ~12% might reflect novel protein coding genes,
ambiguous calls, and/or segmental duplications of protein coding loci. When we carefully
reviewed the loci to eliminate possible artifacts, we identify 66 loci that are likely to be novel
protein coding genes based on their high CSF score, a large open reading frame (>200 amino
acids), and very high levels of evolutionary conservation, comparable to known protein-coding
genes.
We investigated why the novel lincRNA loci had not been identified in our previous
study that identified lincRNAs based on the presence of K4-K36 domains in niESCs. One of the
reason appears to be that our previous study imposed stringent criteria to ensure that the novel
loci were well separated from known protein-coding genes - for example, requiring that a K4-
K36 domain extend over at least 5 Kb and be clearly separated from the nearest known gene
locus 4. Indeed, of the novel intergenic transcripts found in ES cells, 450 (76%) had enrichment
for a K4-K36 domain (a comparable proportion as for protein-coding genes) but failed to meet
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the other two criteria or were too weak to be identified at a genome-wide significance (without
knowing their locus a priori). The genomic loci of the novel lincRNAs tend to be much shorter
than the previously identified set (average -3.5Kb) and have shorter transcript lengths (859bp ±
1230bp SD vs. 3.2Kb ± 2.1Kb SD, with 3.4 exons vs 3.7 exons). On average, they are also closer
to neighboring protein-coding genes (20Kb ± 157Kb SD). These results underscore the increased
power of RNA-Seq to confidently identify lincRNAs compared to a chromatin-based method.
Most lincRNAs are evolutionarily conserved, with 22% of bases under purifying selection
The reconstructed full-length gene structures of lincRNAs allow us to accurately assess
their evolutionary sequence conservation in each exon and in small windows. To this end, we
identified the orthologous sequences for each lincRNA across 29 mammals and considered the
total contraction of the branch length of the evolutionary tree connecting them. Specifically, we
used a constraint metric (4 that reflects the 'contraction' of the branch length compared to the
neutral tree based on the total number of substitutions per base for random genomic regions
(Methods). We calculated o over the entire lincRNA transcript, as well as over individual exons.
Our previous estimates of conservation had relied on approximate definitions of the exons based
on hybridization to tiling arrays4 , leaving open the possibility of mis-estimation.
Based on our high resolution gene structures, the lincRNA sequences show significantly
greater conservation than random genomic regions or introns (Fig. 5c). Their conservation level
is similar to that seen for 8 known functional lincRNAs, including XIST , HOTAIR and
NRON , and is lower than that seen for protein-coding exons, likely reflecting a difference in
the constraints acting on protein coding sequences versus lincRNAs. The results are consistent
with our previous estimates of conservation4. Interestingly, the conservation profiles are
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essentially identical between the chromatin defined lincRNAs from our previous study and the
novel ones identified only in this study (Fig. 5c), further supporting our conclusion above that
they are part of the same class of functional large ncRNA genes.
We also determined the specific regions within each lincRNA that are under purifying
selection and thus likely to be functional. By computing o> within short windows (Methods), we
found that on average, 22% of the bases within the lincRNAs lie within conserved patches,
which is comparable to 25% for the 8 known functional lincRNAs cited above. In contrast, 7%
of intronic bases and 77% of protein coding bases lie within conserved patches. These conserved
patches provide a critical starting point for functional studies, by experimental manipulation and
computational analysis. For example, one such conserved patch in the XIST lincRNA has been
shown to allow the ncRNA to bind to the Polycomb complex 23.
lincRNAs are expressed at comparable levels to moderately expressed protein coding genes
On average, we found that lincRNAs are expressed at readily detectable levels, albeit
slightly lower than those of protein-coding genes. We estimated the expression for each of our
reconstructed transcripts using RPKM (Methods), and found that the median expression level of
the lincRNAs is approximately 3-fold lower than that of protein-coding genes (Fig. 5d). The
distributions show substantial overlap, with -25% of lincRNAs having expression levels higher
than the median level for protein-coding genes (Fig. 5d).
115
100
a10 ------- -- 10
0.8 - 0.8 -
0.6 - 0.6 -
0-4 - - - - --- 0.04 - - - - - - -
0.2 - WwRNA0.0 W
-6000 0 -2000 0 2000 4000 6000 0 260 4000 am
Protein-coding capacity (CSF score) Protein-coding capacity (Longest possible ORF)
o . d 1.0 - -
0.8 - 0.8 -
0.6 -0.6
04 - 0.4 -
a a
02 02 ----- romncoK4406kW*U 02-- K44036Ir
olnRNA Novel
0.0 - - - - - - - - - - - - - - - - - - 0.0 - -- - -
I - I I - -I r I --- I0.0 0.5 1 .0 15 2.0 0 10 2 0 50
II-- Omega '04 Expression level RPKM
Figure 5: Protein coding capacity, conservation levels and expression of lincRNAs and
multi-exonic antisense transcripts. (a-b) Coding capacity of protein coding, lincRNAs and
multi-exonic antisense transcripts. Shown is the cumulative distribution of CSF scores (a) and
maximal ORF length (b) for protein coding transcripts (black), lincRNAs (blue) and multi-
exonic anti-sense transcripts (green). (c) Conservation levels for exons from protein coding
transcripts, lincRNAs, multi-exonic antisense transcripts and introns. Shown is the cumulative
distribution of sequence conservation across 29 mammals for exons from protein-coding exons
(black), introns (red), exons from previously annotated lincRNA loci (blue), exons from newly
annotated lincRNA transcripts (grey), and exons from multi-exonic antisense transcripts (green).
(d) Expression levels of protein coding, lincRNAs and multi-exonic antisense transcripts. Shown
is the cumulative distribution of expression levels (RPKM) in ESC for protein coding transcripts
(black), transcripts from previously annotated lincRNA loci (blue), transcripts from newly




Variations in lincRNA isoforms and expression
A substantial fraction (-41%) of the novel lincRNAs were identified in at least two of the
three cell types. This is comparable to the 45% of the previously identified lincRNAs present in
at least 2 out of the 3 cell types. In contrast, 80% of expressed protein coding genes are
expressed across two of the three cell types. This suggests that lincRNAs are likely to be more
tissue-specific than protein coding genes.
Despite the shared presence of hundreds of lincRNAs in all three cell types, there can be
substantial differences in their expression levels. For example, of the 217 lincRNAs with
detectable expression in all three cell types, 10% were expressed at least 3-fold higher in mESCs
than in either of the other two cell types (3% were most highly expressed in MLFs, 29% were
most highly expressed in NPCs). Conversely, 38% of lincRNAs were expressed at least 3-fold
lower in mESCs than in MLFs and NPCs (11% in MLFs, 5% in NPCs).
A substantial portion of lincRNA loci produce alternative spliced isoforms. For example,
within mESCs we identified two or more alternative splicing isoforms for 25% of lincRNA
genes, comparable for 30% of protein coding genes (16% of lincRNAs in MLFs have alternative
splice isoforms, and 13% in NPCs) Altogether, 27% of the 1640 lincRNA loci have evidence for
alternative isoforms in any of the three cell types.
Discovery of hundreds of novel large antisense transcripts
Our transcriptome reconstruction also includes hundreds of transcripts that overlap
known protein-coding gene loci but are transcribed in the opposite orientation and likely
represent anti-sense transcripts. To focus on novel antisense transcripts, we required that a
protein-coding gene has no known antisense protein-coding genes overlapping the region.
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Furthermore, since Scripture used the orientation of the splice junctions to infer the transcript's
orientation (strand), we required that any identified antisense transcript be multi-exonic.
Using these criteria, we identified 201 antisense multi-exonic transcripts in mESCs (e.g.
Fig. 4b); these transcripts have an average 5 exons ± 8 SD per transcript, and an average
transcript size of 1.7Kb ± 1.6Kb SD (min 121bp, max 15.8Kb). The antisense transcripts overlap
the genomic locus of the overlapping protein coding gene by 1023 bp ± 1620bp SD (83% ± 29%
SD) on average, but their overlap with the exons of the sense transcript is substantially lower at
766bp ± 1581 SD (48% ±43% SD) on average.
We validated the reconstructed mESC anti-sense transcripts by three independent sets of
experimental data. First, the majority of the anti-sense loci carry an H3K4me3 mark at their 5'-
end, consistent with its independent and antisense transcription. Specifically, of the 164
transcripts where it is possible to detect an independent H3K4me3 mark (because the 5'-end of
the anti-sense transcript does not overlap the 5'-ends of the sense gene), we found an
independent H3K4me3 mark at the 5'-ends of the antisense locus in 64% of the cases (e.g. Fig.
4b). Second, we generated and sequenced a strand-specific library in mES cells (Methods) using
a published RNA ligation protocol and sequenced one lane of this library (17.5M reads,
Illumina, Methods). In >90% of cases we were able to confirm the existence of a significant
number of reads on the correct strand of these antisense transcripts. The remaining cases have
lower average expression levels, and thus are likely less readily detected in the more limited
amount of data in the strand-specific library. In no case did the strand-specific library indicate
that Scripture had identified the wrong strand. Finally, we used RT-PCR to unique exons of the
antisense transcript (Methods) followed by Sanger sequencing to individually confirm 5 of 5
anti-sense transcripts tested.
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The majority of the anti-sense transcripts appear to be non-protein coding, by both ORF
analysis and CSF scores (Fig. 5a,b). The novel antisense transcripts largely lack significant
ORFs, with the maximum possible ORF less than 100 amino acids in >95% of cases (Fig. 5b).
Furthermore, -85% are likely to be non-protein-coding based on their CSF scores (Methods,
Fig. 5a). Four of the newly identified antisense transcripts had a large, conserved open reading
frame and are likely novel, previously unannotated protein coding genes.
We obtained similar results for anti-sense transcripts in MLFs and NPCs (159 and 168
multi-exonic anti-sense transcripts, respectively). Altogether, we identified 446 novel anti-sense
transcripts expressed in at least one cell type (372 are cell type specific, 66 in two of the three,
and 8 appear in all three cell types).
The 446 anti-sense transcripts are expressed at comparable levels to the novel lincRNAs
(Fig. 5d), but show substantially lower sequence conservation. When we estimated the
conservation of these genes by calculating the o metric for the transcript (calculated over the
portions that do not overlap protein-coding exons on the sense strand), we found that the
antisense ncRNAs showed very little evolutionary conservation, suggesting that the antisense
ncRNAs are a distinct class from the lincRNAs (Fig. 5c).
DISCUSSION
Despite the availability of the genome sequence of many mammals, a comprehensive
understanding of the mammalian transcriptome has been an elusive goal. While the recent
development of massively parallel RNA-Seq provides a systematic method to comprehensively
sequence the transcriptome of a mammalian cell, the computational tools needed to reconstruct
all full-length transcripts from the wealth of short read data were largely missing. Indeed, most
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methods for analyzing RNA-Seq have assumed the availability of a previously annotated catalog
of protein-coding genes, and are thus not optimal for discovering novel transcript variations in
known genes or for finding novel genes - especially moderately expressed, non-coding ones
such as lincRNAs. A recent study proposed to overcome this limitation experimentally by using
very long reads (e.g. 454 sequencing), as a scaffold for short read reconstruction. This is
applicable, albeit at a substantial cost, for highly expressed genes, but would require incredible
depth to cover more lowly expressed ones.
Here, we present Scripture, a novel computational method to reconstruct a mammalian
transcriptome with no prior knowledge of gene annotations. Scripture relies on spliced reads to
traverse splice junctions and build a connectivity graph between discontiguous (spliced)
segments, uses this graph and both spliced and non-spliced reads to identify transcripts as
significant paths, resolves multiple splice isoforms as alternative paths, and leverages paired-end
information to refine these transcripts, by removing low likelihood transcripts, breaking spurious
connections and combining disconnected ones. At the heart of Scripture is a statistical
segmentation approach, which provides a principled method to identify significant transcripts.
By relying on a range of window sizes to drive the segmentation process, Scripture can identify
both short but strongly expressed transcripts as well as much lower expressed transcripts for
which there is aggregate (diffuse) evidence along the entire transcript length. This latter feature
is critical for the discovery of relatively low expressed transcripts, such as many lincRNAs.
Notably, Scripture does rely on a reference genome sequence (albeit unannotated), but many of
its components can also be used in the development of methods for de novo assembly of
transcripts from read data only (with no read mapping). This will be essential when a reference
genome is not known, as in environmental samples, non-model organisms, and cancer.
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We applied Scripture to RNA-Seq data from pluripotent ES cells and differentiated
lineages and showed that we can accurately reconstruct the majority of expressed annotated
protein coding genes, at a broad range of expression levels. Our results also uncover a large
number of novel isoforms in the protein-coding transcriptome, including thousands of novel 5'
start sites, hundreds of novel 3' ends and hundreds of novel coding exons. We provide strong
evidence from chromatin modification states, polyadenylation signals and sequence conservation
that these novel isoforms are biologically functional. This novel variation within known protein
coding genes may play key regulatory roles. For example, most of the discovered alternative 5'
start sites occur in a cell-type specific fashion, and thus involve cell-specific promoters likely
with distinct regulatory mechanisms. Similarly, novel 3' ends define distinct 3'-UTRs and have
the potential for distinct translational regulation (for example, through different miRNA binding
sites). Finally, the novel tissue-specific protein-coding gene exons that we discover are highly
conserved and preserve the ORF, suggesting that they encode cell type-specific protein products.
Going beyond protein-coding genes, we leverage Scripture's sensitivity and resolution to
reconstruct the gene structures of hundreds of non-coding RNA genes in these 3 cell types,
including both lincRNAs and multi-exonic antisense transcripts. It is clear that the mammalian
genome encodes thousands of large ncRNAs, which are typically moderately expressed and are
hence missed by traditional methods. We had previously identified many lincRNAs by searching
for chromatin signatures of actively transcribed genes that are well-separated from known
protein-coding genes to define novel loci, and by using RNA hybridization to tiling microarrays
to approximately define the exons. In contrast, Scripture identified many additional lincRNAs
(including those that are closer to protein-coding loci and those that have relatively low
expression) and provided precise gene structures for each. In addition, Scripture identified
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hundreds of large antisense ncRNAs, which overlap protein coding gene transcripts and hence
could not be effectively detected using chromatin data alone. Notably, our reconstructions
(despite being based on non-strand specific libraries) resolve such overlapping sense and anti-
sense transcripts at great accuracy, as subsequently validated with strand-specific RNA-Seq.
Overall, we find that there are thousands of large ncRNAs across the three cell types in
our study. Our data show that the ratio of active protein-coding to non-coding genes in these cell
types is roughly 10:1 (although the ratio may fall somewhat as additional cell types are studied,
because ncRNAs appear to be somewhat more tissue specific). However, the total number of
RNA molecules is more heavily biased toward the protein-coding fraction, with a proportion of
-100:1 coding to non-coding RNA.
Scripture identifies precise gene structures for the majority of previously found lincRNA
loci (as well as for the newly discovered ones). These gene structures are a pre-requisite for
further functional studies, both experimental and computational. For example, using these gene
structures, we identified the specific regions within each lincRNA that are under purifying
selection (conservation). These will provide a starting point for experimental manipulation (e.g.
site directed mutagenesis) and computational investigation (e.g. identification of sequence or
RNA structural elements).
Taken together our results highlight the power of ab initio reconstructions - using only
read data and an unannotated reference genome - to discover novel transcriptional variation
within known protein coding genes, and they provide a rich catalog of precise gene structures for
novel non-coding RNAs. The next step is clearly to apply this approach to a wide range of cell





Mouse embryonic stem cells (V6.5) were co-cultured with irradiated MEFs (GlobalStem; GSC-
6002C) on 0.2% gelatin coated plates in a culture media consisting of Knockout DMEM
(Invitrogen; 10829018) containing 10% FBS (GlobalStem; GSM-6002), 1% pen-strep 1% Non-
essential amino acids, 1% L-glutamine, 4ul Beta-mercaptoethanol, and .01% LIF (Millipore;
ESG1106). mES cells were passaged once on gelatin without MEFs before RNA extraction.
V6.5 ES cells were differentiated into neural progenitor cells (NPCs) through embryoid body
formation for 4 days and selection in ITSFn media for 5-7 days, and maintained in FGF2 and
EGF2 (R&D Systems) as described 26. The cells uniformly express nestin and Sox2 and can
differentiate into neurons, astrocytes and oligodendrocytes. Mouse lung fibroblasts (ATCC),
were grown in DMEM with 10% fetal bovine serum and penicillin/streptomycin at 370, 5% CO2.
RNA Extraction & Library Preparation
RNA was extracted using the protocol outlined in the RNeasy kit (Qiagen). Extracts were
treated with DNase (Ambion 2238). Polyadenylated RNAs was selected using Ambion's
MicroPoly(A)Purist kit (AM1919M) and RNA integrity confirmed using Bioanalyzer (Agilent).
A 'regular' RNA sequencing library (non strand specific) was created as previously described,
with the following modifications. 250 ng of polyA' RNA was fragmented by heating at 98'C for
33 minutes in 0.2 mM sodium citrate, pH 6.4 (Ambion). Fragmented RNA was mixed with 3 pig
random hexamers, incubated at 70'C for 10 minutes, and placed on ice briefly before starting
cDNA synthesis. First strand cDNA synthesis was performed using Superscript III (Invitrogen)
for 1 hour at 55'C, and second strand using E. coli DNA polymerase and E. coli DNA ligase at
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16 C for 2 hours. cDNA was eluted using Qiagen MiniElute kit with 30ul EB buffer. DNA
ends were repaired using dNTPs and T4 polymerase, (NEB) followed by purification using the
MiniElute kit. Adenine was added to the 3' end of the DNA fragments to allow adaptor ligation
using dATP and Kelnow exonuclease (NEB; M0212S) and purified using MiniElute. Adaptors
were ligated and incubated for 15 minutes at room temperature. Phenol/choloform/isoamyl
alcohol (Invitrogen 15593-031) extraction followed to remove the DNA ligase. The pellet was
then resuspend in lOul EB Buffer. The sample was run on a 3% Agarose gel (Nusieve 3:1
Agarose) and a 160 - 380 base pair fragment was cut out and extracted. PCR was performed
with Phusion High-Fidelity DNA Polymerase with GC buffer (New England Biolabs) and 2M
Betaine (Sigma). [PCR conditions: 30 sec at 98'C, (10 sec at 98'C, 30 sec at 65'C, 30 sec at
72'C -16 cycles) 5 min at 72'C, forever at 4'C], and products were run on a poly-acrylamide gel
for 60 minutes at 120 volts. The PCR products were cleaned up with Agencourt AMPure XP
magnetic beads (A63880) to completely remove primers and product was submitted for Illumina
sequencing.
The "strand-specific" library was created from 100 ng of polyA* RNA using the previously
published RNA ligation method2 4 with modifications from the manufacturer (Illumina,
manuscript in preparation). The insert size was 110 to 170 bp.
RNA-Seq library sequencing
All libraries were sequenced using the Illumina Genome Analyzer (GAII). We sequenced 3 lanes
for mouse ESC corresponding to 152 million reads, 2 lanes for MLFs corresponding to 161
million reads, and 2 lanes for NPCs corresponding to 180 million reads.
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Alignments of reads to the genome
All reads were aligned to the mouse reference genome (NCBI 37, MM9) using the TopHat
aligner13 . Briefly, TopHat uses a two-step mapping process, first aligning all reads that map
directly to the genome (with no gaps), and then attempting to map all the reads that were not
aligned in the first step using gapped alignment. TopHat uses canonical and non-canonical splice
sites to determine possible locations for gaps in the alignment. While all reported results rely on
TopHat alignments, very similar results are obtained in practice using the BLAT algorithm 27,
when allowing for gaps, and conservatively removing all gapped alignments that are aligned to
less than 80% of the read and do not contain canonical or non-canonical splice sites at the
locations of the gap. Since TopHat uses a global alignment strategy it is more suitable for short
RNA-Seq reads and far more efficient than BLAT.
Generation of connectivity graph
Given a set of reads aligned to the genome, we first identified all spliced reads, as those whose
alignment to the reference genome contains a gap. These reads and the reference genome are
used to construct connectivity graphs. Each connectivity graph contains all bases from a single
chromosome. The nodes in the graph are bases and the edges connect each base to the next base
in the genome as well as to all bases to which it is connected through a 'spliced' read (Fig. 1). In
the analysis presented, we defined an edge between any two bases in the chromosome that were
connected by two or more spliced reads. The connectivity graph thus represents the contiguity
that exists in the RNA but that is interrupted by intron sequences in the reference genome.
Identification of splice site motifs and directionality
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We restricted our analysis to splice reads that mapped connecting donor/acceptor splice sites,
either canonical (GT/AG) or non-canonical (GC/AG). We oriented each mapped spliced read
using the orientation of the donor/acceptor sites it connected.
Construction of transcript graphs
The 'spliced' edges in the connectivity graph reflect bases that were connected in the original
RNA but are not contiguous in the genome. To construct a transcript graph, we 'thread' the
connectivity graph (which was constructed only from the genome and spliced reads) with the
non-spliced (contiguous) reads, to provide a quantitative measure of the reads supporting each
base and edge. We then use a statistical segmentation strategy to traverse the graph topology
directly and determine paths through the connectivity graph that represent a contiguous path of
significant enrichment over the background distribution (below). In this segmentation process,
we scan variable sized windows across the graph and assign significance to each window. We
then merge significant paths into a transcript graph. Specifically, for a window of fixed size, we
slide the window across each base in the connectivity graph (after augmenting it with the non-
spliced reads). If a window contains only contiguous non-spliced reads, then it represents a non-
spliced part of the transcript. However, if the window hits an edge in the connectivity graph
connecting two separate parts of the genome (based on two or more spliced reads), then the path
follows this edge to a non-contiguous part of the genome, denoting a splicing event. Similarly,
when alternative splice isoforms are present, if a base connects to multiple possible places, then
all windows across these alternative paths are computed. Using a simple recursive procedure we
can compute all paths of a fixed size across the graph.
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Identification of significant segments
To assess the significance of each path, we first define a background distribution. We estimate a
genomic defined background distribution by permuting the read alignments in the genome and
counting the number of reads that overlap each region and the frequency by which they each
occur. Specifically, if we are interested in computing the probability of observing alignment a (of
length r) at position i (out of a total genome size of L) we can permute the alignments and ask
how often read a overlaps position i. Under this uniform permutation model, the probability that
read a overlaps position i is simply r/L. Extending this reasoning, we can compute the
probability of observing k reads (of average length r) at position i as the binomial probability.
Given the large number of reads and the large genome size, the binomial formula can be well
approximated by a Poisson distribution where A=np (or the number of reads/number of possible
positions).
Given a distribution for the real number of counts over each position we scan the genome for
regions that deviate from the expected background distribution. First consider a fixed window
size w. We slide this window across each position (allowing for overlapping windows), and
compute the probability of each observed window based on a Poisson distribution with ) =wnp.
Since we are sliding this window across a genome of size L, we correct our nominal significance
for multiple testing, by computing the maximum value observed for a window size (w) across a
number of permutations of the data. This distribution controls the family-wise error rate, defined
28as the probability of observing at least one such value in the null distribution . Notably, we can
estimate this maximum permutation distribution well by a distribution known as the scan statistic
distribution 29, which depends on the size of the genome that we scan, the window size used, and
our estimate of the Poisson k parameter. This method provides us with a general strategy to
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determine a multiple testing corrected P-value for a specified region of the genome in any given
sample. We use this method to compute a corrected significance cutoff for any given region.
Finally, to identify significant intervals, we scan the genome using variable sized windows,
computing significance values for each and filtering by a 5% significance threshold. For each
window size, we merge the significant regions that passed this cutoff into consecutive intervals.
We trim the ends of the intervals as needed, since we are computing significant windows (rather
than regions) and it is possible that an interval need not be fully contained within a significant
region. Trimming is performed by computing a normalized read count for each base in the
interval compared to the average number of reads in the genome. We then trim the interval to the
maximum contiguous subsequence of this value. We test this trimmed interval using the scan
procedure and retain it only if it passes our defined significance level.
We work with a range of different window sizes in order to detect paths (intervals) with variable
support, Small windows have power to identify short regions of strong enrichment (e.g. short
exon which is highly expressed), whereas long windows capture long contiguous regions with
often lower and more 'diffuse' enrichment levels (e.g. a longer lower expression transcript,
whose 'moderate evidence' aggregates along its entire length).
Estimation of library insert size
We estimated the insert size distribution by taking all reconstructed transcripts for which we only
reconstructed a single isoform and computing the distribution of distances between the paired-
end reads that aligned to them.
Weighting of isoforms using paired end edges
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Using the size constraints imposed by the length of the paired ends, we assigned weights to each
path in the transcript graph. We classified all paired ends overlapping a given path and assigned
them to all possible paths that they overlapped. We then assigned a probability to each paired
end of the likelihood that it was observed from this transcript given the inferred insert size for the
pair in that path. We used an empirically determined distribution of insert sizes, estimated from
single isoform graphs. We then scaled each value by the average insert size. We refer to this
scaled value as our insert distribution. For each paired end in a path, we computed I, the inferred
insert size (the distance between nodes following along the full path) minus the average insert
size. We then determined the probability of I as the area in our insert distribution between -I, L
This value is the probability of obtaining the observed paired end insert distance given this
distribution of paired end reads. To aggregate these into weights for each path, we simply weight
each paired end by its probability of observing to the given path. Paired ends that equally support
multiple isoforms will count equally for all, but paired ends with biases toward some isoforms
and against others will provide weighted evidence for each isoform. We assign this weight to
each isoform path. This score is normalized by the number of paired ends overlapping the path.
We filter paths with little support (normalized score<O. 1) of paired reads supporting it.
Determination of expression levels from RNA-Seq data
Expression levels are computed as previously described. Briefly, the expression of a transcript is
computed in Reads Per Kilobase of exonic sequence per Million aligned reads (RPKM) defined
109 r
as: rpkm(transcript) = , where r is the number of reads mapped to the exonic region of the
Rt
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transcript, t is the total exonic length of the transcript, and R is the total number of reads mapped
in the experiment.
Array expression profiling in mES cells
Microarray hybridization data was obtained from our previous studies including ES and NPCs17
and MLFs4.
Comparisons to known annotation
The reconstructed transcripts were compared to the RefSeq genome annotation' 6 (NCBI Release
39). To determine whether a known annotation of a protein coding gene from RefSeq was fully
reconstructed, we first compared the 5' and 3' ends of the reconstructed vs the annotated
transcript. If these overlapped, we further verified that all exons in the annotated transcript
matched those in the reconstructed version. To score the portion of an annotated transcript
covered by our reconstructions, we found the reconstructed transcript whose exons covered the
largest fraction of the annotated transcript, and reported the portion of the annotation that it
covered.
ChIP-seq profiles in mES cells and determination of K4 and K36 regions
To determine regions enriched in chromatin marks from ChIP-seq data we used our previously
described method4 applied to ESC, MLFs, and NPCs data4 '17.
Determination of external and internal 5' start sites
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We identified alternative 5' start sites by comparing the 5' exon of our reconstructed transcripts
to the location of the 5' exon of the annotated gene overlapping it. If the reconstructed 5' start
site resided upstream to the annotated 5' we termed it 'external start site'. For the novel 5' ends
that are downstream of the annotated 5' end (internal) we required a few additional criteria to
avoid reconstruction biases due to low coverage. First, we required that the novel internal 5' end
do not overlap any of the known exons within the known gene. Second, we required that the
reconstructed gene contains a completed 3' end. To determine the presence of H3K4me3
modifications overlapping the promoter regions defined by these novel start sites, we computed
regions of enriched K4me3 genome-wide (as previously described) and intersected the location
of the novel 5' exon (both internal and external) with the location of a K4me3 peak.
Determination of premature/extended 3' end
To determine novel 3' ends, we compared the locations of the 3' exon of our reconstructed 3'
ends and those of annotated genes. If the reconstruction extended past the annotated 3' end, we
classified it as an extended 3' end. If the reconstruction ended before the annotated 3' end we
required that it not overlap any known exon and have a fully reconstructed 5' start site.
Determination of sequence conservation levels
We used the SiPhy30 algorithm and software package to estimate a, the deviation ('contraction'
or 'extension') of the branch length compared to the neutral tree based on the total number of
substitutions estimated from the alignment of the region of interest across 20 placental mammals
(build MM9, http://hgdownload.cse.ucsc.edu/goldenPath/mm9/multiz3Oway/). For global (whole
transcript) conservation, we estimated a for each protein coding, lincRNA and antisense
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transcript exon and compared it to similarly sized regions within introns. To identify local
regions of conservation within a transcript, we computed o for all 12-mers within the transcript
sequence, and assigned a p-value for each 12-mer based on the chi-square distribution, as
previously described 0. We then took all 12-mers showing significance at p< 0.05, collapsed
overlapping 12-mers, and identified constrained regions within the transcript.
ORF determination
We estimated maximal supported open reading frames (ORFs) for each transcript built by
scanning for start codons and computing the length (in nucleotides) until the first stop codon was
reached.
CSF Scores
To further estimate the coding potential of novel transcripts, we evaluated whether evolutionary
sequence substitutions were consistent with the preservation of the reading frame of any detected
peptide. In a nutshell, if a transcript encodes a protein, we expect a reduction in frame shifting
indels, non-synonymous changes and, in general, any substitution that affects the encoded
protein. To assess this, we used Codon Substitution Frequency (CSF) method as previously
described'9.
RT-PCR validations
Primers were obtained for a randomly selected set of predicted lincRNA, protein coding genes,
antisense transcripts, and intron primers; all begining with M13 primer sequence. RNA from
mES cells was extracted using Qiagen's RNeasy kit (74106). A a one-step cDNA /RT-PCR
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reaction was run using Invitrogen's one-step RT-PCR kit (12574-018), following the
manufacturer's instructions, with the following PCR protocol: 55'C for 30 minutes, 94'C for 2
minutes (94'C for 15 seconds, 64'C for 30 seconds, 68'C for 1 minute - 40 cycles) 68'C for 5
minutes, 4'C forever. Samples were separated on a 3% agarose gel, and all bands were cut out
and gel extracted suing the QlAquick Gel Extraction Kit 28706. 30ng of DNA were mixed with
3.2pmol M13 forward or M13 reverse primer for sequencing.
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Chapter 3: Expression patterns implicate lincRNAs in diverse
biological processes
In this chapter, we describe a functional genomics strategy for inferring putative roles for
lincRNAs. The approach suggested functional roles for hundreds of lincRNAs in diverse
biological processes.
Parts of this work were first published as:
Guttman M, Amit I, Garber M, French C, Lin M, Feldser D, Huarte M, Cabili M, Carey BW,
Cassady J, Jaenisch R, Mikkelsen T, Jacks T, Hacohen N, Bernstein BEB, Kellis M, Regev A,
Rinn JL, Lander ES. (2009) Chromatin structure reveals over a thousand highly conserved, large
non-coding RNAs in mammals. Nature. 458(7235):223-7
Huarte M, Guttman M, Feldser D, Garber M, Koziol M, Broz D, Khalil AM, Zuk 0, Amit I,
Rabani M, Attardi L, Regev A, Lander ES, Jacks T, Rinn JL. (2010). A large intergenic




We recently reported the identification of more than a thousand large intergenic ncRNAs
(lincRNAs) that are evolutionarily conserved in mammalian genomes and thus likely to be
functional. Yet, what these functional roles are remains largely uncharacterized. Here, we
develop a novel functional genomics approach that assigns putative functions to each
lincRNA, revealing a diverse range of roles for lincRNAs in processes from ES
pluripotency to cell proliferation. We obtained independent functional validation for the
predictions for over 100 lincRNAs, using cell-based assays. In particular, we identify
several lincRNAs that are regulated by p53, based on two model systems and find that one
of these lincRNAs, termed lincRNA-p21, serves as an important regulator in the p53-
dependent transcriptional responses and is required for proper regulation of cellular
apoptosis. Collectively, our 'guilt-by-association' approaches along with targeted
perturbation studies have demonstrated that lincRNAs play critical regulatory roles across
diverse biological processes.
INTRODUCTION
It has become increasingly clear that the mammalian genome encodes numerous large
1 2non-coding RNAs We have recently reported the identification of more than a thousand large
intergenic non-coding RNAs (lincRNAs) in the mouse genome . Our approach to identify
lincRNAs was based on the fact that they contain a chromatin signature of actively transcribed
genes, consisting of a histone 3-lysine 4 trimethylated (H3K4me3) promoter region and histone
3-lysine 36 trimethylation (H3K36me3) corresponding to the elongated transcript. These
lincRNAs show clear evolutionary conservation, implying that they are functional 3,4.
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Despite the identification of thousands of ncRNAs, their functions remained largely
unknown. Identifying the functional role of a ncRNA requires direct perturbation experiments,
such as loss of function and gain of function. Individual ncRNAs involved in specific processes
have been functionally characterized (Reviewed in5 ). For example, XIST is critical for random
inactivation of the X-chromosome , Air is critical for imprinting control at the Igf2r locus7,
HOTAIR affects expression of the HoxD gene cluster8 as well as multiple genes throughout the
genome -11, HOTTIP affects expression of the HoxA gene cluster , lincRNA-RoR affects
reprogramming efficiency13, NRON affects NFAT transcription factor activity 1 4 , and Tug1
affects retina development through regulation of the cell cycle'5 . While there are now many
examples of large ncRNAs that are required for proper regulation of gene expression, this is just
one function for large ncRNAs which play critical roles in processes ranging from telomere
16 17
replication1 to translation
Yet, global characterization of ncRNA function is challenging because in most cases it is
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unclear what phenotype to explore . One approach to classify the putative functional roles of
ncRNAs utilizes 'guilt by association' 18. These methods associate ncRNAs with biological
processes based on common expression patterns across tissues and thereby identify groups of
ncRNAs associated with specific cellular processes. We utilize expression patterns across 21
mouse cell types and tissues to classify the function of lincRNAs based on their coexpression
with functional protein-coding genesets. Using this approach, we classified the putative
functional roles of hundreds of lincRNAs across diverse biological processes such as stem cell
pluripotency, immune responses, neural processes, and cell cycle regulation.
While such correlations cannot prove that lincRNAs function in these processes, they
provide hypotheses for targeted follow-up using loss-of-function experiments. We demonstrate
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this principle using a group of lincRNAs that are strongly associated with and regulated by the
p53 transcriptional pathway. p53 is an important tumor suppressor gene involved in maintaining
genomic integrity 9. In response to DNA damage, p53 becomes stabilized and triggers a
transcriptional response that causes either cell arrest or apoptosis . While p53 is known to
activate numerous genes, the mechanisms by which p53 leads to gene repression has remained
elusive. We recently reported evidence that many lincRNAs physically associate with repressive
chromatin modifying complexes and suggested that they may serve as regulators in
transcriptional regulatory networks9 . We therefore hypothesized that lincRNAs may also be
directly activated by p53 and subsequently regulate downstream transcriptional repression.
Here we show that lincRNAs play a key regulatory role in the p53 transcriptional
response. By exploiting multiple independent cell-based systems, we identified lincRNAs that
are misregulated upon p53 perturbations and showed that many are transcriptional targets of p53.
Moreover, we find that one of these p53-activated lincRNAs (which we termed lincRNA-p21)
serves as a transcriptional repressor in the p53 pathway and plays a role in the maintenance of
apoptotic function. Together, these results implicate lincRNAs in diverse biological processes
and reveal a direct role for a lincRNA in the p53 transcriptional response.
Results
Functional classification of lincRNAs
Having identified a large collection of conserved lincRNAs, we sought to gain insight into
their biological function by profiling their expression across 16 mouse cell types and tissues.
These samples consisted of the original four cell types (mES, NPC, mEF, mLF), a time course of
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embryonic development (Whole Embryo, Hindlimb and Forelimb at embryonic days 9.5, 10.5
and 13.5), and 4 normal tissues (brain, lung, ovary and testis). The expression compendium
revealed numerous clusters of correlated and anticorrelated lincRNAs. Unsupervised clustering
grouped the tissues and cells in our compendium in a biologically coherent way. For example,
the developmental time course was robustly grouped according to their temporal regulation (p <
105, bootstrap p-value).
The expression data contains a wealth of information about the lincRNAs. As an example,
we searched for lincRNAs with an expression pattern opposite to the known lincRNA HOTAIR.
Interestingly, we found that the most highly anti-correlated lincRNA in the genome lies in the
HOXC cluster, in the same euchromatic domain as HOTAIR; we call this lincRNA, Frigidair
(Figure la). This suggests that Frigidair may repress HOTAIR or perhaps activate genes in the
HOXD cluster.
We then compared the expression profiles of the lincRNAs to the expression profiles of
protein-coding genes (see methods). We first constructed a matrix A showing the correlation
coefficient for the lincRNAs vs. -22,000 protein coding genes, across the 16 cells and tissues;
we found that numerous lincRNAs were associated with groups of protein coding genes. Using
matrix A, we also constructed a matrix B showing the correlation of lincRNAs vs. 1700
functional gene sets; correlations were determined using the gene set enrichment analysis
(GSEA) methodology and the functional gene sets were taken from the Molecular Signatures
Database (MSigDB)21 . We then performed biclustering on matrix B to identify groups of
lincRNAs that are associated with various functional categories22 . Each bicluster represents a
group of lincRNAs with shared functional annotations. Finally, we used Gene Ontology (GO)
analysis to infer functions associated with each bicluster.
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This analysis revealed a wide range of lincRNAs that were associated with distinct and
diverse biological processes. These include cell proliferation, RNA binding complexes, immune
surveillance, neuronal processes, morphogenesis, gametogenesis, and muscle development
(Figure le). The bicluster with the largest number of associated lincRNAs and highest
significance level was associated with cell proliferation, cell-cycle regulation, and RNA binding
genes. The second most significant bicluster was associated with innate immunity, response to
biotic stimulus and inflammatory response genes.
To assess the validity of the inferred functional associations, we examined the gene sets
associated with HOTAIR, a lincRNA of known function (repression of HOXD cluster).
HOTAIR showed negative association with HOXD genes (FDR<0.018) and positive association
with 'Chang Serum Response' (FDR <0.001) a known predictor of breast cancer metastasis23
Together, these associations suggest a role for HOTAIR in breast cancer. Consistent with this
hypothesis, it has been experimentally shown that loss of HOXD expression is a signature of
24,25invasive breast cancer
We then sought to obtain independent experimental validation of the inferred biological
functions for many of the lincRNAs. We focused on three large clusters of lincRNAs associated
with NFKB signalling, embryonic stem cell pluripotency, and the p53-mediated DNA damage
response based on their expression patterns across tissues.
TLR-regulated lincRNAs
We used a similar strategy to investigate lincRNAs associated with the 'immune
surveillance' cluster. To search for lincRNAs related to immune pathways, we stimulated sorted
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CD11 C+ bone marrow-derived dendritic cells with a specific agonist of the toll-like receptor
TLR4, lipopolysaccharide (LPS). LPS is well known to cause dramatic activation of NFKB
transcriptional activity26 and induction of many immune genes. We found 20 lincRNAs whose
expression changed dramatically upon TLR4-stimulation, representing -5% of lincRNAs present
on the array and comparable to the fraction of regulated protein-coding genes 27 . Interestingly,
the greatest change in expression was observed in a lincRNA located -51Kb upstream of the
protein coding gene Cox2, a critical inflammation mediator that is induced by TLR4; we refer to
this as linc-Cox2. Using quantitative PCR, we found that linc-Cox2 is induced -1000 fold over
the course of 12 hours following TLR4 stimulation (Figure 1b). In contrast, only weak
induction of linc-Cox2 was seen upon stimulation of TLR3 (using polyl:C). ,which signals more
strongly through IRF3 than NF-KB, suggesting that lincRNAs provide an additional regulatory
layer in the signaling network defining the specificity of the innate immune response.
ES cell pluripotency and direct regulation by Sox2, Oct4, and Nanog
Using published data from mouse ES cells, we identified 118 lincRNAs whose promoter
28loci were bound by the core transcription factors Oct4 and Nanog . Of those represented on our
expression array 72% resided in the cluster associated with pluripotency, again supporting the
validity of the functional inference. We noticed that one of these lincRNAs, which is only
expressed in ES cells, is located -100 kb from the Sox2 locus, which encodes another key
transcription factor associated with pluripotency. This lincRNA is highly expressed only in the
pluripotent cell state (Figure 1c). We cloned the promoter of this locus (which we will refer to as
lincRNA-Sox2) upstream of a luciferase reporter gene and transfected the construct into mouse
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cells transiently expressing Oct4, Sox2, or both, as well as several controls. We found that Sox2
and Oct4 were each sufficient to drive expression of this lincRNA promoter, while expression of
both Oct4 and Sox2 caused synergistic increases of expression. In addition to ES specific
lincRNAs, we identified other lincRNAs that are exclusively expressed in other cell lineages
such as the neural lineage (Figure 1d).
The ultimate proof of function will be to demonstrate that RNAi-mediated knock-out of
each lincRNAs has the predicted phenotypic consequences. Toward this end, we examined a
recently published shRNA screen of (presumed) protein-coding genes to identify genes that
regulate cell proliferation rates in mouse ES cells 2 9 . The screen involved genes and some
unidentified transcripts that had been identified as expressed in ES cells and showing rapid
decrease in expression upon retinoic acid treatment. Of the top 10 hits in the screen, one
corresponded to a gene of unknown function. We discovered that this gene corresponds to one of
our lincRNAs (located -181 kb from Enc 1) contained in both the 'cell cycle and cell
proliferation' cluster (FDR < 0.001) and the 'embryonic stem cell' cluster (FDR<0.001). This
provides functional confirmation that this lincRNA plays a direct role in cell proliferation in ES
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Figure 1: lincRNAs are differentially expressed in various conditions. (a) Map of mouse
genomic locus (HOXC) containing HOTAIR, shows relative location of HOTAIR and
FrigidAIR. HOTAIR and FrigidAIR show diametrically opposed expression patterns between
mouse forelimb (anterior) and mouse hindlimb (posterior). (b) Map of genomic locus containing





















COX2. qRT-PCR shows that lincRNA-Cox2 is upregulated in TLR4 stimulated cells (NFKB
mediated, green) but not TLR3 stimulated cells (IRF3 mediated, blue). (c) A map of the genomic
locus containing SOX2 shows a lincRNA -50Kb upstream that is similarly expressed
specifically in ES cells. (d) Map of the genomic locus of Brn 1, a key neural lineage transcription
factor, is flanked by two lincRNAs. qRT-PCR shows lineage specific expression, similar to Bn 1,
in neural lineages. (e) Correlation matrix of lincRNA and functional gene sets. Each entry
reflects the association between the lincRNA and the functional gene set based on Gene Set
Enrichment Analysis (GSEA). Functional gene sets (columns) and lincRNAs (rows) are shown
as either positively (red), negatively (blue) or not correlated (white) with lincRNA expression
profiles. Two major cluster are highlighted, 'Cell-Cycle regulation and Cell Proliferation' and
'Immune Surveilence'. Gene ontology of the protein coding genes in these clusters is shown and
plotted as the -log(p-value) for the enrichment of each GO term.
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p53-dependent regulation of lincRNAs
We hypothesized that some of the lincRNAs associated with 'cell cycle and proliferation' might
be regulated by p53. We decided to test this hypothesis in a well-defined DNA damage system
that induces p5330 . This system allows conditional restoration of wildtype Trp53 within an
30++inducible cre-lox system . We will refer to the recombined cells (Trp53 restored): p53*'+ and
non-recombined: p53-' mEFs (Figure 2a). We performed several controls to demonstrate
significant restoration of p53 function upon activation of cre. We obtained p53+'* and p53-'-
MEFs and exposed them to a DNA damaging agent (doxorubicin). We then profiled lincRNA
expression across a time course at 0, 1, 3, 6, and 9 hours post DNA damage induction. We found
38 lincRNAs that increased significantly across the induction time course in the p53*'* cells
(Figure 2b). We found that the promoters of these lincRNAs were significantly enriched for the
p53 cis-regulatory element (compared to all lincRNA promoters, p<.01 Wilcoxon Test). This
suggests that p53 directly binds and regulates the expression of at least some these lincRNA
genes. We then asked if these lincRNAs were also present in the "cell cycle and proliferation"
cluster. Indeed, the p53-induced lincRNAs were strongly enriched in the "cell cycle and
proliferation" cluster (p < lOe-7).
Several lincRNAs are transcriptional targets of p53
To validate the functional importance of these classifications, we focused on lincRNAs
associated with the p53-mediated DNA damage response. We first sought to identify lincRNAs
that could be canonical p53 target genes. We cloned two lincRNA promoter regions with highly
conserved canonical p53-binding motifs 31,32 into a luciferase reporter vector. Both the lincRNA-
p21 and lincRNA-Mkln1 constructs showed significant induction of luciferase driven in p53-
wild type but not in p53-null cells (p<0.01, Figure 2c).
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To determine if the canonical p53-binding motif is required for the observed
transactivation we repeated these experiments in the absence of the p53 binding motif. Mutant
promoters resulted in the abolition of the observed transactivation for lincRNA-p21 and
lincRNA-Mklnl in p5 3 "'+ cells. Finally, we performed Chromatin Immunoprecipitation (ChIP)
experiments to determine if p53 directly binds to the consensus motif of lincRNA-p21 and
lincRNA-Mknll. Indeed, p53 is bound to the consensus motif in the promoters of both lincRNA-
p21 and lincRNA-Mkln1 and is not enriched at negative control sites lacking a canonical p53
binding motif (Fig 2d). Together these results demonstrate that lincRNA-p21 and lincRNA-





















Figure 2: P53 regulated lincRNAs. (a) Experimental layout to monitor p53-dependent
transcription. p53-restored (p53*'*) and non-restored (p5 3 -'-)p 5 3LSULSL MEFs were treated with
500nM dox for 0, 3, 6 and 9 hours (top left). KRAS (p53 LSUL) tumor cells were treated with
hydroxytamoxifen for p53 restoration for 0, 8, 16, 24, 40 or 48 hours (bottom left). RNA was
subjected to microarray analysis of mRNAs and lincRNAs. (b) lincRNAs activated by p53
induction (FDR < 0.05) in MEF or KRAS system. Colors represent transcripts above (red) or
below (blue) the global median scaled to 8 fold activation or repression, respectively. (c) p53-
dependent induction of lincRNA promoters requires the consensus p53 binding elements.
Relative firefly luciferase expression driven by promoters with p53 consensus motif (lincRNA-
p21, lincRNA-Mkln1) or with deleted motif (DlincRNA-p21 and DlincRNA-Mkln1) in p53*'* or
p53~'-cells. Values are relative to p53-'- and normalized by renilla levels. (d) p53 specifically
binds to p53 motifs in lincRNA promoters. p53 ChIP enrichment in p53'* and p53~'- MEFs on
regions with p53 motifs (lincRNA-p21, lincRNA-Mklnl, Cdknla) or two irrelevant regions
(controls). Enrichment values are relative to IgG, and average of 3 technical replicates of a
representative experiment.
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lincRNA-p21 regulates gene expression in the p53 pathway
We next sought to determine the consequence of the loss of lincRNA-p21 function in the
context of the p53 response. We reasoned that, if lincRNA-p21 plays an important role in
orchestrating the p53 transcriptional response, then inhibition of lincRNA-p21 would show
similar effects as inhibition of p53 itself. To test this hypothesis, we used RNAi-mediated
depletion of lincRNA-p21 and p53 and monitored the resulting transcriptional changes by DNA
microarray analysis.
Toward this end, we first designed three pools of siRNA duplexes targeting lincRNA-
p21, p53 or non-targeting control sequences. We validated that they were effective at knocking
down the intended target genes in p53LSULSL restored MEFs (Figure 3a and 3b). We then used
microarray analysis to examine the broader transcriptional consequences of knockdown of p53
and lincRNA-p21 compared to the non-targeting control. We identified 1520 and 1370 genes that
change upon knockdown of p53 or lincRNA-p21, respectively (relative to non-targeting control
siRNA, FDR <0.05). We observed a remarkable overlap of 930 genes in both the lincRNA-p21
and p53 knockdowns, vastly more than would be expected by chance (p<10 2 00 ) (Figures 3c).
Strikingly, 80% (745/930) of the common target genes are derepressed in response to both p53
and lincRNA-p21 knockdown; this proportion is much higher than expected by chance (Figure
3c). In contrast, the genes misregulated by the p53 knockdown alone showed no bias for
upregulation or downregulation, suggesting that lincRNA-p21 participates in downstream p53
dependent transcriptional repression.
To further demonstrate that the observed derepression upon lincRNA-p21 loss-of-
function is indeed p53-dependent and not due to off target effects of the RNAi mediated
depletion experiments, we performed several additional experiments and analyses. First we
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repeated the depletion experiments with four individual siRNAs targeting lincRNA-p2 1,
transfected separately rather than in a pool and confirmed the derepression effect across multiple
duplexes for select target genes in the microarray experiment. Second we confirmed that the
same genes that were derepressed in the lincRNA-p21 and p53 depletion experiments correspond
to genes that are normally repressed upon p53 induction in both the KRAS and MEF systems
(GSEA FDR < 0.002) (Figure 3d). Thus, derepressed genes in the siRNA depletion experiments
are highly enriched for genes that exhibit temporal repression upon induction of p53 in both the
KRAS and MEF systems in the absence of RNAi treatment. Third we demonstrated that forced
over-expression of lincRNA-p21 (Methods) also perturbed the expression of genes that were
affected upon depletion of lincRNA-p2 1. Finally, we did not observe derepression of these genes
upon repeating the same siRNA depletion experiments in the absence of p53 (-AdCre).
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Figure 3: lincRNA-p21 is a global repressor of genes in the p53 pathway. (a) RNAi-mediated
depletion of lincRNA-p21 and p53. Relative RNA levels determined by qRT-PCR in p53-
reconstitued p5 3LSJLSL MEFs transfected with the indicated siRNAs and treated with DOX.
Values are the median of 4 technical replicates. (b) p53 protein levels after lincRNA-p21 and p53
depletion from cells treated as in (A). bActin levels are shown as loading control. (c) Many genes
are corepressed by lincRNA-p21 and p53. Top: Venn diagram of differentially expressed genes
(FDR < 0.05) upon p53 depletion (left) or lincRNA-p21 depletion (right); cells were treated as in
(A) and subjected to microarray analysis. Bottom: expression level of genes in lincRNA-p21 and
p53 siRNA-treated cells relative to control siRNA experiments. Expression values are displayed
in shades of red or blue relative to the global median expression value across all experiments
(linear scale). (d) Genes derepressed by lincRNA-p21 and p53 depletion overlap with the genes
repressed by p53 restoration in the MEF and KRAS systems. The black line represents the
observed enrichment score profile of genes in the lincRNA-p2l/p53 derepressed gene set to the




The activation of the p53 pathway has two major phenotypic outcomes: growth arrest and
apoptosis 33. Consistent with this, our microarray analysis demonstrates that p53 and lincRNA-
p21 share regulation of several apoptosis and cell-cycle regulator genes. However, critical cell-
cycle regulators, such as Cdknla/p21 Cdkn2a or Reprimo are regulated by p53 independently of
lincRNA-p21. In contrast, p53 and lincRNA-p21 share regulation of common genes involved in
apoptosis such as Apaf 1, Noxa, G2e3 or Bcl213. Thus, we aimed to determine the physiological
relevance of lincRNA-p21 in the p53 response.
Toward this end, we used RNAi mediated depletion of lincRNA-p21 in either dox treated
or untreated primary MEFs. We similarly performed RNAi mediated depletion of p53 (as a
positive control) or used the non-targeting siRNA pool (as a negative control) under the same
conditions. We observed a significant increase in viability of cells treated with siRNAs targeting
lincRNA-p21 or p53 in the presence of DNA damage compared to the control siRNA pool
(Figure 4a,b). Such increase in viability was greater for depletion of p53, but still highly
significant for depletion of lincRNA-p21 (P < 0.01). We observed similar results using three
individual siRNA duplexes targeting lincRNA-p2 1, as well as two different control siRNA pools
(Figure 4b). These results demonstrate that lincRNA-p21 plays a physiological role in regulating
cell viability upon DNA damage in this system, although it does not distinguish whether the
effect is due to misregulation of the cell cycle or apoptosis33
To distinguish between these two possibilities, we quantified the proportion of the cell
population undergoing apoptosis by detection of Annexin-V by FACS analysis. We observed a
significant decrease in the number of apoptotic cells in both the lincRNA-p21 and p53 depleted
cells relative to siRNA control, when cells were subjected to DNA damage (P<0.01) (Figure
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4d,e). Consistent with the lincRNA-p21 dependent reduction of apoptosis we observed a
decrease in Caspase 3 cleavage relative to controls (Figure 4). We note that MEFs typically
34respond to DNA damage with cellular arrest, rather than apoptosis . However, we do observe a
reproducible and similar reduction of apoptotic cells in response to DNA damage in both
lincRNA-p21 and p53 experiments. We further determined that the observed apoptosis is
dependent on the dosage of dox-induced DNA damage. Thus, the apoptosis response is clearly
both p53-dependent and lincRNA-p21-dependent, with this dependence being confirmed in
multiple settings (Figures 4b,d,f); The decrease of apoptotic cells in response to knockdown of
lincRNA-p21 was comparable to that caused by knockdown of p53, suggesting that lincRNA-
p21 is required for the p53-dependent induction of apoptosis under the experimental conditions
used (Figure 4c).
We further tested whether depletion of lincRNAp-21 affects cell cycle regulation in
response to DNA damage by measuring 5-bromo-2-deoxyuridine (BrdU) incorporation and
propidium iodide staining of the cells. Consistent with the known function of p53, depletion of
p53 caused a significant increase in BrdU incorporation in response to DNA damage (P<0.01). In
contrast, depletion of lincRNA-p21 neither showed significant changes in BrdU levels nor in the
percentages of cells in any of the cell cycle phases (S, G1 or G2) either treated or untreated with
DOX (Figure 4c). These results suggest that lincRNA-p21 does not substantially contribute to
cell cycle arrest upon DNA damage.
We next wanted to determine whether, conversely to lincRNA-p21 depletion,
overexpression of lincRNA-p21 would result in increased apoptosis. Indeed, lincRNA-p21
overexpression in a lung cancer cell line harboring a KRAS mutation (referred to as LKR) and in
3T3 MEFs caused a significant decrease in cell viability (Experimental Procedures and Figures
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4g). This decrease in viability was due to increased apoptosis in response to DNA damage
(P<0.01) and not to an effect in cell cycle regulation (Figure 4h,i).
Several additional lines of evidence are consistent with the observed apoptosis
phenotype. First, we observed that both lincRNA-p21 and p53 repress genes involved in the
repression of apoptosis and the promotion of cell survival (Bcl213, Stat3, Atf2). Second, although
lincRNA-p21 and p53 depletions exhibit derepression of cell-cycle regulators, some key cell-
cycle genes are regulated by p53 independently of lincRNA-p2 1, including Ckn la/p21. In fact,
depletion of lincRNA-p21 does not perturb the transcript levels of Cdkn la/p21 nor the protein
stability; thus lincRNA-p21 is insufficient to mount a cell-cycle phenotype. Taken together, these
observations demonstrate that lincRNA-p21 plays an important role in the p53-dependent
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Figure 4: lincRNA-p21 is required for proper apoptotic induction. (a) Increased cell viability
of lincRNA-p21 depleted cells. Relative number of siRNA-transfected MEFs treated with
400nM DOX from 24h after transfection (right) or untreated (left) determined by MTT assay.
(b) Depletion of lincRNA-p21 with individual siRNAs increases cell viability. Images of MEFs
treated with different individual siRNAs after 48 hours of DOX treatment (72h post
transfection). (c) LincRNA-p21 depletion doesn't affect cell cycle regulation. Relative cell
numbers in each cell cycle phase determined by FACS of BrdU incorporation and PI staining of
MEFs treated as in (a). Numbers inside bars represent percentages of cells in each phase (average
of 3 biological replicates). (d) LincRNA-p21 depletion causes a decrease in cellular apoptosis.
P53-reconstituted p53LSULSL MEFs transfected with three individual siRNAs targeting lincRNA-
p21 (bottom), two independent control siRNAs (top left and middle) or a siRNA pool targeting
p53 (top right). 24 hours after transfection cells were treated with 400nM doxorubicin and 14
hours later harvested and subjected to FACS analysis. X-axis represents Annexin-V and y-axis 7-
AAD staining. The percentage of cells in each quadrant are indicated. (e) Decreased apoptosis
caused by lincRNA-p21 depletion. Quantification of the relative apoptosis levels by Annexin-V
FACS detection at 38h post transfection (14h of 400nM DOX treatment) in MEFs treated as in
(a). Values are average of 3 biological replicates of a representative experiment. Stars show
significant difference (P<0.01) relative to control. (f) LincRNA-p21 depletion in p53-
reconstituted p53LSULSL MEFs causes decrease in Caspase 3 cleavage. Levels of cleaved Caspase
3 or control bActin in p53 reconstituted-p53LSULSL MEFs treated with the indicated siRNA pools
and 500nM DOX for 14 hours. (g) Decreased cell viability caused by lincRNA-p21
overexpression. Relative numbers of LKR cells overexpressing lincRNA-p21 or control plasmid
determined by MTT assay. Values are average of 3 biological replicates. (h) Overexpression of
lincRNA-p21 causes cellular apoptosis under DNA damage induction. Apoptosis quantification
by Annexin-V FACS in LKR cells overexpressing lincRNA-p21 or control vector treated with
500nM DOX. Values are the average of 3 biological replicates. Star represents P<0.01. (i)
LincRNA overexpression doesn't affect cell cycle regulation. Cell cycle analysis of DOX-treated




We provide a functional genomics pipeline for inferring putative roles for lincRNAs.
This 'guilt-by-association' approach associates lincRNAs with biological processes based on
common expression patterns across tissues and thereby identify groups of ncRNAs associated
with specific cellular processes. This approach suggested functional roles for 150 lincRNAs that
we studied on microarrays, and the independent experiments provided support for the predicted
pathways for -85 lincRNAs. The pipeline thus provides a useful guide for hypothesis-driven
functional studies.
Our analysis strongly suggests the existence of a rich world of functional lincRNAs with
a diversity of biological roles that may resemble that seen for proteins. For example, the
expression patterns of lincRNAs are as diverse as those of protein coding genes across the cell
types and conditions studied, allowing us to associate lincRNAs with a myriad of biological
processes at least at the level of correlated expression. We also show that some lincRNAs are
directly regulated by the key master regulators of stem-cell pluripotency such as Sox2 and Oct4.
And, we validated several functional associations between lincRNAs that are likely regulated by
p53 in cancer and by NFKB during the immune response.
It is important to point out that not all non-coding transcripts act as functional RNA
molecules. Several examples of intergenic transcription have been identified where the act of
transcription alone changes the chromatin and transcription factor binding landscape allowing
activation and repression of neighboring genes35'6 . As such, these correlations cannot prove that
lincRNAs function in these predicted processes but rather provide hypotheses for targeted loss-
of-function experiments. Methods that degrade RNA after its transcription, such as RNAi, can
distinguish between a functional RNA molecule and the act of transcription for which there
should be no observable effect upon RNA degradation.
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We utilize these predictions to show their value in identifying direct functional roles of a
specific lincRNA predicted to play a role in the p53 process. For example, the lincRNA-p21 was
predicted to be associated with the p53-mediated DNA damage response18 . Indeed, lincRNA-p21
was found to be a target of p53 and upon perturbation was shown to regulate apoptosis in
response to DNA damage 37. Another lincRNA, lincEnc l1 , was predicted to have a role in cell-
cycle regulation in embryonic stem cells (ESCs) and shown in a distinct study to affect
proliferation in ESCs 2 9 .
A fundamental issue will now be to elucidate the biological functions and determine the
mechanisms by which lincRNAs act. One clue may come from our previous observation that
HOTAIR represses gene expression and is associated with chromatin remodeling proteins,
38together with recent similar observations for XIST . Based on these observations, we speculate
that many lincRNAs may play a role in transcriptional control, perhaps by guiding chromatin
modifying proteins to target loci. Testing this hypothesis will require biochemical and genetic
studies, including gene knock-down in appropriate settings. Whatever their mechanism, the
lincRNAs appear to be involved in diverse biological process and likely play a direct regulatory
role in these processes.
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Methods
Protein Coding Gene Expression Profiles
We obtained Affymetrix 430 2.0 mouse gene expression data for all RNA samples profiled on
our lincRNA array. For ES, MEF, NPC (GSE8024) and brain, lung, testis, and ovary (GSE9954)
arrays were already available in the Gene Expression Omnibus (GEO) and in these cases we
downloaded the data. For Forelimb, Hindlimb, and Whole Embryo for days 9.5, 10.5, and 13.5,
we generated our own data using Affymetrrix 430 2.0 arrays. For dendridic cells we generated
data for, unstimualted, TLR2 stimulated, TLR4 stimulated, and TLR9 stimulated cells using
Affymetrrix 430A arrays (RNA isolated as mentioned above).
Correlation Matrix Clustering
We generated a correlation matrix between lincRNAs by computing the Pearson correlation
coefficient between all pairs of lincRNAs. A matrix was constructed whoe entries are the
correlation coefficients. This matrix was clustered and visualized using the Gene Pattern
platform for integrative genomics (http://genepattern.broad.mit.edu/) using a Euclidian distance
metric and complete linkage clustering 39. The same procedures were used to produce, cluster,
and visualize the lincRNA-Protein coding gene matrix and the lincRNA-Functional Term matrix.
Gene Set Enrichment Analysis and Functional Term Clustering
Gene Set Enrichment Analysis was performed as previously described 2. Briefly, we used each
lincRNA as a profile, computed the Pearson correlation for each protein coding gene and then
ranked the protein coding genes by their correlation coefficient. The rank of these genes was
used to identify significant gene sets, using the weighted Kolmogorov-Smirnov (KS) testl.
Gene sets were permuted 1000 times to obtain FDR corrected p-values. We constructed an
association matrix between lincRNAs and terms. We then performed biclustering on this matrix
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to identify significant lincRNAs associated with functional terms. Biclusters were obtained using
the Samba algorithm implemented in the Expander software package.
Identifying Differentially Expressed Genes in DNA Damage Stimulated Cells
Tp53LSU+ heterozygous mice were intercrossed and fibroblasts were derived from p53LSULSL and
p53*' embryos as decribed previously30. Sub-confluent cultures were infected on two
consecutive days with adenoviruses expressing green fluorescent protein (AdGFP) or Cre
recombinase (AdCre) (University of Iowa Genetics Core Facility). Cells were then seeded
overnight into 10 cm dishes and treated with 500 nM doxorubicin (Sigma) for the indicated time
course. Cells were harvested into Trizol reagent (Invitrogen) and total RNA was extracted for
subsequent analysis as described 0 .
In parallel, cells were harvested for analysis of p53 protein expression. A monoclonal antibody to
mouse p53 (Gift from Kristian Helin) was used for protein blotting and detected by enhanced
chemiluminescence (GE Healthcare) per manufacturer's instructions. Hsp90 monoclonal
antibody served as a loading control (BD Biosciences).
We identified differentially expressed genes, protein coding and lincRNA, using the Patterns
from Gene Expression (http://www.cbil.upenn.edu/PaGE/) program 41 . Briefly, we determined
differential expression between p53' MEFs compared to p53-'- MEFs at paired times (paired t-
test). We filtered the list by genes that were specifically induced across the time points.
Motif Enrichments
Motifs were represented by Position Weight Matrix (PWM) downloaded from the TRANSFAC
matrix database v8.3 (http://www.gene-regulation.com/pub/databases.html) 42. Given a PWM, for
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each nucleotide position in a promoter, we calculated an affinity score defined as the log
likelihood (LOD score) for observing the sequence given the PWM versus a given random
genomic background. We then found the best conserved motif instance over the entire promoter
region for each PWM. An instance was considered conserved if its conservation score was in the
top 5% of the genome distribution.
We computed this score for each lincRNA promoter and computed enrichment of the motif for
our experimentally determined set compared with all lincRNA promoters. To ensure that
enrichment was not due to nucleotide bias within the promoter, we shuffled the PWM and
computed enrichment for the true PWM compared to the shuffled PWMs. Enrichment was
computed using a two-sided Wilcoxon rank-sum test between the set and the background. We
then computed an FDR to correct for testing of multiple PWMs.
Bone marrow dendritic cell (BMDC) cultures
Bone marrow was harvested from 6-8 week old female mice and cultured for 6 days in GM-
CSF 43 supplemented medium. Non-adherent cells were sorted using anti-CD1 c-beads (Miltenyi
Biotech) according to manufacturer's guidelines. CD1 Ic positive cells where replated 1.5* 106
cells/plate on day 7. BMDCs were left untreated or stimulated with 100 ng/ml LPS for 6 hours or
stimulated with 250 ng/ml Pam3CSK4 for 6 hours (TLR2 stimulation) or with CpG
oligonucleotide luM for 6 hours (TLR9 stimulation) or with poly-inosine:cytosine (polyl:C)
2ug/ml for 6 hours (TLR3 stimulation) . Cells were then collected by scraping and RNA was




cDNA was generated by the use of High-Capacity cDNA Archive Kit (Applied Biosystems).
Real-time PCR assays were performed using SYBR Green I as a fluorescent dye on a lightCycler
480 (Roche), according to the manufacturer's guidelines. Experiments were carried out in
triplicate, and relative gene expression was normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) RNA levels. Real-time PCR primer pairs for protein coding genes
were designed using ProbeLibrary (https://www.roche-applied-
science.com/sis/rtpcr/upl/index.jsp), primer pairs for lincRNA were designed using primer3
(http://frodo.wi.mit.edu/) with similar settings.
Cell lines and in vivo models
KRAS Lung tumor-derived cell lines were isolated from individual tumors . Isolation of matched
p53' and p53-'- MEFs, p513SULSL MEFs, Lymphomas and Sarcomas and p53 restoration as
described 44 . Primary wt MEFs and 3T3 MEF cells were purchased from ATCC. Transfection,
infection and treatment conditions are described in Supplemental Experimental Procedures.
Promoter reporter assays
LincRNA promoters were cloned into the pGL3-basic vector (Promega) and motif deletions were
performed by mutagenesis. p53- reconstituted or control p53LSULSL MEFs were transfected with
800ng of pGL3 and 30ng of TK-Renilla plasmid per 24 well. 24 hours later cells were treated
with 500nM dox for13 hours and cell extracts were assayed for firefly and renilla luciferase
activities with Dual Luciferase Reporter Assay System (Promega E1910).
lincRNA and gene-expression profiling.
RNA isolation, lincRNA expression profiling (Nimblegen arrays) and analysis were performed
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as described 3 and Supplemental Experimental Procedures). Affymetrix, gene-expression
profiling was performed as described 3.
Antibodies
Anti-p53:Novocastra (NCL-p53-CM5p) (western blot) and Vector Labs (CM-5) (ChIP). Anti-
hnRNP-K: Santa Cruz Biotechnology (sc-25373) (western blot) and Abcam (Ab70492 and
Ab39975) (ChIP and RIP). Control rabbit IgG Abcam (Ab37415-5) (RIP and ChIP-chip).
Viability and apoptosis assays and cell cycle analysis
MTT assays were performed using Cell Proliferation Kit I from Roche (11465007001) in 96-
well plates with initial density of 2500 cells/well. For apoptosis quantification, the Apoptosis
Detection Kit I from BD Biosciences (cat#559763) was used followed by FACS 45. Cell cycle
46
analysis was performed as described
Cloning, RNA pull-down, deletion mapping, RIP, ChIP
5' and 3' RACE cloning of lincRNA-p21 was performed from total RNA of dox-treated MEFs
using RLM-RACE Kit (Ambion AM1700). RNA pull-down and deletion mapping were
performed as described 8 using 1mg of mES nuclear extract and 50 pmol of biotinylated RNA.
RNA-bound proteins were resolved in a SDS-PAGE gel, bands were cutout and analyzed by
47 8Mass Spec as described or detected by western blot. Native RIP was carried out as described
For cross-linked RIP, cells were cross-linked with 1% formaldehyde, 6ug of antibody was added
and incubated overnight, recovered with protein G magnetic Dynabeads and washed three times
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in RIPA buffer. After reverse-crosslink, RNA was analyzed by qRT-PCR. P53 ChIP and hnRNP-
K ChIP-chip experiments were performed as previously described 8
RNA interference and lincRNA-p21 overexpression
siRNA transfections were done in 6-well plates of subconfluent cells with 75nM of siRNA and
3ul of Lipofectamine 2000 (Invitrogen) per well following manufacturer's instructions. For
overexpression, lincRNA-p21 was cloned into the pBABE vector and after transfection cells
were selected with 2ug/ml puromycin for 8 days.
Cell lines, p53 restoration and DNA damage induction
Lung tumor-derived cell lines were isolated from individual tumors from KrasLA2/+;
Trp53LSIJLSL Rosa26CreERT2 animals (D.F. and T.J. manuscript in preparation). Lymphomas
and Sarcomas were isolated when they formed in Trp53LSIULSL Rosa26CreERT2 animals as
described (Ventura et al. 2007). For p53 restoration, cultured tumor cell lines were incubated
with 500nM 4-hydroxytamoxifen (Sigma) for the indicated time points and p5 3LSULSL MEFs,
were infected with AdenoCre virus or AdenoGFP for 24h (University of Iowa) at moi of 5. For
DNA damage, cells were treated with 100 to 500nM doxorubicin hydrochloride (Sigma D1515).
lincRNA and Protein Coding Gene Expression Profiling
High resolution DNA tiling arrays were designed on the Nimblegen platform to represent a
random sampling of -400 lincRNAs identified in the mouse genome. Total RNA from different
experimental conditions was amplified using poly-dT and labeled as described 3
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Identifying Differentially Expressed lincRNAs
We designed custom Nimbelgen tiling microarrys which tile the exonic regions of each mouse
lincRNA at l0bp resolution. To identify lincRNAs that were differentially expressed in these
conditions, we first determined which lincRNAs are significantly expressed in each sample. We
then used this set of expressed lincRNAs to test for differential expression.
To determine expressed lincRNAs we used our previously developed statistical algorithm
to identify peaks in hybridization. We first normalized the data by dividing each probe value by
the average probe intensity across the array. We scanned each region and computed a score
defined as the sum of the normalized probe intensities. To determine the significance of this
score we permuted the intensity values assigned to each probe and recalculated the statistic. We
took the value for each permutation as the maximum score obtained for any random region. We
performed 1000 permutations and assigned a multiple testing corrected p-value to each region
based on its rank within this distribution. All exons with a p-value less than 0.05 were retained.
We computed differentially expressed exons by extending the above strategy but
computed a t-statistic between each group (ie Ohr vs 8hr). We assessed a multiple testing
corrected p-value by permuting the probe values across all conditions and recomputing the t-
statistic. We performed 1000 permutations and generated a maximum distribution for each
permutation and assigned FWER corrected p-values. We retained all exons with p-values < 0.05.
We performed post-processing of these results to ensure robust differential lincRNAs.
Specifically, for MEF time course we required that a lincRNA exon was differentially expressed
between P53*'* and P53-' cells and also differentially expressed between any time point and time
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0. For the KRAS experiment we required that any differential exon be differentially expressed in
2 consecutive time points compared to time 0.
Protein Coding Gene Expression Profiles
We generated expression profiles for protein coding gene expression using Affymetrix 430 2.0
arrays. We identified differentially expressed genes using the Patterns from Gene Expression
(http://www.cbil.upenn.edu/PaGE/) program. Briefly, we determined differential expression
using a t-statistic between groups and permutation distribution to compute an FDR for each gene.
We filtered all genes with an FDR<0.05 as significantly differentially expressed. We filtered the
list by genes similar to the criteria used for the lincRNA (tiling arrays). We required differential
expression between P53+1+ and P53~'- for each time point and differential expression compared to
time 0. For the RAS experiment we required differential expression of each gene for at least 2
consecutive time points.
Gene Set Enrichment Analysis and Functional Term Clustering
Gene Set Enrichment Analysis was performed as previously described (Grant et al., 2005, 21
Briefly, we used each condition as a group (ie siLincRNA-p21 vs siControl) and ranked the gene
list based on differential expression between the groups. The rank of these genes was used to
identify significant gene sets, using the weighted Kolmogorov-Smirnov (KS) test '". Gene sets
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were permuted 1000 times to obtain FDR corrected p-values. We used gene sets representing the
Molecular Signatures Database or custom gene sets defined by other experiments.
p53 Motif Analysis
To scan for conserved motifs in putative P53 targets we used an extension of the a method that
scores conservation at single nucleotide resolution based on the evolutionary substitution pattern
inferred for the site 48. Motifs were represented by Position Weight Matrix (PWM) downloaded
from the TRANSFAC matrix database v8.3 (http://www.gene-
regulation.com/pub/databases.html) 48. Given a PWM, for each nucleotide position in a
promoter, we calculated an affinity score defined as the log likelihood (LOD score) for observing
the sequence given the PWM versus a given random genomic background. We then found the
best conserved motif instance over the entire promoter region for each PWM. An instance was
considered conserved if its conservation score was in the top 5% of the genome distribution.
We computed this score for each lincRNA promoter and computed enrichment of the motif for
our experimentally determined set compared with all lincRNA promoters. To ensure that
enrichment was not due to nucleotide bias within the promoter, we shuffled the PWM and
computed enrichment for the true PWM compared to the shuffled PWMs. Enrichment was
computed using a two-sided Wilcoxon rank-sum test between the set and the background. We
then computed an FDR to correct for testing of multiple PWMs.
RNA interference and lincRNA-p21 overexpression
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siRNA oligos targeting lincRNA-p21 (#1 UGAAAAGAGCCGUGAGCUA, #2
AAAUAAAGAUGGUGGAAUG and #3 AGUCAAAGGCAAUGAGCAU) and hnRNP-K
(siRNA smart pool M-048002) were purchased from Dharmacon. p53 siRNAs (#1
AGAAGAAAAUUUCCGCAAA and #2 ACAGCGUGGUGGUACCUUA) were purchased
from Ambion. Non-targeting siRNAs were purchased from Dharmacon (D-001206-14) and
Ambion (AM4636). siRNA transfections were done in 6-well plates of subconfluent cells with
75nM of siRNA and 3 ul of Lipofectamine 2000 (Invitrogen) per well following manufacturer's
instructions. For overexpression, LincRNA-p21 was cloned into the pBABE vector and after
transfection cells were selected with 2mg/ml puromycin for 8 days. For gene expression profiling
of lincRNA-p21 overexpression, pBABE plasmid expressing lincRNA-p21 or empty vector were
transfected into p53-reconstituted p53LSULSL MEFs and 24 hours later treated with 500nM
doxorubicin. 14h after treatment total RNA was extracted for microarray analysis.
Nuclear fractionation
For nuclear fractionation 107 cells were harvested and resuspended in lml of PBS, 1ml of buffer
C1 (cell lysis buffer, Qiagen) and 3ml of water, and incubated for 15 minutes on ice. Then cells
were centrifuged for 15 minutes at 2,500 rpm, the supernatant was discarded and the nuclear
pellet was kept for RNA extraction.
172
References
1 Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: insights into
functions. Nature reviews 10, 155-159 (2009).
2 Ponting, C. P., Oliver, P. L. & Reik, W. Evolution and functions of long noncoding
RNAs. Cell 136, 629-641 (2009).
3 Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature 458, 223-227 (2009).
4 Ponjavic, J., Oliver, P. L., Lunter, G. & Ponting, C. P. Genomic and transcriptional co-
localization of protein-coding and long non-coding RNA pairs in the developing brain.
PLoS Genet 5, e1000617 (2009).
5 Mattick, J. S. The genetic signatures of noncoding RNAs. PLoS Genet 5, e1000459
(2009).
6 Penny, G. D., Kay, G. F., Sheardown, S. A., Rastan, S. & Brockdorff, N. Requirement for
Xist in X chromosome inactivation. Nature 379, 131-137 (1996).
7 Sleutels, F., Zwart, R. & Barlow, D. P. The non-coding Air RNA is required for silencing
autosomal imprinted genes. Nature 415, 810-813 (2002).
8 Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human
HOX loci by noncoding RNAs. Cell 129, 1311-1323 (2007).
9 Khalil, A. M. et al. Many human large intergenic noncoding RNAs associate with
chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A
106, 11667-11672 (2009).
10 Tsai, M. C. et al. Long noncoding RNA as modular scaffold of histone modification
complexes. Science 329, 689-693 (2010).
11 Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to
promote cancer metastasis. Nature 464, 1071-1076 (2010).
12 Wang, K. C. et al. A long noncoding RNA maintains active chromatin to coordinate
homeotic gene expression. Nature 472, 120-124 (2011).
13 Loewer, S. et al. Large intergenic non-coding RNA-RoR modulates reprogramming of
human induced pluripotent stem cells. Nat Genet 42, 1113-1117 (2010).
14 Willingham, A. T. et al. A strategy for probing the function of noncoding RNAs finds a
repressor of NFAT. Science 309, 1570-1573 (2005).
15 Young, T. L., Matsuda, T. & Cepko, C. L. The noncoding RNA taurine upregulated gene
1 is required for differentiation of the murine retina. Curr Biol 15, 501-512 (2005).
16 Zappulla, D. C. & Cech, T. R. Yeast telomerase RNA: a flexible scaffold for protein
subunits. Proc Natl Acad Sci U S A 101, 10024-10029 (2004).
17 Korostelev, A. & Noller, H. F. The ribosome in focus: new structures bring new insights.
Trends Biochem Sci 32, 434-441 (2007).
18 Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature 458, 223-227 (2009).
19 Vazquez, A., Bond, E. E., Levine, A. J. & Bond, G. L. The genetics of the p53 pathway,
apoptosis and cancer therapy. Nat Rev Drug Discov 7, 979-987 (2008).
20 Riley, T., Sontag, E., Chen, P. & Levine, A. Transcriptional control of human p53-
regulated genes. Nat Rev Mol Cell Biol 9, 402-412 (2008).
173
21 Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545-
15550 (2005).
22 Tanay, A., Sharan, R. & Shamir, R. Discovering statistically significant biclusters in gene
expression data. Bioinformatics (Oxford, England) 18 SuppI 1, S136-144 (2002).
23 Chang, H. Y. et al. Robustness, scalability, and integration of a wound-response gene
expression signature in predicting breast cancer survival. Proceedings of the National
Academy of Sciences of the United States of America 102, 3738-3743 (2005).
24 Carrio, M., Arderiu, G., Myers, C. & Boudreau, N. J. Homeobox D10 induces phenotypic
reversion of breast tumor cells in a three-dimensional culture model. Cancer research 65,
7177-7185 (2005).
25 Charboneau, A., East, L., Mulholland, N., Rohde, M. & Boudreau, N. Pbx1 is required
for Hox D3-mediated angiogenesis. Angiogenesis 8, 289-296 (2005).
26 Kawai, T. & Akira, S. TLR signaling. Seminars in immunology 19, 24-32 (2007).
27 Huang, Q. et al. The plasticity of dendritic cell responses to pathogens and their
components. Science 294, 870-875 (2001).
28 Loh, Y. H. et al. The Oct4 and Nanog transcription network regulates pluripotency in
mouse embryonic stem cells. Nat Genet 38, 431-440 (2006).
29 Ivanova, N. et al. Dissecting self-renewal in stem cells with RNA interference. Nature
442, 533-538 (2006).
30 Ventura, A. et al. Cre-lox-regulated conditional RNA interference from transgenes.
Proceedings of the National Academy of Sciences of the United States of America 101,
10380-10385 (2004).
31 Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E. & Shay, J. W. A transcriptionally
active DNA-binding site for human p53 protein complexes. Molecular and cellular
biology 12, 2866-2871 (1992).
32 el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W. & Vogelstein, B. Definition
of a consensus binding site for p53. Nature genetics 1, 45-49 (1992).
33 Levine, A. J., Hu, W. & Feng, Z. The P53 pathway: what questions remain to be
explored? Cell Death Differ 13, 1027-1036 (2006).
34 Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V. & Kastan, M. B. Wild-type p53 is a cell
cycle checkpoint determinant following irradiation. Proceedings of the National Academy
of Sciences of the United States of America 89, 7491-7495 (1992).
35 Martens, J. A., Laprade, L. & Winston, F. Intergenic transcription is required to repress
the Saccharomyces cerevisiae SER3 gene. Nature 429, 571-574 (2004).
36 Schmitt, S., Prestel, M. & Paro, R. Intergenic transcription through a polycomb group
response element counteracts silencing. Genes Dev 19, 697-708 (2005).
37 Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global
gene repression in the p53 response. Cell 142, 409-419 (2010).
38 Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J. & Lee, J. T. Polycomb proteins targeted by a
short repeat RNA to the mouse X chromosome. Science (New York, N.Y 322, 750-756
(2008).
39 Reich, M. et al. GenePattern 2.0. Nature genetics 38, 500-501 (2006).
174
40 Rinn, J. L., Bondre, C., Gladstone, H. B., Brown, P. 0. & Chang, H. Y. Anatomic
demarcation by positional variation in fibroblast gene expression programs. PLoS
genetics 2, e 119 (2006).
41 Grant, G. R., Liu, J. & Stoeckert, C. J., Jr. A practical false discovery rate approach to
identifying patterns of differential expression in microarray data. Bioinformatics (Oxford,
England) 21, 2684-2690 (2005).
42 Matys, V. et al. TRANSFAC and its module TRANSCompel: transcriptional gene
regulation in eukaryotes. Nucleic acids research 34, D108-110 (2006).
43 Palliser, D. et al. A role for Toll-like receptor 4 in dendritic cell activation and cytolytic
CD8+ T cell differentiation in response to a recombinant heat shock fusion protein. J
Immunol 172, 2885-2893 (2004).
44 Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature
445, 661-665 (2007).
45 van Engeland, M., Ramaekers, F. C., Schutte, B. & Reutelingsperger, C. P. A novel assay
to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in
culture. Cytometry 24, 131-139 (1996).
46 Brugarolas, J. et al. Radiation-induced cell cycle arrest compromised by p21 deficiency.
Nature 377, 552-557 (1995).
47 Shevchenko, A. et al. A strategy for identifying gel-separated proteins in sequence
databases by MS alone. Biochem Soc Trans 24, 893-896 (1996).
48 Garber, M. et al. Identifying novel constrained elements by exploiting biased substitution
patterns. Bioinformatics 25, i54-62 (2009).
175
176
Chapter 4: Many human large intergenic noncoding RNAs associate
with chromatin-modifying complexes and affect gene expression
In this chapter, we show that many lincRNAs bind to chromatin regulatory proteins and act
through their physical interactions to regulate shared gene expression programs.
Parts of this work were first published as:
Khalil AM*, Guttman M*, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A,
Bernstein BE, van Oudenaarden A, Regev A, Lander ES, Rinn JL. (2009) Many human large
intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene
expression. Proceedings of the National Academies of Science_106(28):11667-72
177
178
We recently showed that the mammalian genome encodes more than a thousand
large intergenic non-coding RNAs (lincRNAs) that are clearly conserved across mammals
and thus functional. Gene expression patterns have implicated these lincRNAs in diverse
biological processes including cell cycle regulation, immune surveillance, and embryonic
stem cell pluripotency. However, the mechanism by which these lincRNAs function is
unknown. Inspired by the observation that the well-characterized lincRNA HOTAIR bind
the Polycomb Repressive Complex 2 (PRC2), we tested whether many lincRNAs are
physically associated with PRC2. Remarkably, we observe that -20% of lincRNAs
expressed in various cell types are bound by PRC2, and that additional lincRNAs are
bound by other chromatin-modifying complexes. Moreover, we show that siRNA-mediated
depletion of certain lincRNAs associated with PRC2 leads to changes in gene expression
and that the upregulated genes are enriched for those normally silenced by PRC2. We
propose a model in which some lincRNAs guide chromatin-modifying complexes to specific
genomic loci to regulate gene expression.
Introduction
Mammalian genomes produce a wide variety of non-coding RNA transcripts' -3.
addition to classical RNAs (such as ribosomal RNAs, transfer RNAs and others) and more
recently discovered classes of small non-coding RNAs (such as microRNAs and promoter
associated small RNAs)4, there are many large non-coding RNAs of unknown functions
Several, such large non-coding RNAs have been biologically characterized (including XIST,
TSIX, HOTAIR and AIR) (Reviewed in reference3 ), but shotgun cDNA sequencing and
microarray hybridization have suggested that the vast majority of the mammalian genome can
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produce RNA transcripts under some circumstances 2,6,7. The biological significance of these
transcripts, however, has been highly controversial because most occur at extremely low levels
and show little evolutionary conservation' 9.
Recently, we developed a new approach for identifying large non-coding RNAs based on
a distinctive chromatin signature that marks actively transcribed genesI. The signature consists
of a short region with Histone 3 Lysine 4 trimethylation (H3K4me3) (corresponding to the
promoter) and a longer region with Histone 3 Lysine 36 trimethylation (H3K36me3,
corresponding the transcribed region)' 0 '". We refer to this chromatin signature as a K4-K36
domain. We generated chromatin-state maps across four mouse cell types, searched for K4-K36
domains and then eliminated those corresponding to known protein-coding genes. We found
1586 novel K4-K36 domains in the four mouse cell types and showed that the vast majority
encode large intergenic non-coding RNAs (lincRNAs). These lincRNAs show similar
expression levels as protein-coding genes, but lack any protein-coding capacity. Importantly,
lincRNAs show significant evolutionary conservation relative to neutral sequences, providing
strong evidence that they have been functional in the mammalian lineage'. This is in contrast to
some recent catalogs of large non-coding RNAs obtained by shotgun sequencing, which show
8,9little or no evolutionary conservation within the RNA transcripts,9. (We note that these non-
conserved RNAs could be functional, but biological evidence such as loss-of-function
experiments would be needed to establish their functionality).
Our previous studies demonstrated that groups of lincRNAs exhibit expression patterns
across cell types and tissues that correlate with patterns seen for protein-coding genes involved in
cellular processes such as cell-cycle regulation, innate immunity responses, and stem cell
pluripotency'. While these studies clearly demonstrate that there are many functional lincRNAs,
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key questions remain, including: How many lincRNAs are encoded in mammalian genomes?
How do lincRNAs exert their functions? To begin to investigate the number of lincRNAs, we
extended our approach of mapping K4-K36 domains to six human cell types. The results expand
our catalog to 3289 lincRNAs, which show clear evolutionary conservation within their
transcripts. Extrapolation suggests that the total number may approach -5000 lincRNAs.
To examine the biochemical mechanism by which lincRNAs function, we drew
inspiration from one of the few well-studied lincRNAs: HOTAIR. We previously reported
HOTAIR as a lincRNA transcribed from within the HOXC cluster and showed that it acts to
repress genes in the HOXD cluster, by binding to the Polycomb Repressive Complex 2 (PRC2)
and recruiting it to the locus12. PRC2 is a methyltransferase that trimethylates H3K27 to repress
transcription of specific genes'3,14. Recently, several other large non-coding RNAs have been
found to associate with chromatin modifying complexes - including a large non-coding RNA
encoded within the 5' of XIST that can target PRC2 to the inactive X chromosome1 5 ,16 , the
antisense transcript AIR that is associated with the chromatin-modifying complex G9a, an
H3K9me2 methyltransferase 7 ; and the Kcnqlotl transcript that binds both G9a and PRC218.
Some recent studies have demonstrated that large non-coding RNAs bind chromatin proteins that
add activating modifications (e.g. Trithorax)'9,20
These few examples raised the possibility that many lincRNAs might be physically
associated with chromatin-modifying complexes and might potentially target them to specific
genomic regions. To test this hypothesis, we performed RNA Co-immunoprecipitation (RIP)
with antibodies directed against several proteins involved in chromatin-modifying complexes
(PRC2 and CoREST), and found that this is indeed the case. We find that as many as 38% of the
lincRNAs expressed in the cell types studied are reproducibly associated with one of these
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complexes. Moreover, we show that RNA-interference-based depletion of various PRC2-
associated lincRNAs results in activation of genes known to be repressed by PRC2. Together,
our results indicate that thousands of functional lincRNAs are encoded in the human genome and
a significant proportion of lincRNAs are physically associated with chromatin-modifying
complexes. We propose that some lincRNAs function by regulating the epigenetic landscape at
distinctive target loci.
RESULTS
Many lincRNAs are associated with PRC2
We explored the mechanism by which lincRNAs function. As noted above, the lincRNA
HOTAIR has been shown to physically associate with the Polycomb Repressive Complex
PRC2 2 . This physical association was shown by an RNA immunoprecipitation-polymerase
chain reaction (RIP-PCR) assay: total (non-crosslinked) nuclear extract was incubated with an
antibody against the SUZ12 protein, a component of PRC2; the extract was precipitated with
Protein-A-coupled beads; and the co-precipitated RNA was then subjected to locus-specific
reverse transcriptase (RT)-PCR to demonstrate the presence of HOTAIR.
To test whether other lincRNAs are also associated with PRC2, we designed a 'RIP-
Chip' assay (see Methods) to assay many lincRNAs simultaneously (Figure 1). Briefly, we used
antibodies against the proteins SUZ12 and EZH2, components of PRC2 . The antibodies were
incubated with non-crosslinked nuclear extracts from three human cell types: HeLa cells, lung
fibroblasts (hLF) and foot fibroblasts (hFF); these cell types were chosen because they have
previously been shown to have distinctive epigenetic landscapes and diverse gene expression
patterns . We analyzed the co-precipitated RNAs by hybridization to a custom 'exon-tiling'
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array (at 10 base resolution), containing exons from -900 human lincRNA loci and -1000
human protein-coding genes; the protein-coding genes were previously known to be expressed in
at least one of the three cell types. In parallel, we carried out a mock control with a non-immune
rabbit IgG polyclonal antibody to assess non-specific interactions that may occur in RIP.
To identify lincRNAs and protein-coding genes that are co-precipitated with each of the
PRC2 components, we analyzed the hybridization data with a peak-calling algorithm that finds
regions in which the signal from the RIP assay is significantly enriched over the signal from the
mock controls (see Methods). Regions were defined based on a maximum family-wise error rate
(FWER) < 0.05 (see Methods'). Given that RIP assays are known to show considerable
variability (with typical reproducibility of -60% ), we performed several biological replicates
for each cell type. We observed that -76% of the genes detected in one replicate are also
detected in a second replicate (hLF: 70%, hFF: 75%, HeLa: 83%).
As a positive control, we checked whether HOTAIR and XIST were detectably co-
precipitated in our RIP-Chip data. Consistent with previous reports, HOTAIR co-precipitated
with PRC2 in both HeLa and foot fibroblasts, but not in lung fibroblasts. Similarly, XIST, which
is expressed only in female cells, was detectably co-precipitated in the hLF cells (which came
from a female source) but not the hFF cells (which came from a male source) (Figure 1). These
results were consistent across all replicates.
In addition to the RIP assay, we also assayed expression patterns of lincRNAs and
protein-coding genes on the custom exon-tiling array. We extracted total RNA from the same
three human cell types (HeLa, hLF, hFF), prepared poly(A*)-amplified cDNA and hybridized the
product to the exon-tiling array. Of the lincRNA genes on the array, we found that 47% were
detectably expressed in at least one of the three cell types (HeLa: 25%; hLF: 37%; and hFF:
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33%). Consistent with the design of the tiling array, essentially all of the protein-coding genes
were detectably expressed in the relevant cell type.
Analysis of the RIP-Chip results in conjunction with the expression analysis suggests that
a significant proportion of all lincRNAs expressed in one of these 3 cell types are physically
associated with PRC2. Specifically, we find that -30% of expressed lincRNAs are detected in at
least one of the replicates. As a conservative estimate, we only considered lincRNAs detected in
at least two replicates. Using this criterion, we observe that 24% of lincRNAs (114 of 469)
expressed in one of the three cell types is detected as physically associated with PRC2 (Figure
1).
As an independent validation of the association with PRC2, we selected five lincRNAs
that were detected in our RIP-Chip data as associated with PRC2 in both HeLa and hFF and
performed RIP-qPCR assays for these transcripts, using quantitative RT-PCR. In all 10 tests
(five lincRNAs in two cell types), the results were confirmed. Notably, the RIP-qPCR assays
showed a higher degree of enrichment than the RIP-Chip assays - consistent with the fact that
22arrays have a narrower dynamic range
As a validation that the associations of lincRNAs with PRC2 are specific, we tested
whether the enrichment in the RIP-Chip experiment was simply a reflection of transcript
abundance (which would suggest non-specific interactions). We found no significant correlation




























































Numerous lincRNAs are physically associated with chromatin-modifying
(A) Several examples of lincRNA exons (black box) that are enriched in RIP
relative to the IgG control in hFF (left column), hLF (middle column) and Hela
(right column) cells. lincRNAs were in enriched in RIP experiments performed with antibodies
recognizing the chromatin modifying complexes: PRC2 (blue), CoREST (red), but not with
antibodies recognizing the chromatin protein H3K27me3 (grey). Coprecipitated RNA for each
antibody and for the respective control (IgG) was hybridized to the DNA tiling arrays. The
hybridization values for each probe within a lincRNA exon are plotted as the log2 values for RIP
hybirdization intensity divided by control (IgG) hybridization intensity.
185
Foot F8
As a second approach to assess the specificity of PRC2 binding to lincRNAs, we
examined the proportion of mRNAs bound to PRC2. In sharp contrast to the lincRNAs, very
few of the protein-coding genes assayed in the RIP-Chip experiment showed physical association
with PRC2. Of the 1000 protein-coding genes represented on the array, only 16 (<2%) were
detected in two replicates (Figure 2a); we suspect that many of these 16 cases are artefacts,
because only a small proportion (less than 1% of ex ressed mRNAs) are detected in three
replicates. The proportion of transcripts associated with PRC2 is thus much higher for lincRNAs
than for protein-coding mRNAs. To demonstrate that this result is not simply due to a low
concentration of protein-coding mRNAs in the nucleus, we compared the concentration of
lincRNAs and mRNAs in the nucleus (see Methods). While lincRNAs tend to have greater
abundance in the nucleus than mRNAs, we find that the distributions of nuclear abundance of
lincRNAs and mRNAs show substantial overlap, with at least 25% of mRNAs being expressed
at levels comparable to the 501h percentile level for lincRNAs.
We also reasoned that lincRNAs associated with PRC2 should have significant
representation in the nucleus. To test this, we examined the abundance of lincRNAs in the
nucleus, and we found that PRC2-bound lincRNAs show a significantly higher abundance in the
nucleus than non-PRC2-bound lincRNAs (methods). We also performed fluorescent in situ
hybridization (FISH) on HOTAIR, XIST and four novel lincRNAs detected as associated with
PRC2. In all cases, the lincRNAs showed either exclusively nuclear or nuclear and cytoplasmic
localization (Figure 2b).
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Finally, we explored whether a lincRNA that is expressed in two cell types (A and B) and
associated with PRC2 in one cell type (A) is also associated with PRC2 in the second cell type
(B). Considering all pairs of cell types, we found that this was the case for -85% of lincRNAs
(Supplemental Table 3). Collectively, these results provide strong evidence that a substantial
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Figure 2: Diversity and nuclear localization of chromatin associated lincRNAs. (A)
Subcellular localization analysis of lincRNAs by RNA fluorescence in situ hybridization (RNA
FISH) demonstrates localization of a large majority of lincRNAs to the nucleus. Each panel
represents the in situ hybridization of approximately 40 fluorescently labeled DNA oligos with
complementarity to the interrogated lincRNA. RNA FISH experiments were performed in male
hFF for each represented lincRNA (XIST, HOTAIR, TUG-1, lincMKLN-1, lincFOXF1, and
lincSFPQ) and also in female hLF for XIST (XX). White 'speckles' indicate the subcellular
localization of each lincRNA. The nuclear compartment is demarked by DAPI staining (purple).
(B) Venn diagrams demonstrating the number of lincRNAs bound to PRC2 in hLF (red), hFF
(green) and Hela (blue) cells. (C) Pie charts indicating many lincRNAs, but not protein-coding
genes are physically associated with chromatin-modifying complexes. Top: pie chart
representing the percentage of unique lincRNAs expressed in all three tested cell types (hFF,
hLF and Hela) that are bound only to PRC2 (red), only to CoREST (green), bound by both PRC2
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a TUG-1
and CoREST (yellow) and those not bound by either complex (black). The percentage is
calculated by adding the number of unique lincRNAs bound by each complex or those bound by
both complexes in all three cell types and dividing by the total number of lincRNAs expressed in
hLF, hFF and Hela cells. Bottom: pie chart indicating the percentage of protein-coding genes
(black) reproducibly bound to PRC2 and or CoREST in all three cell types relative to the total
number of expressed protein-coding genes (grey).
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Association of lincRNAs with other chromatin-modifying complexes
Having found that many lincRNAs are associated with PRC2, we were interested to
explore whether they might be associated with additional repressive chromatin-modifying
complexes. We examined CoREST, a repressor of neuronal genes23 . We performed RIP-Chip
using an antibody against CoREST in the same three cell types (HeLa, hLF, and hFF). Applying
the analysis above, we found that 63 of the 469 lincRNAs expressed in HeLa cells were
reproducibly detected as bound to CoREST. As with PRC2, <2% of protein-coding genes co-
precipitated with CoREST.
We note that about 60% of the lincRNAs associated with CoREST are not associated
with PRC2 in HeLa cells, indicating that each complex has specific lincRNAs associated with it.
The observation that 40% of the lincRNAs associated with CoREST are also associated with
PRC2 may reflect the fact that the two complexes are known to share some regulatory targets
23,24
Considering PRC2 and CoREST together, we find that -38% of lincRNAs expressed in
at least one of the cell types examined are reproducibly bound to at least one of the two
complexes (180 of 469 expressed). This proportion is likely to be an underestimate, because we
only count lincRNAs that were detected in at least two replicates; the proportion could be as high
as 52%. These results raise the possibility that lincRNAs may be associated with additional
chromatin-modifying proteins.
We also tested whether chromatin proteins themselves (rather than chromatin-modifying
proteins) are associated with lincRNAs. Specifically, we performed RIP-Chip with antibodies
against the modified histones H3K27me3 and H3K4me2. We found no significant enrichment of
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lincRNAs (Figure 1). These findings are consistent with other studies that identified XIST to
16
co-precipitate with PRC2, but not H3K27me3 despite their immediate nuclear proximity'
Functional evidence that lincRNAs act through the PRC2 pathway
Having found that a substantial fraction of lincRNAs are physically associated with
PRC2, we sought evidence that they play a functional role in polycomb-mediated repression.
Previous studies have shown that depletion of HOTAIR and XIST causes up-regulation of genes
normally repressed by PRC2 1". To test whether other lincRNAs have a similar effect, we
studied HOTAIR and six additional lincRNAs found to be associated with PRC2. For each of
these seven lincRNAs, we designed pools consisting of four small-interfering RNAs (siRNAs)
targeting each lincRNA (see Methods). We also used standard control siRNA pools that do not
correspond to any human sequence. We transfected the siRNA pools into hLF (three pools), hFF
(three pools) or both (one pool), with each experiment performed in duplicate. We measured the
level of lincRNA knock-down by qRT-PCR and compared the results to the control siRNA pool;
we only used experiments in which we achieved >2-fold depletion.
We hybridized the total RNA from these experiments to standard gene-expression arrays
to measure the resulting changes in gene expressions. Specifically, for each of the seven
lincRNAs, we determined the gene sets (Si, S2, ... , S7) that were up-regulated relative to the
control siRNA pools (at a false discovery rate (FDR) < 0.1). These sets contained between 30
and 134 genes (Figure 3a). The sets of genes affected by each lincRNA did not show significant
overlap suggesting that each lincRNA has distinct target sets. We searched for, but found no
common motifs enriched among the upregulated genes for each lincRNA. However, given the
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small number of target genes and the inability to distinguish between direct and indirect targets
this result may simply reflect the low statistical power in analyzing a relatively small set of
genes. Additionally, no lincRNA knock-down significantly affected the expression level of
nearby genes (a window of at least 10 genes in either direction) suggesting that these lincRNAs
are not likely to function via a cis-acting mechanism. This suggests that influence on gene
regulation by PRC2 associated lincRNAs is likely exerted by a trans mechanism, similarly to
12what we have previously shown for HOTAIR
We then sought to determine whether the up-regulated gene sets were highly enriched in
genes normally repressed by PRC2 in human fibroblasts. Toward this end, we analyzed
published data 13 in which the investigators measured gene expression changes in human
embryonic fibroblasts in response to depletion of three key components of PRC2 (EZH2, SUZ12
and EED-1) with short-hairpin RNAs (shRNAs). For each component, we ranked all genes
based on their change in expression level; the ranked lists are similar for each of the three
components. We then used Gene Set Enrichment Analysis (GSEA) to test whether the gene
sets upregulated in response to depletion of the seven lincRNAs (Si, S2 , ... , S7) were enriched
among the genes up-regulated in response to depletion of the PRC2 components. The resulting
enrichments were highly significant (FDR < 0.001) for each of the seven lincRNAs and each of
the three PRC2 components (21 analyses in all, Figure 3a). As a negative control we examined
the genes affected by the shRNA-mediated depletion of YY 126, a transcription factor associated
with chromatin. In contrast to depletion of the lincRNAs, we found no significant enrichment of
PRC2 target genes. These results show that depletion of lincRNAs associated with PRC2 causes
changes in gene expression and these genes are strongly enriched for genes normally repressed
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by PRC2. This provides functional evidence that many lincRNAs likely function through their
interaction with PRC2.
An example: TUG1 represses p53-dependant cell cycle regulation
Finally, we decided to focus on a specific PRC2-associated lincRNA, TUG1. TUG1 was
originally identified as a transcript upregulated by taurine, and siRNA-based depletion of TUG1
in the developing mouse eye was found to block retinal development 27,28; the mechanism by
which TUG1 depletion produces this phenotype is unknown. In our study, we found that TUG1
is ubiquitously expressed in human and mouse cell types and tissues and is bound to PRC2 in all
three of the cell types examined. Previously, we studied regulation of lincRNAs in response to
DNA damage and found that TUG1 was among the 39 lincRNA specifically induced in p53-wild
type but not p53-mutant cells 1 (Figure 3c). Moreover, the TUGI promoter contains many highly
conserved binding sites for p53 (Figure 3d).
We selected TUG1 as one of the seven lincRNAs above that we depleted with siRNA
pools. Depletion of TUG1 led to significant upregulation of 71 genes, which were strongly
enriched for those involved in cell-cycle regulation (regulation of mitosis, spindle formation and
cell-cycle phasing, Figure 3b). TUGI thus is induced by p53, binds to PRC2 and plays a role in
repressing specific genes involved in cell-cycle regulation. Interestingly, p53 is well known to
cause both activation and repression of many genes. While p53 has been shown to be a direct
activator of many genes, the mechanism of p53-induced repression remains unknown. Our
results suggest the intriguing hypothesis that TUGI, and perhaps other lincRNAs, may function
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Figure 34: Genes repressed by PRC2 associated lincRNA overlap with genes repressed by
PRC2. (A) Gene set enrichment analysis (GSEA) comparing the protein-coding genes that are
upregulated upon depletion of a PRC2 bound lincRNA and those upregulated upon depletion of
various components of PRC2. The black line represents the observed enrichment score profile of
protein-coding genes in the lincRNA gene set to the PRC2 gene set. To represent the significance
of the black line we permuted the enrichment score profiles for 100 random (size matched) gene
sets. The dark grey region indicates distribution from the median to the 9 5 "h percentile and the




are significant at p < 0.05. The enrichment profiles for all lincRNAs tested were significant at p
< 0.05, whereas as the enrichment profile for an unrelated protein depletion (YY-1) was not
significant. The rank of each gene in the lincRNA gene set is indicated by tick marks (below
each enrichment score plot) on a schematic color bar indicating levels of differential expression,
upregulation in red and down regulation in blue. (B) Gene Ontology (GO) enrichment analysis
identified numerous cell-cycle regulation pathways that were specifically derepressed upon
knock down of lincRNA TUG1. The enrichment false discovery rate (FDR) is plotted as -
log(FDR) on the x-axis. Results are shown from knockdown experiments in lung fibroblasts
(grey) and in foot fibroblasts (black). Dashed line denotes FDR < 0.05. (C) lincRNA TUG1 is
transcriptionally regulated by p53 in response to DNA damage. The y-axis indicates the log2
ratio of lincRNA TUG1 expression in p53 wild-type cells divided by the expression value in p53
knock-out cells. The x-axis indicates time after induction of DNA damage. (D) The lincRNA
TUGI promoter exhibits highly conserved p53 binding motifs (boxed region) whereas the
transcriptional unit does not exhibit enrichment. The log odd conservation score (methods) is
shown for the p53 binding motif at each position along the lincRNA TUGI promoter.
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Discussion
It is becoming clear that the mammalian genome encodes thousands of lincRNAs that are
highly conserved and thus biologically functional'. Expression patterns suggest that these
lincRNAs are involved in diverse biological processes, including cell cycle regulation, innate
immunity, and ES pluripotency, but the mechanisms by which they play their roles were
completely unknown.
Inspired by studies of the lincRNAs HOTAIR' 2 and XIST16 , we investigated the idea that
many lincRNAs are involved in the establishment of chromatin states. In this study, we report
that a substantial proportion (24%) of lincRNAs expressed in a cell type are physically
associated with the repressive chromatin modifying complex PRC2, and the proportion is even
larger (38%) when additional chromatin modifying proteins (CoREST and SCMX) are included.
It thus seems likely that significant fraction of lincRNAs will be associated with chromatin
modifying proteins. Beyond the physical association, our functional analysis demonstrates that
siRNA-mediated depletion of these lincRNAs results in preferential derepression of PRC2
regulated genes at distant loci, consistent with a trans acting mechanism. Together, these results
suggest that many lincRNAs collaborate with chromatin modifying proteins to repress gene
expression at specific loci.
There is a growing body of literature from yeast to mammals suggesting the non-coding
29,30RNAs play an important role in chromatin-state formation . In Schizosaccharomyces pombe, a
process known as RNA Induced Transcriptional Silencing (RITS) has been shown to play an
important role in heterochromatin formation over centromeric repeats (reviewed in 3 '). Similarly,
short RNAs have been shown to play an important role in the establishment of heterochromatic
silencing in plants. In C. elegans, genetic screens have identified polycomb homologs to be
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required for proper gene silencing in an RNA dependent manner30. In mammals, only a few
specific RNAs (such as HOTAIR and XIST) have been implicated in directing chromatin
modification. However, there is evidence that RNA plays a key role in shaping mammalian
epigenetic landscapes. For example, depletion of single-stranded RNA (ssRNA) in mouse
fibroblasts inhibits global heterochromatin formation32 . Similarly, ssRNA but not ssDNA is
required for the maintenance of the histone modifications H3K27me3 and H3K9me333
Our results suggest an intriguing hypothesis: that lincRNAs bind to chromatin-modifying
complexes to guide them to specific locations in the genome. Whereas chromatin-modifying
proteins are often ubiquitously expressed, they establish epigenetic states that differ markedly
among cell types and conditions". Under our model, differentially expressed lincRNAs could
bind to these complexes and help establish cell type specific epigenetic states. In particular, the
PRC2 complex is involved in establishing repressive chromatin states involving H3K27me3.
Together, PRC2 and a lincRNA might play the role of a transcriptional repressor by directing
silencing to specific loci.
Such a mechanism could function within a larger regulatory program. Specifically, a
newly induced transcription factor might establish a particular cellular state by (i) directly
activating some downstream genes and (ii) activating lincRNAs that (with PRC2) repress genes
involved in a previous or competing cellular state. Our observations concerning the lincRNA
TUGI suggest that it may function in such a program. Upon DNA damage, TUGI is induced in a
p53-dependent manner, likely through direct binding of p53, in view of many p53-binding sites
in its promoter. It then binds PRC2 (based on our RIP-Chip data) and is involved in repressing
important cell-cycle related genes (based on siRNA-based depletion of TUG1). Thus, we
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speculate that TUGI may serve as a downstream transcriptional repressor in the p53 pathway to
repress cell cycle progression in response to DNA damage.
Similarly, we have recently shown that HOTAIR serves as a transcriptional repressor of
HOXD genes. We now know that HOXA13, the key distal regulator, directly transcribes
HOTAIR to establish positional identity by repressing the appropriate HOX clusters 4 . Thus,
HOTAIR serves as a downstream repressor in the HOXA13 transcriptional network (Presser et
al. in preparation). This model raises many mechanistic questions, including (i) whether most
lincRNAs associated with chromatin modifying complexes directly guide the complexes to
specific loci and (ii) if so, how the guidance is accomplished (for example, by direct base pairing
at specific sequence motifs). Future studies are needed to resolve the mechanism.
Our experiments have focused on chromatin-modifying complexes that add repressive
chromatin marks. It is possible that many additional lincRNAs are associated with chromatin-
modifying complexes that confer activating modifications, as has been recently reported in a few
cases 19,20. These questions can be addressed by performing RIP experiments with a wide range
of antibodies across a wide range of cell types, to create a catalog of lincRNA-protein
interactions.
Finally, while we have found that a substantial proportion of lincRNAs are associated
with repressive chromatin modifying complexes, we do not mean to suggest that all lincRNAs
necessarily function in this manner. There may be classes of lincRNAs that function in entirely
different ways. For example, the lincRNAs NEAT 1 and NEAT2 have been recently shown to be
important in the formation of the nuclear speckle 35,36 , and the lincRNA NRON plays a role in
repressing nuclear import3 7. It is possible that additional lincRNAs play roles in these and
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numerous other cellular pathways. The full range of biological diversity of lincRNAs and their
mechanisms clearly remains to be explored.
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Chapter 5: lincRNAs function in the molecular circuitry controlling
pluripotency and differentiation in embryonic stem cells
In this chapter, we describe a systematic loss-of-function study, which demonstrated that
lincRNAs play a clear functional role in the cell and that many lincRNAs play an essential role
in maintaining the pluripotent cell and repressing differentiation programs.
Parts of this work were first published as:
Guttman M, Donaghey J, Carey BW, Garber M, Grenier J, Munson G, Young G, Lucas AB,
Ach R, Bruhn L, Yang X, Amit I, Meissner A, Regev A, Rinn JL, Root DE, Lander ES. (2011).
lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature
477(7364):295-300




While thousands of large intergenic non-coding RNAs (lincRNAs) have been identified in
mammals, few have been functionally characterized leading to debate about their biological
role. To address this, we performed loss-of-function studies on most lincRNAs expressed in
mouse embryonic stem cells (ESC) and characterized the effects on gene expression. Here
we show that knockdown of lincRNAs have major consequences on gene expression
patterns, comparable to knockdown of well-known ESC regulators. Notably, lincRNAs
primarily affect gene expression in trans. We identify dozens of lincRNAs whose
knockdown causes an exit from the pluripotent state or upregulation of lineage
commitment programs. We integrate lincRNAs into the molecular circuitry of ESCs and
show that lincRNA genes are regulated by key transcription factors and that lincRNA
transcripts physically bind to multiple chromatin regulatory proteins to affect shared gene
expression programs. Together, the results demonstrate that lincRNAs have key roles in
the circuitry controlling ESC state.
INTRODUCTION
The mammalian genome encodes many thousands of large non-coding transcripts'-4
including a class of -3500 large intergenic ncRNAs (lincRNAs) identified using a chromatin
signature of actively transcribed geness 7. These lincRNA genes have been shown to have
interesting properties, including clear evolutionary conservation5-9, expression patterns correlated
with various cellular processes 5'1-12 and binding of key transcription factors to their
promoters5'-113, and the lincRNAs themselves physically associate with chromatin regulatory
proteins7'1' 4-16. Yet, it remains unclear whether the RNA transcripts themselves have biological
functions 17 ,1'. Few have been demonstrated to have phenotypic consequences by loss-of-
function experiments". As a result, the functional role of lincRNA genes has been widely
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debated. Various proposals include that lincRNA genes act as enhancer regions, with the RNA
transcript simply being an incidental by-product 1 -19, that lincRNA transcripts act in cis to
activate transcription20, and that lincRNA transcripts can act in trans to repress transcription3 '14.
We therefore sought to undertake systematic loss-of-function experiments on all
lincRNAs known to be expressed in mouse embryonic stem cells (ESCs)s,6 . ESCs are pluripotent
cells that can self-renew in culture and can give rise to cells of any of the three primary germ
layers including the germline2 1. The signalling21-23 , transcriptional 24-29, and chromatin24,30-34
regulatory networks controlling pluripotency have been well characterized providing an ideal
system to determine how lincRNAs may integrate into these processes.
Here we show that knockdown of the vast majority of ESC-expressed lincRNAs has a
strong effect on gene expression patterns in ESCs, of comparable magnitude to that seen for the
well-known ESC regulatory proteins. We identify dozens of lincRNAs that upon loss-of-function
cause an exit from the pluripotent state and dozens of additional lincRNAs that, while not
essential for the maintenance of pluripotency, act to repress lineage-specific gene expression
programs in ESCs. We integrate the lincRNAs into the molecular circuitry of ESCs by
demonstrating that most lincRNAs are directly regulated by critical pluripotency-associated
transcription factors and -30% of lincRNAs physically interact with specific chromatin
regulatory proteins to affect gene expression. Together, these results demonstrate a regulatory
network in ESCs whereby transcription factors directly regulate the expression of lincRNA
genes, many of which can physically interact with chromatin proteins, affect gene expression
programs, and maintain the ESC state.
RESULTS
Functional effects of lincRNAs on gene expression
To perform loss-of-function experiments on lincRNAs, we generated five lentiviral-based
shRNAs 35 targeting each of the 237 lincRNAs previously identified in ESCs5 ,6 (see Methods).
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These shRNAs successfully targeted 147 lincRNAs and reduced their expression by an average
of -75% compared to endogenous levels in ESCs (see Methods, Figure la). As positive
controls, we generated shRNAs targeting -50 genes encoding regulatory proteins, including both
transcription factor and chromatin factor genes that have been shown to play critical roles in ESC
regulation 29,32,36; we obtained validated hairpins against 40 of these genes. As negative controls,
we performed independent infections with lentiviruses containing 27 different shRNAs with no
known cellular target RNA.
We then studied the effects of knocking down each lincRNA on global transcription. We
infected each shRNA into ESCs, isolated RNA after 4 days, and profiled their effects by
hybridization to genome-wide microarrays (Figure la, see Methods). We employed a stringent
procedure to control for non-specific effects due to viral infection, generic RNAi responses, or
'off-target' effects. Expression changes were deemed significant only if they exceeded the
maximum levels observed in any of the negative controls, showed a two-fold change in
expression compared to the negative controls, and had a low false discovery rate (FDR) assessed
across all genes based on permutation tests (Figure 1b, see Methods). This approach controls for
the overall rate of non-specific effects by estimating the number and magnitude of observed
effects in the negative control hairpins, where all effects are non-specific.
For 137 of the 147 lincRNAs (93%), knockdown caused a significant impact on gene
expression, with an average of 175 protein-coding transcripts affected (range: 20-936) (Figure
1c). These results were similar to those obtained upon knockdown of the 40 well-studied ESC
regulatory proteins: 38 (95%) showed significant effects on gene expression, with an average of
207 genes affected (range: 28 (for DNMT3L) to 1187 (for Oct4)) (Figure ic). Although some
individual lincRNAs have been found to lead primarily to gene repression 3,14, we find that
knockdown of the lincRNAs studied here largely led to comparable numbers of activated and
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repressed genes. To further assess whether the expression changes were due to 'off-target'
effects, we also profiled the effects of the second-best validated shRNA targeting 10 randomly
selected lincRNA genes. In all cases, second shRNAs against the same target produced
significantly similar expression changes (see Methods). Together, these results indicate that the
vast majority of lincRNAs have functional consequences on overall gene expression of
comparable magnitude (in terms of number of affected genes and impact on levels) to the known
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Figure 1: Functional effects of lincRNAs. (a) A schematic of lincRNA perturbation
experiments. ESCs are infected with shRNAs targeting lincRNA genes. The knockdown level is
computed compared to negative control hairpins. The best hairpin is selected and RNA levels are
profiled on expression arrays. Differential gene expression is computed relative to negative
control hairpins. (b) Representative example of a lincRNA knockdown effect on gene
expression. Top: Genomic locus containing a lincRNA. Bottom: Heatmap of the 95 genes
affected by knockdown of the lincRNA, expression for control hairpins (red line) and expression

















knockdown of 147 lincRNAs (blue) and 40 well-known ESC regulatory proteins (red). Points
corresponding to five specific ESC regulatory proteins are marked. (d) Effects of knockdown of
13 lincRNAs on the 10 neighbour genes on each side (downregulation in blue, upregulation in
red). For the remaining 134 lincRNA genes, no neighbouring genes are affected. (e) Distance to
the closest affected gene upon knockdown of a lincRNA (blue) or protein-coding gene (red).
Grey Inset: A close-up of the region from 0-5 Mb. The grey dashed line represents a distance of
300 kb in both panels.
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lincRNAs affect gene expression in trans
The discovery of XIST as a ncRNA immediately suggested a model for how it can act in
an allele specific manner3. In theory, a ncRNA possess intrinsic cis regulatory capacity since it
can function while remaining tethered at its own locus 3 7 ,3 8 whereas an mRNA must be
dissociated, exported, and translated to function. In this review, we define a cis regulator as one
that exerts its function on a neighboring gene on the same allele from which it is transcribed and
a trans regulator if it does not meet this criteria. Because of the unique cis regulatory capability
of ncRNAs, it has been speculated that cis regulation may be a common mechanism for large
ncRNAs 20,38 . However, global functional evidence strongly suggests that this is not the case (see
Figure 2).
To distinguish cis and trans regulatory models, initial studies used correlation analysis
and identified significant correlations of expression between ncRNAs and their neighboring
protein-coding genes'9,39 . However, several of these cases have been demonstrated to be trans
models and the apparent correlations are due to shared upstream regulation (such as lincRNA-
p2113 and lincRNA-Sox2 5), positional correlation (such as HOTAIR 14), transcriptional 'ripple
effects' 19 and indirect regulation of neighboring genes (Figure 2). Consistent with these
explanations, a recent study showed that the increased correlation of expression between
ncRNAs and neighboring genes is comparable to that observed for protein-coding genes40.
Some recent papers have claimed that most lincRNAs act primarily in cis We
found no evidence to support this latter notion: knockdown of only 2 lincRNAs showed effects
on a neighbouring gene, only 13 showed effects within a window of ten genes on either side
(Figure 1d), and only 8 showed effects on genes within 300 kb (Figure le); these proportions
are no greater than observed for protein-coding genes (Figure le). In short, lincRNAs appear to
affect expression largely in trans.
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Our results contrast with a recent study that concluded that lincRNAs act in cis, based on
the observation that knockdown of 7 out of 12 lincRNAs affected expression of a gene within
300Kb2 0. The explanation appears to be that the threshold for significant changes in gene
expression used in the study failed to account for multiple hypothesis testing within the local
region. Accounting for this, the effects on neighbouring genes are no greater than expected by
chance and are consistent with our observations here (see Methods).
While perturbation experiments can demonstrate that an RNA works in trans, evidence
that an RNA works in cis is more difficult to obtain (see Figure 2). As an example, perturbation
experiments demonstrate that the JPX ncRNA affects the expression of the neighboring XIST
41gene yet it was demonstrated to perform this role by acting in trans . The ultimate proof of cis
regulation requires demonstrating that an RNA regulates a neighbouring gene on the same allele
(Figure 2). To date, few studies have performed such tests and it is unclear what percentage of
ncRNAs suggested to act in cis by loss-of-function experiments 20,42 will pass this test.
While it is clear that some lincRNAs can regulate gene expression in cis20,42-44
determining the precise proportion of cis regulators requires more direct experimental
approaches. We note that our results are consistent with observed correlations between lincRNAs
and neighbouring genes ,39 , which may represent shared upstream regulation 5' or local
transcriptional effects 9' 45 . In addition, the lincRNAs studied here should be distinguished from
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a cis regulator then several
observations will be true: (i) the gene expression levels of a neighboring gene will be correlated
with the RNA expression across conditions, (ii) loss-of-function of the RNA would affect
expression of a neighboring gene, and (iii) the ncRNA would affect expression of a neighboring
gene on the same allele that it is expressed from. The absence of any of these criteria supports
regulation in trans. We illustrate this point using 5 common regulatory models (left), this table
displays what would be observed using specific computational and experimental methods for
each regulatory model. Check boxes (black) indicate observed effects on neighboring genes for
each method and crosses (red) indicate no observed effects on neighboring genes. Known
ncRNA examples of each of these regulatory models are shown to the right of the table.
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lincRNAs are required to maintain the pluripotent state
We next sought to investigate whether lincRNAs play a role in regulating the ESC state.
Regulation of the ESC state involves two components, maintaining the pluripotency program and
repressing differentiation programs 24. To determine whether lincRNAs play a role in the
maintenance of the pluripotency program, we studied their effects on the expression of Nanog, a
key transcription factor that is required to establish 46 and uniquely marks the pluripotent
47,48state . We infected ESCs carrying a luciferase reporter gene expressed from the endogenous
Nanog promoter 49 with shRNAs targeting lincRNAs or protein-coding genes. We monitored loss
of reporter activity after 8 days relative to 25 negative control hairpins across biological
replicates (see Methods). To ensure that the observed effects were not simply due to a reduction
in cell viability, we excluded shRNAs that caused a reduction in cell numbers (see Methods).
Altogether, we identified 26 lincRNAs that had major effects on endogenous Nanog levels with
many at comparable levels to the knockdown of the known protein-coding regulators of
pluripotency such as Oct4 and Nanog (Figure 3a). This establishes that these lincRNAs have a
role in maintaining the pluripotent state.
To further validate the role of these 26 lincRNAs in regulating the pluripotent state, we
knocked down these lincRNAs in wild-type ESCs and measured mRNA levels of Oct4 and
Nanog after 8 days across biological replicates. For -90% of these lincRNAs, we identified a
significant decrease in both Oct4 and Nanog levels. For the 16 lincRNAs for which we had a
second effective hairpin, we found comparable reductions in Oct4 expression levels upon
knockdown using these hairpins (Figure 3b). Notably, >90% of lincRNA knockdowns affecting
Nanog reporter levels led to loss of the ESC morphology (Figure 3c). In summary, inhibition of


















Figure 3: lincRNAs are critical for the maintenance of pluripotency. (a) Activity from a
Nanog promoter driving luciferase, following treatment with control hairpins (black) or hairpins
targeting luciferase (green), selected protein-coding regulators (red), and lincRNAs (blue). (b)
Relative mRNA expression levels using qPCR of Oct4 following knockdown of selected protein-
coding (red) and lincRNA (blue) genes affecting Nanog-luciferase levels. The best hairpin
(black line) and second best hairpin (grey line) are shown. All knockdowns are significant with a
p-value<0.001. Error bars represent standard error across replicate infections (n=4). (c)
Morphology of ESCs and immunofluorescence staining of Oct4 for a negative control hairpin
(black line), a hairpin targeting Oct4 (red line), and hairpins targeting two lincRNAs (blue
line). The first row shows bright field images of infected ESCs. The second row shows















lincRNAs repress lineage-specific gene expression programs
We next sought to explore the biological roles of ESC lincRNAs by classifying the
overall gene expression patterns resulting from a lincRNA knockdown. To interpret the patterns,
we compared them to a curated set of >100 publicly available gene expression profiles and
signatures resulting from perturbations or differentiation of ESCs (see Methods)504. We mapped
our observed profiles onto these previously identified states by comparing the expression
changes induced by knockdown of the lincRNA with the expression changes in the previously
studied states; we assessed significance using a permutation-derived FDR (see Methods)55'5 6 . The
states include differentiation into the endoderm, ectoderm, mesoderm, and trophectoderm
lineages5 0 ,5 1,5 3 ,5 4 . As a positive control for our analytical method, we confirmed the expected
results that the expression pattern caused by Oct4 knockdown was strongly associated with the
trophoectoderm lineage5 7 and by Nanog knockdown with endoderm differentiation 48 (Figure
4a).
Using this approach, we identified 30 lincRNAs whose knockdown produced expression
patterns similar to differentiation into specific lineages (Figure 4a). Amongst the lincRNAs
associated with differentiation, 13 are associated with differentiation into the endoderm lineage,
7 with ectoderm differentiation, 5 with neuroectoderm differentiation, 7 with mesoderm
differentiation, and 2 with the trophectoderm lineage (Figure 4a). Consistent with these
functional assignments, we observe that the majority (>85%) of the 30 lincRNAs associated with
specific differentiation lineages showed upregulation of the well-known marker genes for the
identified states 2 9' 5 3 ,5 4 upon knockdown (such as Sox17 (endoderm), Fgf5 (ectoderm), Pax6
(neuroectoderm), Brachyury (mesoderm), and Cdx2 (trophectoderm)) (Figure 4b).
The fact that knockdown of these 30 lincRNAs induce gene expression programs
associated with specific early differentiation lineages suggests that these lincRNAs normally act
as a barrier to such differentiation. Interestingly, most of the lincRNA knockdowns (-85%) that
induce gene expression patterns associated with these lineages did not cause the cells to
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differentiate as determined by Nanog reporter levels (Figure 3a). This is consistent with
observations for several critical ESC chromatin regulators, such as the polycomb complex; loss-
of-function of these regulators similarly induce lineage-specific markers without causing
30,58,59differentiation
Together, these data indicate that many lincRNAs play important roles in regulating the
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Figure 4: lincRNAs repress specific differentiation lineages. (a) Expression changes for each
lincRNA compared to gene expression of five differentiation patterns. Shown are associations
for Oct4 and Nanog (left) and for lincRNAs with a significant (FDR<0.01) association with these
lineages (right). Each box shows significant positive association with known expression patterns
(red). (b) Expression changes upon knockdown of Oct4 and Nanog (black bars) and
representative lincRNAs (grey bars) for five lineage marker genes. The expression changes
(FDR<0.05) are displayed on a log scale as the t-statistic compared to a panel of negative control
hairpins for each lineage gene.
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lincRNAs are direct regulatory targets of the ESC transcriptional circuitry
Having demonstrated a functional role for lincRNAs in ESCs, we sought to integrate the
lincRNAs into the molecular circuitry controlling the pluripotent state. First, we explored how
lincRNA expression is regulated in ESCs. Toward this end, we utilized published genome-wide
maps of 9 pluripotency-associated transcription factors (TFs)26,60 and determined whether they
bind to the promoters of lincRNA genes expressed in ESCs. We observe that -75% of the 237
lincRNA promoters are bound by at least one of 9 pluripotency-associated TFs (including Oct4,
Sox2, Nanog, cMyc, nMyc, Klf4, Zfx, Smad, and Tcf3) with a median of 3 factors bound to each
promoter (Figure 5a), comparable to the proportion reported for protein-coding genes26
Interestingly, the 3 core factors (Oct4, Sox2, and Nanog) bind to the promoters of ~12% of all
lincRNAs and -50% of lincRNAs involved in the regulation of the pluripotent state.
To determine if lincRNA expression is functionally regulated by the pluripotency-
associated TFs, we used shRNAs to knock down the expression of 5 of the 9 pluripotency-
associated TF genes for which we could obtain validated hairpins and profiled the resulting
changes in lincRNA expression after 4 days. Upon knockdown of a TF, expression changes are
seen at -50% of lincRNAs genes whose promoters are bound by the TF (Figure 5a, bottom); the
proportion is comparable to that seen for protein-coding genes whose promoters are bound by the
TF. The strong but imperfect correlation between TF-binding and effect of TF-knockdown is
consistent with previous observations 61-63 and may reflect regulatory redundancy in the
28,64pluripotency network . In addition, we profiled the knockdown of an additional 7
pluripotency-associated transcription factors (including Esrrb, Zfp42, and Stat3). Altogether, for
-60% of the ESC lincRNAs, we identified a significant downregulation upon KD of one of these
11 TFs (Figure 5b).
We also characterized the expression of the ESC lincRNAs following retinoic-acid-
induced differentiation of the ESCs. The ESC lincRNAs show temporal changes across the time
course with -75% showing a decrease in expression compared to untreated ESCs (Figure 5c).
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Notably, all of the lincRNAs shown to regulate pluripotency are down-regulated upon retinoic
acid treatment (Figure Sc). Our results establish that lincRNAs are direct transcriptional targets
of the pluripotency-associated TFs and are dynamically expressed across differentiation.
Collectively, these results demonstrate that lincRNAs are an important regulatory component
within the ESC circuitry.
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Figure 5: lincRNAs are direct regulatory targets of the ESC transcriptional circuitry. (a) A
heatmap representing enrichment for lincRNA promoters (rows) by ChIP-Seq for 9 transcription
factors (columns). The percentages of bound promoters downregulated upon knock-down of a
TF, are indicated in boxes beneath the associated column ('na' were not measured). lincRNA
promoters were grouped into two main clusters: one bound by Oct4, Sox2, and Nanog (Core
regulated) and the other bound by cMyc and nMyc amongst other factors (Myc regulated). Right:
Example lincRNAs in each cluster showing their genomic neighbourhood and TF binding. (b) A
heatmap representing changes in lincRNA expression (rows) following knockdown of 11 TFs
(columns), relative to negative control hairpins. Middle: Effect of knockdown of Sox2, Oct4 and
Nanog on expression levels of linc 1405 (gray) and Oct4 (black). Right: Effect of knockdown of
Klf2, Klf4, nMyc, and Esrrb on expression levels of linc1428.
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lincRNAs physically interact with diverse chromatin regulatory proteins
To explore how lincRNAs carry out their regulatory roles, we studied whether lincRNAs
physically associate with chromatin modifying proteins in ESCs. We previously showed that
many human lincRNAs can interact with the polycomb repressive complex 7, a complex that
30,31plays a critical functional role in the regulation of ESCs . To determine whether the ESC
lincRNAs physically associate with the polycomb complex, we crosslinked RNA-Protein
complexes using formaldehyde, immunoprecipitated the complex using antibodies specific to
both the Suz 12 and Ezh2 components of Polycomb, and profiled the co-precipitated lincRNAs
using a direct RNA quantification method (see Methods). We performed immunoprecipitation
of the Polycomb complex across 5 biological replicates and 8 mock-IgG controls, and we
assessed significance using a permutation test (see Methods). Altogether, we identified 24
lincRNAs (-10% of the ESC lincRNAs) that were strongly enriched for both Polycomb
components (Figure 6b).
To determine if lincRNAs interact with additional chromatin proteins, we systematically
analysed chromatin-modifying proteins that have been shown to play critical roles in ESCs3 0-
34,66,67. Specifically, we screened antibodies against 28 chromatin complexes (see Methods) and
identified 11 additional chromatin complexes that are strongly and reproducibly associated with
the lincRNAs (see Methods). These chromatin complexes are involved in 'reading' (PRC 1,
Cbx 1, and Cbx3), 'writing' (Tip60/P400, PRC2, Setd8, ESET, and Suv39h 1), and 'erasing'
histone modifications (Jaridlb, JaridIc, and HDAC1) 68, as well as a chromatin-associated DNA
binding protein (YYl) (Figure 6a). Altogether, we found that 74 (-30%) of the ESC lincRNAs
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are associated with at least one of these 12 chromatin complexes (Figure 6b). While most of the
identified interactions are with repressive chromatin regulators, this is likely due to limitations of
our selection criteria and available antibodies.
Interestingly, we note that many lincRNAs are strongly associated with multiple
chromatin complexes (Figure 6b). For example, we identified 8 lincRNAs that bind to the PRC2
H3K27 and ESET H3K9 methyltransferase complexes ('writers' of repressive marks) and the
Jaridlc H3K4 demethylase complex (an 'eraser' of activating marks). Consistent with this, the
PRC2 and ESET complexes have been reported to bind at many of the same 'bivalent' domains 33
69,7
and to functionally associate with the Jaridlc complex ,70. Similarly, we identified a distinct set
of 17 lincRNAs that bind to the PRC2 complex ('writer' of K27 repressive marks), PRC1
complex ('reader' of K27 repressive marks), and Jaridlb complex ('eraser' of K4 activating
marks) (Figure 6c), as well as other functionally consistent 'reader', 'writer', and 'eraser'
combinations (Figure 6c). One of several potential models consistent with this data is that
lincRNAs may bind to multiple distinct protein complexes, perhaps serving as 'flexible
scaffolds' to bridge functionally related complexes as previously described for telomerase
71RNA.
To determine if the identified lincRNA-protein interactions have a functional role on
gene expression, we examined the effects on gene expression resulting from knockdown of
individual lincRNAs that are physically associated with particular chromatin complexes and
from knockdown of genes encoding the associated complex itself (see Methods). For >40% of
these lincRNA-protein interactions, we identified a highly significant overlap in affected gene
expression programs compared to just -6% for random lincRNA protein pairs (see Methods).
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Other cases may reflect the limited power to detect the overlaps, because specific lincRNA-
protein complexes may be related to only a fraction of the overall expression pattern mediated by
the chromatin complex.
Together, these data suggest that many of the ESC lincRNAs physically associate with
multiple different chromatin regulatory proteins and that many of these interactions are likely to
be important for the regulation of gene expression programs.
224
aChromatin readers Chromatbn writers Chromatin erasers
b C)
F- 0 OMM
< < U C) Dc C13 9
Cluster 1: K27 reader/writer,
K4 eraser
Cluster 2: K27/K9 writer,
K4 eraser
Cluster 3: K9 writers
Cluster 4: K9 writer/reader
Figure 6: lincRNAs physically interact with chromatin regulatory proteins. (a) A schematic
of the classes of chromatin regulators profiled: 'readers' (blue), 'writers' (orange), and 'erasers'
(green). (b) A heatmap showing the enrichment of 74 lincRNAs (rows) for one of 12 chromatin
regulatory complexes (columns). The names are color-coded by their chromatin-regulatory
mechanism. Major clusters are indicated by vertical lines with a description of the chromatin
components. (c) Examples of each cluster, enrichment levels for lincRNAs are shown for the
indicated complexes. Enrichments are shown as the t-statistic compared to five mock-IGG




While the mammalian genome encodes thousands of lincRNA genes, few have been
functionally characterized. We performed an unbiased loss-of-function analysis of lincRNAs
expressed in ESCs and show that lincRNAs are clearly functional and primarily act in trans to
affect global gene expression. Our results establish that lincRNAs are key components of the
ESC transcriptional network that are functionally important for maintaining the pluripotent state,
and that many are down-regulated upon differentiation. The ESC lincRNAs physically interact
with chromatin proteins, many of which have been previously implicated in the maintenance of
30,32-34the pluripotent state3 '3-3. In addition to chrornatin proteins, lincRNAs interact with other
protein complexes including many RNA-binding proteins.
Our data suggests a model whereby a distinct set of lincRNAs is transcribed in a cell type
and interacts with ubiquitous regulatory protein complexes to give rise to cell-type-specific
RNA-protein complexes that coordinate cell-type specific gene expression programs (Figure 7).
Because many of the lincRNAs studied here interact with multiple different protein complexes,
one hypothesis is that they act as cell-type specific 'flexible scaffolds' 7 1,72 to bring together
protein complexes into larger functional units (Figure 7). This model has been previously
demonstrated for the yeast telomerase RNA 7 1 and suggested for the XIST 72-74 and HOTAIR 75
lincRNAs. The hypothesis that lincRNAs serve as flexible scaffolds could explain the uneven
patterns of evolutionary conservation seen across the length of lincRNA genes6: the more highly
conserved patches could correspond to regions of interaction with protein complexes.
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While a model of lincRNAs acting as 'flexible scaffolds' is attractive, it is far from
proven. Testing the hypothesis for lincRNAs will require systematic studies, including defining
all protein-complexes with which lincRNAs interact, determining where these protein
interactions assemble on RNA, and ascertaining whether they bind simultaneously or
alternatively. Moreover, understanding how lincRNA-protein interactions give rise to specific
patterns of gene expression will require determination of the functional contribution of each






Figure 7: A model for lincRNA integration into the molecular circuitry of the cell. ESC-
specific transcription factors (such as Oct4, Sox2, and Nanog) bind to the promoter of a lincRNA
gene and drive its transcription. The lincRNA can then bind to different ubiquitous regulatory
proteins, giving rise to cell-type specific RNA-protein complexes. Through different
combinations of protein interactions, the lincRNA-protein complex can give rise to unique
transcriptional programs. Right: A similar process may also work in other cell types with specific
transcription factors regulating expression of lincRNAs, creating cell-type-specific RNA-protein






V6.5 and Nanog-Luciferase 49 cells were co-cultured with irradiated C57BL/6 MEFs
(GlobalStem; GSC-6002C) on pre-gelatinized plates as previously described 76 . Briefly, cells
were cultured in mES media consisting of knock-out DMEM (Invitrogen; 10829018)
supplemented with 10% FBS (GlobalStem; GSM-6002), 1% penicillin-streptomycin (Invitrogen;
15140-163), 1% L-glutamine (Invitrogen; 25030-164), 0.001% Beta-mercaptoethanol (Sigma;
M3148-100ML) and 0.01% ESGRO (Millipore; ESG 1106).
Picking lincRNA gene candidates
Using our previous catalogue of K4-K36 defined lincRNAs5 along with the reconstructed full-
length sequences we determined using RNA-Seq 6, we designed shRNA hairpins targeting each
lincRNA identified in both sets. Specifically, we used the conservative K4-K36 definitions from
our previous work5 that were expressed in mouse ES cells. We further filtered the list to include
only multi-exonic lincRNAs that were reconstructed in mouse ES cells6 . Together, this yielded
237 lincRNA genes.
Picking protein-coding gene candidates
We selected protein coding gene controls consisting of both transcription factors and chromatin
proteins. These proteins were selected based on their well-characterized role in regulating mouse
ES cells and include Pou5fl (Oct4)5'77, Sox2 29,78 , Nanog48'79, Stat323 , Klf480, and Zfp42
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(Rex 1)8 1. In addition, we selected additional transcriptional and chromatin regulators that were
identified by RNAi screens as regulators of pluripotency 29,32,36 and/or were found in smaller
focused studies to have critical roles in the maintenance of the pluripotent state (such as Carm182
Chdl 83, Thap 118, Suz12 30,31,s, and Setdb133,34). A full list is provided in Supplemental Table 4.
shRNA Design Rules
For each lincRNA we designed 5 hairpins by extending the previously described design rules 35
accounting for the sequence content of the hairpin, miRNA seed matches, uniqueness to the
target compared to the transcriptome and the genome, and number of lincRNA isoforms covered.
For each lincRNA we enumerated all 21-mer sub-sequences as follows: (i) A "clamp score" was
computed by looking at the nucleotides at positions 18, 19, and 20. If all three positions
contained an A/T it was assigned a score of 4, if two positions were A/T it was assigned a score
of 1.5 and if one was A/T it was assigned a score of 0.8. We then looked at positions 16, 17, and
21 if all 3 were A/T it was assigned a score of 1.25, if 2 were A/T it was assigned a score of 1.1,
and if 1 was A/T is was assigned a score of 0.8. The clamp score was computed as the product of
these two scores. (ii) A "GC score" was computed by looking at the total GC percentage of the
21-mer sequence. If the sequence was <25% GC it was assigned a score of 0.01 if it was <55% it
was assigned a score of 3, if it was <60% it was assigned a score of 1, and if >60% it was
assigned a score of 0.01. (iii) A "4-mer penalty" of 0.01 was assigned for any hairpin containing
the same nucleotide in 4 subsequent nucleotides. (iv) A "7 GC penalty" of 0.01 was assigned to
any hairpin containing any 7 consecutive G/C nucleotides. (v) We removed all hairpins
containing an A in either position 1 or position 2 of the hairpin. (vi) We removed all hairpins
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containing a repeat masked nucleotide. (vii) Finally, we computed a "miRNA-seed penalty" by
looking at the forward positions 11-17, 12-20, and 13-19 of the hairpin as well as the reverse
complement of positions 14-20, 15-2 1, or 16-21 plus a 3' C. We then looked up whether these
positions matched known miRNA seeds and with what frequency. We computed the scores for
the forward and reverse positions and defined the score as the product of the forward and reverse
scores. The final score for each hairpin sequence is defined as the product of all seven scores
values.
We then sorted the candidate hairpin sequences by score, breaking high scoring ties by
the total number of lincRNA isoforms that are covered by the hairpin. We then aligned each
hairpin sequence against both the genome and the RefSeq-defined transcriptome (NCBI Release
39), and filtered any hairpin with fewer than three mismatches to any other gene or position in
the genome. Candidate sequences were chosen for shRNA production by first picking the highest
scoring candidate and then proceeding to successively lower scores. As each hairpin was
selected, all other hairpins overlapping this hairpin were removed. We repeated this process until
we identified 5 hairpins that covered each lincRNA.
shRNA cloning and virus prep
We designed 1,144 hairpins targeting 237 lincRNA genes. Of these, we successfully cloned 1087
hairpins targeting 223 lincRNAs. These hairpins were cloned into a vector containing a
puromycin resistance gene and incorporated into a lentiviral vector as previously described35.
Briefly, synthetic double stranded oligos that represent a stem-loop hairpin structure were cloned
into the second-generation TRC (the RNAi Consortium) lentiviral vector, pLKO.5; the
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expression of a given hairpin produces shRNA that targets the gene of interest. Lentivirus was
prepared as previously described 35 . Briefly, 100ng of shRNA plasmid, 100ng of packaging
plasmid (psPAX2) and lOng of envelope plasmid (VSV-G) were used to transfect packaging
cells (293T) with TranslT-LT1 (Mirus Bio). Virus was harvested 48 and 70 hours post-
transfection. Two harvests were combined. Virus titers were measured as previously described3 s
Briefly, we measured virus titers by infecting A549 cells with appropriately diluted viruses. 24
hours post infection, puromycin was added to a final concentration of 5ug/ml and the selection
proceeded for 48 hours. The number of surviving cells, which is correlated to virus titer, was
measured by alamarBlue (BioSource) staining utilizing the Envision 2103 Multilabel plate reader
(PerkinElmer)
Infection and selection protocol
V6.5 ES cells were plated at a density of 5000 cells/well in 100ul mES media onto pre-
gelatinized 96-well dishes (VWR; BD356689). Cells were infected with 5ul of a lentiviral
shRNA stock and incubated at 37'C for 30 minutes. Puromycin resistant DR4 MEFs
(GlobalStem; GSC-6004G) were then added to the plates at a density of -6000/well and
incubated overnight at 37'C, 5% C02. After 24 hours, all media was removed from the cells
and replaced with media containing lug/mL puromycin. Media was then changed every other
day with fresh media containing lug/mL puromycin. The end-point depended on the assay and




ES cells were infected and lysed at day 4 with 150ul of Qiagen's RLT buffer and 3 replicates of
each virus plate were pooled for RNA extraction using Qiagen's RNeasy 96-well columns
(74181). RNA extraction was completed following Qiagen's RNeasy 96-well protocol with the
following modifications: 450ul of 70% ethanol was added to 450ul total lysate prior to the first
spin. An additional RPE wash was added to the protocol, for a total of 3 RPE washes.
lincRNA primer design and prescreen
lincRNA primers were designed using primer3 (http://frodo.wi.mit.edu/primer3/). Specifically,
we designed primers spanning exon-exon junctions by specifying each of the regions as
preferred inclusion regions in the primer3 program. When a low scoring primer pair (primer
penalty <1) was available it was used. If none was available, we then identified all primers that
contained amplicons that spanned an exon-exon junction. In a few cases, when we could not
identify a primer pair spanning an exon-exon junction, we designed primers within an exon of
the lincRNA. For each primer pair, we tested the specificity against the transcriptome85 (Ref Seq
NCBI Release 39) and the genome (Mouse MM9) using the isPCR (http://genome.ucsc.edu/cgi-
bin/hgPcr) program. Specifically, we required that the primer pair amplify the lincRNA gene and
no other genomic of gene amplicon.
For each primer pair, we validated the quantification and specificity prior to use.
Specifically, we tested primers in qPCR reactions using a dilution series of mouse ES cDNA
including a no reverse transcriptase (RT) sample. We excluded any primer that did not have
robust quantification across a 64-fold dilution curve, had high signal in the no RT sample, or had
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low detectable expression in the undiluted sample (cycle number >34). For primers that failed
this validation we redesigned and tested new primers.
Knockdown validation using qPCR
To determine if lincRNA hairpins were effective at knocking down the lincRNA of interest, we
infected each hairpin into mouse embryonic stem cells, selected for lentiviral integration, and
measured changes in the targeted lincRNA expression level. We isolated total cellular RNA after
4 days; this time-point was chosen to allow for identification of robust changes while minimizing
secondary effects due to differentiation of the ES cells. We reasoned that this would allow us to
determine more direct effects due to RNAi rather than to differentiation.
Gene panels were constructed that contained all 5 hairpins targeting a gene along with an
empty vector control pLKO.5-nullT and the GFP-targeting hairpin clonetechGfp_437s1ci.
cDNA was generated using lOul of RNA and lOul of 2x cDNA master mix containing 5x
Transcriptor RT Reaction Buffer (Roche), DTT, MMLV-RT (Roche), dNTPs (Agilent; 200415-
51), Random 9-mer oligos (IDT), Oligo-dT (IDT) and water. cDNA was diluted 1:9 and
quantitative PCR was performed using 250 nM each primer in 2x Sybr green master mix (Roche)
and run on a Roche Light-Cycler 480. Target lincRNA expression and GAPDH levels were
computed for each panel. lincRNA expression levels were normalized by GAPDH levels and this
normalized value was compared to the reference control hairpins within the panel. Knockdown
levels were computed as the average of the fold decrease compared to the two control hairpins.
Hairpins showing a knockdown greater than 60% of the endogenous level were considered
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validated and the best validated hairpin from a lincRNA panel was selected for subsequent
studies.
Picking candidates for microarray analysis
To assess the effects of a lincRNA on gene expression, we profiled the changes in gene
expression after knocking down each lincRNA gene. Specifically, for each lincRNA with at least
1 validated hairpin we profiled the genome-wide expression level changes after knockdown
across 2 independent infections (see above). To control for expression changes due to viral
infection, we performed five independent infections containing no RNAi hairpin (pLKO.5-
nullT). This control hairpin was embedded in each RNA prep plate. To control for effects due to
an off-target RNAi effect, we profiled 27 distinct negative control hairpins which do not have a
known target in the cell. These hairpins included 6 RFP hairpins, 10 GFP hairpins, 6 Luciferase
hairpins, and 5 LacZ hairpins. These hairpins provide a measurement of the variability of the
RNAi response triggered due to non-specific effects. Furthermore, we profiled hairpins targeting
147 lincRNAs, including 10 with a second best hairpin, and 40 protein-coding genes in
biological replicate. The hairpins and their replicates were randomly distributed across 7 96-well
plates and prepared in batches. Each RNA preparation batch contained 1 pLKO hairpin and 1
clonetechGfp_437slc1 hairpin in a random location on the plate. To minimize batch effects, the
plate locations of the biological replicates were scrambled and the positions within the plates
were scrambled for all hairpins and replicates.
Agilent Microarray hybridization
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Using Agilent's One-Color Quick Amp Labelling kit (5190-0442), we amplified and labelled
total RNA for hybridization to prototype mouse lincRNA arrays (G4140-90040) according to
manufacturer's instructions with a few variations. The custom Agilent SurePrint G3 8x60K
mouse array design used for this study (G4102A, AMADID 025725 G4852A) has probes to
21,503 Entrez genes and 2,230 lincRNA genes. A new updated version of this mouse design is
commercially available that contains probes to 34,017 Entrez gene targets as well as 2,230
lincRNA genes (G4825A). The cRNA samples were prepared by diluting 200ng of RNA in
8.3ul water and adding positive control one-color RNA spike-in mix (Agilent, 5188-5282) that
was diluted serially 1:20, then 1:25 and finally 1:10. We annealed the T7 promoter primer from
the kit by incubating at 65'C for 10 minutes. We prepared the cDNA master mix and added to
the annealed RNA and incubated at 40'C for 2 hours, followed by 65'C for 15 minutes. We
prepared the cRNA transcription master mix and added it to the cDNA and incubated at 40'C for
2 hours protected from light. We purified the labeled cRNA using Qiagen's RNeasy 96-well
columns (Qiagen, 74181) by adding 350ul of Qiagen RLT (without BME) to the cRNA followed
by the addition of 250ul of 95% ethanol before applying to the plate column. After a 4 minute
spin at 6000RPM, we washed the columns 3 times with 800ul buffer RPE. We dried the columns
by spinning for 10 minutes and eluted the cRNA with 50ul of water. We measured the cRNA
yield and dye incorporation using the Nanodrop 8000 Microarray measurement setting. We
mixed 600ng of cRNA with blocking agent and fragmentation buffer (Agilent, 5190-0404) and
fragmented for 30 minutes in the dark at 60'C. We added 2x Hybridization Buffer to each
sample and loaded 40ul onto an 8-pack Hybridization gasket. We placed the microarray slides
on top, sealed in the Hybridization Chamber, and incubated for 18 hours at 65'C. We washed
the slides for 1 minute in room temperature GE Wash Buffer 1 and then for 1 minute in 370 C GE
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Wash Buffer 2 (Agilent 5188-5327, no triton addition). We scanned the microarrays using an
Agilent Scanner C (G2565CA) using the following settings: Dye Channel = Red&Green, Scan
Region = ScanArea (61x21.6mm), Scan Resolution = 3gm. We prepared all of the samples
simultaneously using homogenous master mixes to limit variability. Fragmentation and
hybridization was staggered over time in batches of 3 to 4 slides (24 to 32 samples).
Array filtering, Normalization, and Probe filtering
Each array was processed and data extracted using the Agilent feature extraction software
(G4462AA, Version 10.7.3). Samples were retained if they passed all the following quality
control statistics:
AnyColorPrcntFeatNonUnifOL<1,
eQCOneColorSpikeDetectionLimit >0.01 and <2.0,
MetricabsGElElaSlope between 0.9 and 1.2,
Metric-gE 1 aMedCVProcSignal <8,






SpotAnalysisPixelSkewCookiePct >0.8 and <1.2
Gene expression values were determined using the gProcessedSignal intensity values. Probes
were flagged if they were not detectable well above background or had an expression level lower
than the lowest detectable spike-in control value. The values were floored across all samples by
taking the maximum of the minimum non-flagged values across all experiments. Any value less
than this maximum value were set to the maximum. This conservatively eliminates any detection
variability across the samples due to stringency or other array variables.
The result of this is a single value for each probe per array. To normalize expression
values across arrays, we performed quantile normalization as previously described 86 . Briefly, we
ranked each array from lowest to highest expression. For each rank, we computed the average
expression and each experiment with this value at the associated rank. For each probe, we
computed the difference between the second smallest expression value and the second largest
expression value. If this difference was less than 2, we filtered the probe. This metric was chosen
to eliminate bias due to single sample outliers.
Identifying significant gene expression hits from RNAi KDs
To control for effects due to non-specific effects of shRNAs, we profiled 27 distinct
negative control hairpins which do not have a known target in the cell. These hairpins provide a
measurement of the variability of the expression profiles due to random variability or triggered
by 'off-target' effects of the shRNA lentiviruses. Assuming that any observed effects in the
negative control hairpins are due to 'off-target' effects and observed effects in the targeting
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hairpins include a mix of both 'off-target' effects and 'on-target' effects, we use permutations of
the negative controls to assign a false discovery rate (FDR) confidence level for being an 'on-
target' hit to each gene. As such, a gene would only reach genome-wide significance if the
number of genes and scale of the effect was much larger than would be observed randomly
among all of the expression changes found for the negative control hairpin.
Specifically, for each gene we computed a t-statistic between shRNAs targeting the
lincRNA and control shRNA samples. To assess the significance of each gene we permuted the
sample and control groups retaining the relative sizes of the groups and computing the same t-
statistic. We then assigned an FDR value to each gene by computing the average number of
values in the permuted t-statistics that were greater than the observed value of interest and
divided this by the number of all observed t-statistics that were greater than the observed value.
We defined genes as significantly differentially expressed if the FDR was <5% and the fold-
change compared to the negative controls was >2-fold. Using this approach, an effect would
only reach a significant FDR if the scale is significantly larger than would be observed in the
negative controls. Knockdown of a lincRNA was considered to have a significant effect of gene
expression if we identified at least 10 genes that had an effect that passed all of the criteria.
Gene-Neighbour analysis
We identified neighbouring genes based on the RefSeq genome annotation85 (NCBI Release 39).
We excluded from analysis all RefSeq genes that corresponded to our lincRNA of interest but
included all other coding and non-coding transcripts. We identified a significant hit as any
lincRNA affecting a neighbour within 10 genes on either side with an FDR<.05 and 2-fold
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expression change. To compute the closest affected neighbour, we classified all genes affected
upon knockdown of the lincRNAs using the same criteria above. We computed the distance
between each affected gene and the locus of the lincRNA gene (and protein-coding gene) that
was perturbed and took the minimum absolute distance across all affected genes.
Analysis of expected number of neighbouring genes that will change by chance
To determine the expected number of differentially expressed "neighbouring" genes occurring
by chance assuming that the knockdown has no effect on gene expression, we calculated the
average number of genes in a 300Kb window around a randomly selected gene in the human and
mouse genome. We calculated this to be 11.2 (human) and 11.8 (mouse). For simplicity, we will
conservatively round this down to 11. Assuming that no genes are changing between the
knockdown and control, using a nominal p-value, which has a uniform distribution under the null
hypothesis (nothing effected), we would expect to see a difference called in 5% of cases at a p-
value of 0.05. If we test one locus, which has on average 11 neighbours we would expect to
identify 0.55 hits by chance (11 x 0.05=0.55). However, if we now test 12 loci we would expect
to see 6.6 (12 x 0.55) knockdowns which appear to have an effect under the null hypothesis.
Luciferase analysis of Nanog ES lines
ES cells containing a Nanog-Luciferase construct4 9 were infected in biological duplicate and
monitored after 7 days. Luciferase activity was measured using Bright-Glo (Promega). All
reagents and cells were equilibrated to room temperature. 100ul Bright-Glo solution was added
to each plate well. Plates were incubated in the dark at room temperature for 10 minutes and
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luciferase was measured on a plate reader. The luciferase units were normalized to the control
hairpins and a z-score compared to the negative controls (excluding luciferase hairpins) was
computed. For each hairpin, we computed a Z-Score relative to the negative control hairpins and
identified hits reducing Luciferase levels more than 6 standard deviations (Z<-6) for both
independent replicates. In all cases we were able to identify a significant reduction in luciferase
levels when using distinct hairpins targeting luciferase. To exclude hits that were due to an
overall reduction in proliferation (which would also cause a reduction of nanog positive cells in
this read-out) we excluded all hairpins that caused a reduction in proliferation as measured by
AlamarBlue incorporation (described below). AlamarBlue incorporation was measured in the
same cells immediately before reading out Nanog-Luciferase levels.
AlamarBlue analysis of ES lines
After a 7 day infection, Nanog-Luciferase cell viability was measured using AlamarBlue
(Invitrogen; DAL 1025). AlamarBlue was mixed with mES media in a 1:10 ratio, added to the
cells and incubated at 37'C for 1 hour. Absorbance readings at 570nm were taken. To control
for possible effects due to virus titer, we measured AlamarBlue incorporation on both puromycin
treated and non-puromycin treated samples for each infection.
Immunofluorescence
We crosslinked cells in 4% paraformaldehyde for 15 minutes, and washed in 1x PBS three times.
To permeabilize the cells, we washed with lx PBS + 0.1% Triton and then blocked in 1x PBS +
0.1% Triton + 1% BSA for 45 minutes at room temperature. We incubated cells with a-Pou5f 1
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antibody (Santa Cruz: SC-908 1) at 1:100 dilution in blocking solution for 1.5 hours at room
temperature and then washed in blocking solution three times. Next, we incubated cells in a-
rabbit secondary antibody coupled to GFP (Jackson ImmunoResearch: 111-486-152) at a
dilution of 1:1000 in blocking solution for 45 minutes. Finally, we thoroughly washed cells in
blocking solution three times, and added vectashield containing DAPI (VWR: 101098-044) to
each well.
Public Dataset curation
Traditionally, lineage markers are used to identify changes in phenotypic states. While
these markers can be good indicators of differentiation potential, there are two major limitations
with this approach. First, there are multiple genes that are associated with each lineage so simply
looking at one can often be misleading. Second, this approach only works for classifying states
with well-characterized marker genes but would not work for a comprehensive characterization
of the function in the cell. Therefore, we decided to take a different approach and look at the
entire gene expression profile of each lincRNA knockdown to determine what cell state each
lincRNA resembles.
We curated a set of ES perturbations and differentiation states from publicly available
sources. Specifically, we utilized the NCBI e-utils (http://eutils.ncbi.nlm.nih.gov/) to
programmatically identify all published datasets containing keywords associated with embryonic
stem cells. We filtered the list to only include mouse data sets that were generated across one of
three commercial array platforms (Affymetrix, Agilent, and Illumina). Following this approach,
we manually curated the list to include datasets associated with ESC perturbations (genetic
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deletions, RNAi, or chemical perturbations) and differentiation or induced differentiation
profiles. This curation yielded 41 GEO datasets corresponding to >150 samples.
Specifically, we defined differentiation lineage states using the following datasets.
1. Neuro-ectoderm. We downloaded a dataset (GSE12982) corresponding to mouse ES
cells containing a Sox 1 -GFP reporter construct. Upon differentiation of Sox 1 -GFP ES
cells into Embryoid bodies (EBs), Sox1-GFP positive cells were collected and their
global expression was profiled5. In addition, we downloaded a dataset (GSE4082)87
corresponding to direct neuroectoderm differentiation88.
2. Mesoderm. We downloaded the same dataset (GSE12982) as above, where the authors
differentiated Brachyury-GFP reporter ES cells into EBs and sorted and profiled
50Brachyury-GFP positive cells
3. Endoderm. We downloaded a dataset (GSE 11523) corresponding to mouse ES cells
which were engineered to overexpress GATA65 1 . GATA6 overexpression has been
shown to drive ES cells into a primitive endoderm-like state 9.
4. Ectoderm. We downloaded a dataset (GSE4082) 87 corresponding to mouse ES cells
differentiated into primitive ectoderm like cells with defined media 8.
5. Trophectoderm. We downloaded a dataset (GSE11523)51 corresponding to mouse ES
cells which were engineered to deplete Oct457. These cells have been shown to enter a
trophectoderm-like state57 . To ensure specificity to the trophectoderm state, we also
compared the expression effects to trophoblast stem cells. For all lincRNAs identified,
we required a significant enrichment for both induced Oct4 knock-out and trophoblast
stem cell programs.
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In addition, for all lineage states we utilized a curated discrete gene expression signature of
differentiation which was previously functionally tested and shown to correspond specifically
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to differentiation into the associated states
Continuous enrichment analysis and Phenotype-projection analysis
To determine relationships between lincRNA knockdowns and functional states, we
employ a modified Gene Set Enrichment Analysis5 5 approach that accounts for the continuous
nature of the two datasets, similar to previously described extensionsss,56,90. For each lincRNA
knockdown by functional pair we compute a continuous enrichment score. Specifically, (i) for
each lincRNA knockdown we compute a normalized score matrix compared to a panel of
negative control hairpins by computing a t-statistic for each gene between the replicate lincRNA
knockdown expression values and the control knockdown values. (ii) For each experiment, we
sort the matrix by the normalized score such that the most differentially expressed upregulated
gene is first and the most differentially expressed downregulated genes is last. Using this
ordering we sort the functional dataset such that the ordering corresponds to the differential rank
of the lincRNA knockdown set. (iii) We compute a score Si as the running average of values
from the first position to position i. We then define the enrichment score E as the maximum of
the absolute value of Si for all values of i> 10. We require i>10 to avoid small fluctuations in the
beginning of the ranked list causing fluctuations in the enrichment score. This score is computed
for each lincRNA knockdown by functional set. Since we have many lincRNA knockdowns and
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functional sets, in reality we have a matrix of scores and we will refer to the enrichment score of
the ith knockdown and jth functional set as Ej.
To assess the significance of these scores, we compute a permutation derived false
discovery rate and assign a confidence value for each projection. Specifically, to assess the
significance of E1, we permute the lincRNA knockdown samples and control samples and
compute the enrichment score for each pair across all permutations. To account for the false
discovery rate associated with many lincRNAs and functional sets, we use the values of all
permutations directly to assess the FDR level of E3. Specifically, to assess the FDR for each
enrichment value Eg, we accumulate all the permutation values for all lincRNA knockdowns and
functional sets and compute the number of values greater than Egj as well as a vector of values
greater than E1 corresponding to each permutation. The FDR is computed as the average number
of permuted values greater than Ey divided by the observed number greater than E1. Using this
approach, we assign an FDR value to each lincRNA knockdown by functional set and identify
significant hits as those with an FDR<0.01.
To highlight the accuracy of this approach, we observed that for publicly available gene
perturbations for which we also perturbed the gene we were able to identify a significant
association of target genes in -75% of cases. While the remaining few did not pass our
conservative significance criteria, they also showed increased enrichments consistent with their
common effects. In addition, the projected effects are highly reproducible across distinct
experiments originating from many groups and across multiple expression platforms.
Highlighting the specificity of this approach, we note that there are many profiles for which no
lincRNA had a similar effect.
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Analysis of gene-expression overlaps between independent hairpin knockdowns
To determine whether independent hairpins targeting the same lincRNA gene share common
gene targets, we computed a continuous enrichment score described above. Briefly, we
computed a t-statistic for both hairpins against the negative controls. We then took the second
best hairpin and sorted the genes. We scored the best hairpin affected genes based on this ranked
order. We assessed the significance of this enrichment by permuting the samples and controls
and assigned an FDR of the overlap of the expression effect (as described above).
Discrete gene set analysis
Discrete gene sets were analysed using the Gene Set Enrichment Analysis with a slight
modification to the scoring procedure to be more analogous to our continuous scoring procedure
(described above). Specifically, we computed the average of the expression changes (defined by
the t-statistic) for all genes within the discrete gene set upon knockdown 4 . Significance was
assessed by permuting the control and sample labels and recomputing the average statistic for
each permutation. The FDR was assessed off of these values as described above.
Lineage marker gene analysis
We curated lineage marker gene sets from published work and publicly available sources29 535 4
We identified lineage marker genes as significantly upregulated using the differential expression
criteria outlined above. We validated the expression of these lineage marker genes for a selected
set of lineage marker genes using qPCR (as described above) after an 8-day infection.
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Specifically, we looked at the expression of FGF5 (ectoderm), SoxI (neuroectoderm), Sox17
(endoderm), Brachyury (mesoderm), and Cdx2 (trophectoderm). Expression estimates were
normalized to GAPDH and compared to a panel of 25 negative control hairpins.
Identifying bound lincRNA promoters
We obtained genome-wide transcription factor binding data in mouse ES cells from 2 sources.
The transcription factors Oct4, Sox2, Nanog, and Tcf3 were downloaded from the Gene
Expression Omnibus (GSE11724) and the cMyc, nMyc, Zfx, Stat3, Smadl, Klf4, and Esrrb from
GEO (GSE11431). For each ChIP-Seq dataset, the raw reads were obtained from the SRA
(http://www.ncbi.nlm.nih.gov/sra) and processed as follows. (i) The reads were all aligned to the
mouse genome assembly (build MM9) using the Bowtie aligner91 , requiring a single best
placement of each read. All reads with multiple acceptable placements were removed from the
analysis. (ii) Binding sites were determined from the aligned reads using the MACS92
(http://liulab.dfci.harvard.edu/MACS/) algorithm using the default parameters with -mfold 8 to
account for varying read counts in the libraries. (iii) lincRNA promoter regions were defined as
previously described5,6 using the location of the K4me3 peaks overlapping or within 5Kb of the
transcriptional start site determined by RNA-Seq reconstruction. (iv) The transcription factor
binding locations and lincRNA promoter locations were intersected and the enrichment level of
the peak overlapping a lincRNA promoter was assigned transcription factor binding enrichment
for each lincRNA. We defined transcription factor binding locations for protein-coding genes in
a comparable way. (v) To exclude the possibility that some of this binding might be due to
transcription factor binding at distal enhancers, we excluded all binding events that showed
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evidence of P300, a protein associated with active enhancers 93, localization. Altogether, we only
identified -5% of promoters overlapping with any P300 enrichment signal, a slightly lower
percentage than identified for protein-coding gene promoters with detectable P300 signal.
Identifying TF-regulated lincRNA genes
lincRNA probes on the Agilent microarray were analysed using the differential expression
methodology described above after knockdown of the transcription factor and comparison to the
negative control hairpins. To confirm the expression changes of these lincRNAs, we hybridized
12 transcription factor knockdowns on a custom lincRNA codeset using the Nanostring nCounter
assay . The knockdowns were profiled in biological duplicate along with 15 negative controls.
Regulated lincRNAs were identified using the differential expression approach described above.
Nanostring probeset design
Nanostring probes against lincRNA genes were designed following the standard nanostring
design principles with the following modifications specifically for the lincRNA probes. (i) To
exclude possible cross-hybridization, probes were screened for cross-hybridization against both
the standard mouse transcriptome as well as a background database constructed from all the
lincRNA sequences. (ii) To account for isoform coverage, a first pass design attempted to select
a probe that would target as many isoforms as possible for each lincRNA. In cases where it was
not possible to target all isoforms for a given lincRNA, the probe that targeted the largest number
was selected, and additional probes were chosen when possible to target the remaining isoforms.
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(iii) The standard restrictions on Tm and sequence composition were relaxed to include probes
for as many lincRNAs as possible.
RA differentiation
V6.5 cells were cultured on gelatin-coated dishes in mES media in the absence of LIF. 5[tM of
retinoic acid was added daily and cell samples were taken daily for 6 days. RNA was extracted
using Qiagen's RNeasy spin columns following the manufacturer's protocol.
Western blots
30ug of mESC nuclear protein extracts were run on 10% Bis-Tris gels (Invitrogen NPO316BOX)
in MOPS buffer (Invitrogen NPOOO1) at 75 volts for 20 minutes followed by 120 volts for 1
hour. Gels were incubated for 30 minutes in 20% methanol transfer buffer (Invitrogen NP0006-
1) and transferred onto PVDF membranes (Invitrogen 831605) at 20 volts for 1 hour using the
Bio-Rad semi-dry transfer system (170-3940). Membranes were blocked in Blotto (Pierce,
37530) at room temperature for 1 hour. Antibodies were diluted in Blotto and membranes were
incubated overnight at 4'C. Antibodies were diluted in using the following concentrations. Ezh2
1:2000, Suz 12 1:5000, hnRNPH 1:1000, Ruvbl2 1:1000, Jarid lb 1:500, HDAC 11:250, Cbx6
1:500, YY1 1:500. All antibodies tested were raised in rabbit. The next day, membranes were
washed 3x in 0.1% TBST for 5 minutes each. The membranes were probed with anti-Rabbit-
horse radish peroxidase (GE Healthcare; NA9340V) at a 1:10,000 dilution, washed 3x in 0.1%
TBST, incubated in ECL reagent (GE Healthcare RPN2132), and exposed.
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Crosslinked RNA immunoprecipitation
V6.5 mES cells were fixed with 1% formaldehyde for 10 minutes at room temperature,
quenched with 2.5M glycine, washed with 1x PBS (3x) harvested by scraping, pelleting, and
resuspended in modified RLPA lysis buffer (150mM NaCl, 50mM Tris, 0.5% Sodium
deoxycholate, 0.2% SDS, 1% NP-40) supplemented with RNase inhibitors (Ambion, AM2694)
and protease inhibitors. For UV crosslinking experiments, cells were irradiated with 254nm UV
2light. Cells were kept on ice and crosslinked in lx PBS using 400,000 [joules/cm.
Cell suspension was sonicated using Branson 250 Sonifier for 3 x 20 s cycles at 20%
amplitude. lOul of Turbo DNase (Ambion, AM2238) was added to sonicated material, incubated
at 370 C for 10 minutes, and spun down at max speed for 10 minutes at 4'C. Protein-G beads
were washed and pre-incubated with antibodies for 30 minutes at room temperature. Lysate and
beads were incubated at 4'C for 2 hours. Beads were washed 3x using the following wash buffer
(lx PBS, 0.1% SDS, 0.5% NP-40) and crosslinks were reversed and proteins were digested with
5ul proteinase-K (NEB, P8102S) at 650 for 2-4 hours. RNA was purified using
phenol/chloroform/isoamyl alcohol and RNA was precipitated in isopropanol.
Nanostring hybridization
500ng of total RNA was hybridized for 17 hours using the lincRNA codeset. The
hybridized material was loaded into the nCounter prep station followed by quantification on the
nCounter Digital Analyzer following the manufacturer's protocol. For RNA
immunoprecipitation experiments, we used a modified protocol. After reverse crosslinking, RNA
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was extracted using phenol/chloroform and ethanol precipitation methods and resuspended in
1Oul of H20. Sul of the eluted material was hybridized for 17 hours using the lincRNA codeset.
Nanostring analysis
Probe values were normalized to negative control probes by dividing the value of the probe by
the maximum negative control probe. Probe values were floored to a normalized value of 3 (3-
fold higher than maximum negative control). Probes with no value greater than this floor across
all samples were removed from the analysis. The values were log transformed. To control for
variability between runs and different input material amounts, we normalized all samples
simultaneously using the quantile normalization approach described above. The result is a set of
normalized log-expression values for each probe normalized across all experiments.
Validation of RNA immunoprecipitation methods
To validate our formaldehyde based RNA immunoprecipitation method we immunoprecipitated
the RNA binding protein hnRNPH, which plays a role in mRNA splicing9 4 and identified the
associated RNAs. Consistent with known interactions, we identified a strong enrichment for its
binding to intronic regions of mRNA genes. We validated these observed results in mouse ES
cells by performing UV-crosslinking experiments 95-97 and identified nearly identical results. We
identified a similar correlation between the UV and formaldehyde crosslinked samples as for
biological replicates of UV crosslinked samples and formaldehyde crosslinked samples and
highly comparable enrichments (Supplemental Figure 13).
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Antibody Selection
We selected chromatin proteins that have been implicated in regulation of the pluripotent
state along with their known associated 'reader', 'writer', and 'eraser' complexes. Specifically,
we tested antibodies against 40 chromatin proteins, corresponding to 28 chromatin complexes. In
many cases, we tested multiple antibodies against the same target protein to try and identify an
antibody that worked well for immunoprecipitation. A full list of tested complexes and their
associated antibodies are listed in Supplemental Table 20.
Determining significant chromatin-lincRNA enrichments
We tested each antibody using formaldehyde crosslinked cells and had a two-step
procedure for considering an antibody successful. (i) We tested all selected antibodies in batches,
with each batch containing a mock-IGG (Santa Cruz) negative control and hnRNPH (Bethyl)
positive control. Batches with variability in either the mock-IGG or hnRNPH controls were
excluded and retested. For each successful batch, we computed enrichment for each lincRNA
between the tested antibody and mock-IGG. We considered an antibody successful in the first
step if the highest enrichment level exceeded a 5-fold change compared to the mock-IGG control
and more than 10 lincRNAs exceeded this threshold. While this approach can yield false
positives (antibodies that pass but are not efficient) it significantly reduced the number of
antibodies to be tested in the next step. (ii) For all antibodies that successfully passed the first
criteria, we performed immunoprecipitation on two additional biological replicates along with 4
mock-IGG controls. We computed a t-statistic for each lincRNA compared to the controls and
252
assessed the significance using a permutation test, by permuting the samples and IGG samples
(as above). Hits were considered significant if they exceed a t-statistic cutoff of 2 (log scale)
compared to the controls and had an FDR<0.2. We allowed a slightly higher FDR cutoff since
the number of permutations was far smaller yielding lower power to estimate the FDR. Only
antibodies yielding significant lincRNAs were considered successful. In total, we identified 12 of
the 28 complexes (55 antibodies) with at least one successful antibody.
Determining significant overlaps between lincRNA and chromatin protein knockdown
effects
To determine the functional overlap between the lincRNA and the chromatin complexes it
physically interacts with, we compared the effects on gene expression upon knockdown of the
lincRNA and the associated protein complex. To do this, we utilized the gene expression profiles
determined for each lincRNA knockdown and knockdowns of 9 of the 12 identified chromatin
complexes for which we had good hairpins. We defined each interaction between a lincRNA and
protein, and compute a continuous enrichment score, generated all permutations of the control
hairpins and sample hairpins and assigned a false discovery rate to the scores (as described
above). At an FDR<0.05 we identified 43% of the interactions to be significant. For 69% of the
interactions, we were able to identify an overlap at an FDR<O. 1.
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Chapter 6: Future Directions
In this chapter, we describe the outlook for the future of large ncRNA research.
Parts of this work were first published as:




Large ncRNAs as scaffolds of proteins
One emerging theme for many large ncRNAs is the formation of multiple distinct RNA-
protein interactions to carry out their role (Figure 1). An initial clue for this phenomenon came
from the discovery of telomerasel. Telomerase activity requires an RNA component, TERC 2,
which serves as a template for telomeric regulation and as a scaffold for the polymerase enzyme
around the RNA3 (Figure 1b). Importantly, genetic studies demonstrated that the RNA plays a
modular functional role as genetically swapping particular domains of the RNA retained the
overall function4 . This demonstrated that the RNA was made up of discrete functional modules
that simply needed to be brought into proximity.
More recently, HOTAIR has been shown to contain distinct protein-interaction domains
that can associate with PRC25 and the CoREST/LSD 1 complex6, which together enable its
function (Figure 1b). XIST also contains discrete functional domains. Through a series of
genetic deletions it was demonstrated that XIST contains at least two discrete domains
responsible for silencing (RepA) and localization (RepC)7 (Figure 1b). These functional
domains could be independently deleted without affecting the role of the other domain, thus
suggesting the modularity of the RNA 7. The XIST ncRNA was also shown to have multiple
protein interaction domains; the silencing domain (RepA) binds to PRC2 and the localization
domain (RepC) binds to YYl 8 and hnRNPU 9. These examples illustrate that large ncRNAs can
act as molecular scaffolds for protein complexes. Importantly, this phenomenon may generalize,
as our recent studies have demonstrated that -30% of ESC lincRNAs associate with multiple
10
regulatory complexes.
In addition to interacting with multiple proteins, several examples of ncRNAs have been
reported to interact directly with both DNA and RNA. In a few cases, ncRNAs have been
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reported to form triplex structures with DNA' (Figure la) such as a ncRNA that binds to the
ribosomal DNA promoter and interacts with the DNMT3b protein to silence expression".
Moreover, RNA can also form traditional duplex base pairing interactions with DNA, a property
long speculated for large ncRNAs13 . Finally, RNA can form base-pair interactions with RNA
(Figure 3a), which are crucial for processes such as tRNA-mRNA anticodon recognition14,
miRNA targeting' 5 , ribosome structure as a ribozyme 16, and splicing' 7 amongst many others.
Despite these few examples, the interactions between large ncRNAs and genomic DNA and
other RNAs are not well characterized.
A Potential Modular RNA Code
Collectively, these studies suggest an intriguing hypothesis for large ncRNAs as flexible
modular scaffolds4,6,7,10. In this model, RNA contains discrete domains that interact with specific
protein complexes. These RNAs, through a combination of domains, bring specific regulatory
components into proximity resulting in the formation of a unique functional complex. These
RNA regulatory complexes can include interactions with proteins but may also extend to RNA-
DNA and RNA-RNA regulatory interactions.
RNA is well suited for such a role since RNA is a malleable evolutionary substrate
14
compared to a protein, allowing for the selection of discrete interaction domains . Specifically,
RNA can be easily mutated, tested, and selected without breaking its core functionality 4. This
model of modular interactions may explain the observation that there are highly conserved
'patches' within large RNA genes'8-20 that may have evolved for specific protein
7,21,22interactions . The remaining regions may be more evolutionarily flexible, allowing for
formation of new functional domains by random mutation and selection. This is consistent with
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the observation, based on genetic deletion experiments, that non-constrained regions of
telomerase are dispensable4.
The model of a modular scaffold is not limited to protein interaction. RNA can also base-
pair with DNA, which might be used to 'guide' complexes to specific DNA sequences.
Alternatively, RNAs might 'guide' complexes by bridging together sets of DNA-binding
proteins. Such a model could explain how the same protein complexes are 'guided' to different
DNA loci in distinct cell types.
Large ncRNAs can also form RNA-RNA interactions, raising additional intriguing
possibilities for future experimental exploration. For example, two large RNA scaffolds might be
linked through RNA-RNA interactions. Another possibility is that RNA-RNA interactions may
result in unique RNA structures that can interact with protein complexes not attainable by the
individual units. This has been observed in the ribosome, where the combination of RNA-RNA
and RNA-Protein interactions are required for proper complex formation.
Outlook
The mechanism by which large ncRNAs carry out their regulatory role is only beginning
to emerge. While a modular RNA regulatory code is an attractive hypothesis, it remains to be
tested. Specifically, how large ncRNA-Protein interactions occur and their molecular principles
remain unknown. Determining these principles will require identifying the sites of RNA-protein
interactions and the direct RNA binding proteins in vivo. Moreover, how large ncRNAs localize
to targets genes is unknown, but may involve direct RNA-DNA interactions (Figure la) or
interactions with proteins containing DNA recognition elements (as suggested for XIST 8 and
HOTAIR6). To gain insight, it will be important to catalog the interactions that ncRNAs form
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with genomic DNA and RNAs. Together, this data will help elucidate the rules guiding
interaction and the functional implications of these associations which can be tested
experimentally.
If large ncRNAs are truly modular, then each individual domain would carry out a unique
functional role independent of the other domains. Demonstrating modularity will require genetic
deletions of domains and spacer regions as well as domain swapping experiments. Learning
these principles would result in a defined 'modular RNA code' for how RNAs can affect cell
states. A true understanding of the 'modular RNA code' will allow for the creation of
synthetically engineered RNAs that can interact with both nucleic acids and protein modules to
carry out engineered regulatory roles.
In addition, large ncRNAs may work by other mechanisms that may not fit neatly into
this 'modular RNA code'. However, it is premature to dismiss large ncRNAs having other
mechanisms that may not fit neatly into this 'modular RNA code'. In the meantime, it is clear
that mammalian genomes encode a diverse cast of functional large important ncRNAs whose









1 + 2 = DHFR
1 + 3 = Hotair and Xist
1 + 4 = Ribosome
1 + 2 + 3 = Telomerase
Figure 1: Modular principles of large RNAs. (a) Four principles of nucleic acid and protein
interactions. (1) RNA-Protein interactions, (2) DNA-RNA hybridization based interactions, (3)
DNA-Protein interactions, and (4) RNA-RNA hybridization based interactions. (b) Each of these
principles can be combined to build distinct complexes. For example, combining RNA-Protein
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and RNA-DNA interactions a protein complex can be localized to a specific DNA sequence in
an RNA dependent manner as has been implicated for the DHFR99 promoter and localization of
DNMT3b98 . Combining RNA-Protein and Protein-DNA principles can also localize a diverse set
of proteins scaffolded by RNA to a specific DNA sequence in a protein dependent manner. The
ribosome is a multifaceted combination of RNA-Protein interactions that facilitate proper RNA-
RNA interactions for the ribozyme activity of the ribosome. The telomere replication activity of




1 Greider, C. W. & Blackburn, E. H. Identification of a specific telomere terminal
transferase activity in Tetrahymena extracts. Cell 43, 405-413 (1985).
2 Feng, J. et al. The RNA component of human telomerase. Science 269, 1236-1241
(1995).
3 Lingner, J. et al. Reverse transcriptase motifs in the catalytic subunit of telomerase.
Science 276, 561-567 (1997).
4 Zappulla, D. C. & Cech, T. R. Yeast telomerase RNA: a flexible scaffold for protein
subunits. Proc Natl Acad Sci USA 101, 10024-10029 (2004).
5 Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human
HOX loci by noncoding RNAs. Cell 129, 1311-1323 (2007).
6 Tsai, M. C. et al. Long noncoding RNA as modular scaffold of histone modification
complexes. Science 329, 689-693 (2010).
7 Wutz, A., Rasmussen, T. P. & Jaenisch, R. Chromosomal silencing and localization are
mediated by different domains of Xist RNA. Nat Genet 30, 167-174 (2002).
8 Jeon, Y. & Lee, J. T. YY1 Tethers Xist RNA to the Inactive X Nucleation Center. Cell
146, 119-133 (2011).
9 Hasegawa, Y., Brockdorff, N., Kawano, S., Tsutui, K. & Nakagawa, S. The matrix
protein hnRNP U is required for chromosomal localization of Xist RNA. Dev Cell 19,
469-476 (2010).
10 Guttman, M. et al. lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature 477, 295-300 (2011).
11 Schmitz, K. M., Mayer, C., Postepska, A. & Grummt, I. Interaction of noncoding RNA
with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes.
Genes Dev 24, 2264-2269 (2010).
12 Martianov, I., Ramadass, A., Serra Barros, A., Chow, N. & Akoulitchev, A. Repression
of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature
445, 666-670 (2007).
13 Lee, J. T. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers
to the epigenome. Genes Dev 23, 1831-1842 (2009).
14 Gesteland, R. F., Cech, T. & Atkins, J. F. The RNA world: the nature of modern RNA
suggests a prebiotic RNA world. 3rd edn, (Cold Spring Harbor Laboratory Press, 2006).
15 Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
(2009).
16 Korostelev, A. & Noller, H. F. The ribosome in focus: new structures bring new insights.
Trends Biochem Sci 32, 434-441 (2007).
17 Eddy, S. R. Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2, 919-
929 (2001).
18 Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature 458, 223-227 (2009).
19 Guttman, M. et al. Ab initio reconstruction of cell type-specific transcriptomes in mouse
reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol 28, 503-510
(2010).
267
20 Ponjavic, J., Ponting, C. P. & Lunter, G. Functionality or transcriptional noise? Evidence
for selection within long noncoding RNAs. Genome Res 17, 556-565 (2007).
21 Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J. & Lee, J. T. Polycomb proteins targeted by a
short repeat RNA to the mouse X chromosome. Science 322, 750-756 (2008).
22 Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global
gene repression in the p53 response. Cell 142, 409-419 (2010).
268
